Business & Finance finance assignment

PitchBook_Public_Company_Financials_2024_04_18_01_13_25.xlsx

Home >Business & Finance homework help >Business & Finance finance assignment

Key Metrics

Key Metrics (Fiscal Year)
Downloaded On: 18-Apr-2024	Summary Stats
Company: Pfizer (Pharmaceuticals) (NYS: PFE)	Median	Mean	Min	Max	25th pctile	75th pctile	Std. Dev	Coefficient of Variation	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Amounts in Thousands, USD (except Ratios, Multiples & per share items)
									Filed: 22-Feb-2024	Filed: 22-Feb-2024	Filed: 22-Feb-2024	Filed: 24-Feb-2022	Filed: 24-Feb-2022
									View 10-K	View 10-K	View 10-K	View 10-K	View 10-K
Income Statement
Total Revenue									58,496,000	100,330,000	81,288,000	41,651,000	40,905,000
Gross Profit									33,542,000	65,986,000	50,467,000	33,167,000	32,851,000
Total Operating Profit/(Loss)									3,359,000	37,272,000	23,704,000	8,829,000	7,311,000
EBITDA (Analyst Normalized)									13,726,000	45,220,000	29,972,000	21,009,000	18,545,000
EBIT (Analyst Normalized)									12,169,000	43,765,000	28,527,000	16,232,000	12,790,000
Net Income from Continuing Operations									2,172,000	31,401,000	22,459,000	6,666,000	10,738,000
Net Income (Analyst Normalized)									10,526,000	37,732,000	23,117,000	12,803,000	15,681,000
Diluted EPS from Continuing Operations									0.37	5.47	3.93	1.18	1.89
EPS (Analyst Normalized)									1.84	6.58	4.07	2.27	2.76
Diluted Weighted Average Shares Outstanding									5,643,000,000	5,733,000,000	5,708,000,000	5,632,000,000	5,675,000,000
Common Dividend per Share (Ex-date)									1.64	1.60	1.56	1.52	1.44
Balance Sheet
Total Current Assets									43,333,000	51,259,000	59,693,000	35,067,000	32,803,000
Net Property, Plant and Equipment									18,940,000	16,274,000	14,882,000	13,745,000	12,969,000
Total Non-Current Assets									183,168,000	145,944,000	121,782,000	119,161,000	134,791,000
Total Assets									226,501,000	197,205,000	181,476,000	154,229,000	167,594,000
Total Current Liabilities									47,794,000	42,138,000	42,671,000	25,920,000	37,304,000
Total Non-Current Liabilities									89,419,000	59,151,000	61,343,000	64,836,000	66,843,000
Total Liabilities									137,213,000	101,289,000	104,014,000	90,756,000	104,147,000
Total Equity									89,288,000	95,916,000	77,462,000	63,473,000	63,447,000
Equity Attributable to Parent Stockholders									89,014,000	95,661,000	77,201,000	63,238,000	63,143,000
Total Debt									70,845,000	34,859,000	36,998,000	38,274,000	50,840,000
Total Shares Outstanding (TSO)									5,646,413,292	5,613,314,537	5,620,000,000	5,567,000,000	5,534,000,000
Working Capital									(4,461,000)	9,121,000	17,022,000	9,147,000	(4,501,000)
Cash Flow
Cash Flow from Operating Activities, Indirect									8,700,000	29,267,000	32,580,000	14,403,000	12,588,000
Cash Flow from Investing Activities									(32,278,000)	(15,783,000)	(22,546,000)	(4,271,000)	(3,945,000)
Cash Flow from Financing Activities									26,066,000	(14,834,000)	(9,816,000)	(9,649,000)	(8,485,000)
Change in Cash									2,488,000	(1,350,000)	218,000	483,000	158,000
Capital Expenditure (Calc)									3,907,000	3,236,000	2,711,000	2,226,000	2,046,000
Issuance of/(Payments for) Common Stock, Net									0	(2,000,000)	0	0	(8,865,000)
Cash Dividends Paid									(9,247,000)	(8,983,000)	(8,729,000)	(8,440,000)	(8,043,000)
Cash and Cash Equivalents, Beginning of Period									468,000	1,983,000	1,825,000	1,350,000	1,225,000
Cash and Cash Equivalents, End of Period									2,917,000	468,000	1,983,000	1,825,000	1,350,000
Ratios
EBITDA Margin									13.56%	40.65%	37.84%	31.67%	45.04%
Revenue % Growth									-41.70%	23.43%	95.16%	1.82%	0.20%
EBITDA % Growth									-80.55%	32.59%	133.20%	-28.41%	71.75%
EBIT % Growth									-95.40%	39.70%	203.92%	-33.60%	176.80%
Current Ratio									[$-en-US]0.91	[$-en-US]1.22	[$-en-US]1.40	[$-en-US]1.35	[$-en-US]0.88
Quick Ratio									[$-en-US]0.58	[$-en-US]0.88	[$-en-US]1.10	[$-en-US]0.90	[$-en-US]0.51
Debt to Equity									[$-en-US]0.68	[$-en-US]0.33	[$-en-US]0.45	[$-en-US]0.56	[$-en-US]0.55
Total Debt to Equity									[$-en-US]0.79	[$-en-US]0.36	[$-en-US]0.48	[$-en-US]0.60	[$-en-US]0.80
Total Asset Turnover									[$-en-US]0.28	[$-en-US]0.53	[$-en-US]0.48	[$-en-US]0.25	[$-en-US]0.25
Normalized Return on Equity									10.90%	43.34%	32.69%	19.48%	26.99%
Normalized Return on Assets									4.98%	19.79%	13.75%	7.40%	10.34%
Normalized Return on Invested Capital									7.28%	31.23%	22.32%	11.71%	16.29%
Multiples*
Stock Price									28.79	51.24	59.05	36.81	37.12
Market Cap									162,560,239	287,626,237	331,439,773	204,604,579	216,826,914
EV									182,245,239	287,439,237	340,426,773	255,869,579	260,704,914
EV to Revenue									[$-en-US]2.66	[$-en-US]2.88	[$-en-US]5.35	[$-en-US]5.26	[$-en-US]4.92
EV to EBIT (Analyst Normalized)									[$-en-US]9.51	[$-en-US]6.86	[$-en-US]14.93	[$-en-US]13.67	[$-en-US]11.91
EV to EBITDA (Analyst Normalized)									[$-en-US]8.80	[$-en-US]6.64	[$-en-US]13.63	[$-en-US]10.74	[$-en-US]9.26
Price to Earnings (Analyst Normalized)									[$-en-US]10.03	[$-en-US]8.22	[$-en-US]15.92	[$-en-US]16.73	[$-en-US]12.93
Forward Price to Earnings									[$-en-US]12.84	[$-en-US]10.69	[$-en-US]10.34	[$-en-US]12.89	[$-en-US]14.36
Price to Book (PB)									[$-en-US]1.68	[$-en-US]3.10	[$-en-US]4.37	[$-en-US]3.13	[$-en-US]3.33
Price to Cash Flow (PCF)									[$-en-US]8.44	[$-en-US]9.03	[$-en-US]22.60	[$-en-US]14.70	[$-en-US]12.78
Price to Tangible Book Value									[$-en-US]31.36	[$-en-US]19.12
Data Origination
Preliminary									No	No	No	No	No
Original									No	No	No	No	No
Restated									Yes	Yes	Yes	Yes	Yes
Calculated									No	No	No	No	No
© PitchBook Data, Inc. 2024
Public Fundamental Data provided by Morningstar, Inc.

https://my.pitchbook.com/?c=11597-86 https:/my.pitchbook.com?sec_f=10599505378&financialGroup=KEY_METRICS&period=ANN&exchangeId=NYS&exchangeSymbol=PFE https://my.pitchbook.com/?c=11597-86 https://my.pitchbook.com/?c=11597-86 https://my.pitchbook.com/?c=11597-86 https://my.pitchbook.com/?c=11597-86 https:/my.pitchbook.com?sec_f=10599505634&financialGroup=KEY_METRICS&period=ANN&exchangeId=NYS&exchangeSymbol=PFE https:/my.pitchbook.com?sec_f=10599505570&financialGroup=KEY_METRICS&period=ANN&exchangeId=NYS&exchangeSymbol=PFE https:/my.pitchbook.com?sec_f=10599505506&financialGroup=KEY_METRICS&period=ANN&exchangeId=NYS&exchangeSymbol=PFE https:/my.pitchbook.com?sec_f=10599505442&financialGroup=KEY_METRICS&period=ANN&exchangeId=NYS&exchangeSymbol=PFE

Income Statement

Income Statement (Fiscal Year)
Downloaded On: 18-Apr-2024	Summary Stats
Company: Pfizer (Pharmaceuticals) (NYS: PFE)	Median	Mean	Min	Max	25th pctile	75th pctile	Std. Dev	Coefficient of Variation	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003	FY 2002	FY 2001	FY 2000	FY 1999	FY 1998	FY 1997	FY 1996	FY 1995	FY 1994	FY 1993	FY 1992	FY 1991	FY 1990	FY 1989	FY 1988	FY 1987	FY 1986	FY 1985	FY 1984	FY 1983	FY 1982	FY 1981	FY 1980	FY 1979
Amounts in Thousands, USD (except Ratios, Multiples & per share items)
									Filed: 22-Feb-2024	Filed: 22-Feb-2024	Filed: 22-Feb-2024	Filed: 24-Feb-2022	Filed: 24-Feb-2022	Filed: 25-Feb-2021	Filed: 27-Feb-2020	Filed: 28-Feb-2019	Filed: 22-Feb-2018	Filed: 23-Feb-2017	Filed: 29-Feb-2016	Filed: 31-Dec-2012	Filed: 31-Dec-2011	Filed: 31-Dec-2010	Filed: 31-Dec-2009	Filed: 31-Dec-2008	Filed: 31-Dec-2007	Filed: 31-Dec-2006	Filed: 31-Dec-2005	Filed: 31-Dec-2004	Filed: 31-Dec-2003	Filed: 31-Dec-2002	Filed: 31-Dec-2001	Filed: 31-Dec-2000	Filed: 31-Dec-1999	Filed: 31-Dec-1998	Filed: 31-Dec-1997	Filed: 31-Dec-1996	Filed: 31-Dec-1995	Filed: 31-Dec-1994	Filed: 31-Dec-1993	Filed: 31-Dec-1992	Filed: 31-Dec-1991	Filed: 31-Dec-1990	Filed: 31-Dec-1989	Filed: 31-Dec-1988	Filed: 31-Dec-1987	Filed: 31-Dec-1986	Filed: 31-Dec-1985	Filed: 31-Dec-1984	Filed: 31-Dec-1983	Filed: 31-Dec-1982	Filed: 31-Dec-1981	Filed: 31-Dec-1980	Filed: 31-Dec-1979
									View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K/A	View 10-K	View 10-K
Gross Profit
Revenue
Business Revenue									58,496,000	100,330,000	81,288,000	41,651,000	40,905,000	40,825,000	52,546,000	52,824,000	48,851,000	49,605,000	51,584,000	54,657,000	61,035,000	65,165,000	50,009,000	48,296,000	48,418,000	48,371,000	47,405,000	48,988,000	44,736,000	32,294,000	29,024,000	29,355,000	27,376,000	23,231,000	11,055,000	9,864,000	10,021,400	8,281,300	7,477,700	7,230,200	6,950,000	6,406,000	5,671,500	5,385,400	4,919,800	4,476,000	4,024,500	3,854,500	3,750,000	3,496,000	3,249,700	3,029,300	2,746,000
Total Revenue									58,496,000	100,330,000	81,288,000	41,651,000	40,905,000	40,825,000	52,546,000	52,824,000	48,851,000	49,605,000	51,584,000	54,657,000	61,035,000	65,165,000	50,009,000	48,296,000	48,418,000	48,371,000	47,405,000	48,988,000	44,736,000	32,294,000	29,024,000	29,355,000	27,376,000	23,231,000	11,055,000	9,864,000	10,021,400	8,281,300	7,477,700	7,230,200	6,950,000	6,406,000	5,671,500	5,385,400	4,919,800	4,476,000	4,024,500	3,854,500	3,750,000	3,496,000	3,249,700	3,029,300	2,746,000
Cost of Revenue
Cost of Goods and Services									24,954,000	34,344,000	30,821,000	8,484,000	8,054,000	8,987,000	11,228,000	12,322,000	9,648,000	9,577,000	9,586,000	9,821,000	12,500,000	14,788,000
Total Cost of Revenue									24,954,000	34,344,000	30,821,000	8,484,000	8,054,000	8,987,000	11,228,000	12,322,000	9,648,000	9,577,000	9,586,000	9,821,000	12,500,000	14,788,000	8,888,000	8,112,000	11,239,000	7,640,000	7,232,000	6,391,000	9,589,000	4,014,000	3,823,000	5,007,000	4,663,000	4,215,000	1,348,000	1,336,000	1,790,100	1,626,600	1,513,800	1,760,400	1,956,500	2,034,600	1,855,200	1,825,600	1,734,900	1,573,300	1,416,200	1,397,000	1,428,900	1,444,100	1,454,800	1,362,400	1,243,800
Total Gross Profit									33,542,000	65,986,000	50,467,000	33,167,000	32,851,000	31,838,000	41,318,000	40,502,000	39,203,000	40,028,000	41,998,000	44,836,000	48,535,000	50,377,000	41,121,000	40,184,000	37,179,000	40,731,000	40,173,000	42,597,000	35,147,000	28,280,000	25,201,000	24,348,000	22,713,000	19,016,000	9,707,000	8,528,000	8,231,300	6,654,700	5,963,900	5,469,800	4,993,500	4,371,400	3,816,300	3,559,800	3,184,900	2,902,700	2,608,300	2,457,500	2,321,100	2,051,900	1,794,900	1,666,900	1,502,200
Operating (Income)/Expenses
Selling, General and Administrative Expenses									14,771,000	13,677,000	12,703,000	11,597,000	12,726,000	12,612,000	14,804,000	14,844,000	14,809,000	14,097,000	14,355,000	15,171,000	17,581,000	18,973,000	14,875,000	14,537,000	15,626,000	15,589,000	15,313,000	15,304,000	15,108,000	10,829,000	9,717,000	11,223,000	10,810,000	9,563,000	4,401,000	3,859,000	5,297,100	4,390,200	4,792,400	3,762,500	3,495,900	3,092,800	2,641,000	2,353,400	2,082,100	1,795,900	1,598,800	1,497,200	1,449,000	1,332,100	1,188,200	1,095,200	975,200
Research and Development Expenses									10,679,000	11,428,000	10,360,000	9,393,000	8,385,000	7,760,000	7,683,000	7,892,000	7,690,000	8,393,000	6,678,000	7,482,000	8,681,000	9,483,000	7,845,000	8,578,000	8,089,000	7,599,000	7,256,000	7,513,000	7,487,000	5,208,000	4,776,000	4,435,000	4,036,000	3,305,000	1,805,000	1,567,000
Depreciation, Amortization and Depletion
Depreciation and Amortization
Amortization									4,733,000	3,609,000	3,700,000	3,348,000	4,429,000	4,736,000	4,758,000	4,056,000	3,728,000	4,039,000	4,599,000	5,109,000	5,465,000	5,364,000	2,877,000	2,668,000	3,128,000	3,261,000	3,399,000	3,352,000	2,187,000	22,000	94,000	120,000
Total Depreciation and Amortization									4,733,000	3,609,000	3,700,000	3,348,000	4,429,000	4,736,000	4,758,000	4,056,000	3,728,000	4,039,000	4,599,000	5,109,000	5,465,000	5,364,000	2,877,000	2,668,000	3,128,000	3,261,000	3,399,000	3,352,000	2,187,000	22,000	94,000	120,000	905,000	797,000	428,000	359,000	374,000	292,000	258,200	263,900	244,100	224,800	207,100	194,500	162,000	147,100	129,500	126,800	114,500	110,200	96,200	86,600	80,000
Total Depreciation, Amortization and Depletion									4,733,000	3,609,000	3,700,000	3,348,000	4,429,000	4,736,000	4,758,000	4,056,000	3,728,000	4,039,000	4,599,000	5,109,000	5,465,000	5,364,000	2,877,000	2,668,000	3,128,000	3,261,000	3,399,000	3,352,000	2,187,000	22,000	94,000	120,000	905,000	797,000	428,000	359,000	374,000	292,000	258,200	263,900	244,100	224,800	207,100	194,500	162,000	147,100	129,500	126,800	114,500	110,200	96,200	86,600	80,000
Other (Income)/Expense, Operating																							(195,000)	2,804,000
Total Operating (Income)/Expenses									30,183,000	28,714,000	26,763,000	24,338,000	25,540,000	25,108,000	27,245,000	26,792,000	26,227,000	26,529,000	25,632,000	27,762,000	31,727,000	33,820,000	25,402,000	28,587,000	26,843,000	26,449,000	25,968,000	26,169,000	24,782,000	16,059,000	14,587,000	15,778,000	15,751,000	13,665,000	6,634,000	5,785,000	5,671,100	4,682,200	5,050,600	4,026,400	3,740,000	3,317,600	2,848,100	2,547,900	2,244,100	1,943,000	1,728,300	1,624,000	1,563,500	1,442,300	1,284,400	1,181,800	1,055,200
Total Operating Profit/(Loss)									3,359,000	37,272,000	23,704,000	8,829,000	7,311,000	6,730,000	14,073,000	13,710,000	12,976,000	13,499,000	16,366,000	17,074,000	16,808,000	16,557,000	15,719,000	11,597,000	10,336,000	14,282,000	14,205,000	16,428,000	10,365,000	12,221,000	10,614,000	8,570,000	6,962,000	5,351,000	3,073,000	2,743,000	2,560,200	1,972,500	913,300	1,443,400	1,253,500	1,053,800	968,200	1,011,900	940,800	959,700	880,000	833,500	757,600	609,600	510,500	485,100	447,000
Non-Operating Income/(Expenses)
Net Finance (Income)/Expense
Net Interest (Income)/Expense
Interest Expense Net of Capitalized Interest									2,209,000	1,238,000	1,291,000	1,449,000	1,573,000	1,316,000	1,270,000	1,186,000	1,199,000	1,360,000	1,414,000	1,522,000	1,681,000	1,797,000	1,233,000	516,000
Interest Income									1,624,000	251,000	36,000	73,000	225,000	333,000	391,000	470,000	471,000	425,000	403,000	382,000	456,000	400,000	746,000	1,288,000
Total Net Interest (Income)/Expense									585,000	987,000	1,255,000	1,376,000	1,348,000	983,000	879,000	716,000	728,000	935,000	1,011,000	1,140,000	1,225,000	1,397,000	487,000	(772,000)
Total Net Finance (Income)/Expense									585,000	987,000	1,255,000	1,376,000	1,348,000	983,000	879,000	716,000	728,000	935,000	1,011,000	1,140,000	1,225,000	1,397,000	487,000	(772,000)
Net Investment Income
Gain/(Loss) on Investments and Other Financial Instruments									1,590,000	(1,273,000)	1,344,000	540,000	454,000	445,000	269,000	53,000			459,000	0	0
Income from Associates, Joint Ventures and Other Participating Interests
Share of Profit and Interest from Joint Ventures									505,000	436,000	471,000	298,000	17,000	0	0
Total Income from Associates, Joint Ventures and Other Participating Interests									505,000	436,000	471,000	298,000	17,000	0	0
Gain/(Loss) on Foreign Exchange																	(806,000)	0	0
Total Net Investment Income									2,095,000	(837,000)	1,815,000	838,000	471,000	445,000	269,000	53,000	(806,000)	0	459,000	0	0
Irregular (Income)/Expenses
(Gain)/Loss on Asset Disposals												237,000	(32,000)	(71,000)	45,000	1,661,000	(232,000)	(288,000)	(320,000)	(52,000)	(40,000)	(243,000)
Impairment/Write Off/Write Down of Capital Assets									3,024,000	421,000	86,000	1,691,000	2,792,000	3,115,000	395,000	1,447,000	818,000	469,000	878,000	890,000	885,000	1,790,000
Impairment/Write Off/Write Down of Other Assets																		0
(Gain)/Loss on Extinguishment of Debt															999,000	312,000	0
Litigation (Income)/Expense									474,000	230,000	182,000	28,000	292,000	84,000	240,000	510,000	975,000	993,000	(1,307,000)	2,220,000	784,000	1,723,000
Merger and Acquisition (Income)/Expense												(6,000)	(8,107,000)	0	0								68,000
Restructuring and Reorganization (Income)/Expense									2,943,000	1,375,000	802,000	579,000	901,000	1,121,000	422,000	1,826,000	1,434,000	418,000	1,182,000	1,810,000	2,841,000	3,145,000	4,337,000	2,675,000	2,534,000	1,323,000	1,356,000	1,151,000	1,058,000	630,000	819,000	3,257,000	33,000
Other Irregular Income/(Expenses)									40,000	765,000	3,073,000	(326,000)	(168,000)	(476,000)	(217,000)	(108,000)									(377,000)	368,000	2,318,000	1,873,000	6,137,000	(44,000)	84,000	(296,000)	48,000
Total Irregular (Income)/Expenses									6,481,000	2,791,000	4,143,000	2,203,000	(4,322,000)	3,773,000	1,884,000	5,648,000	2,995,000	1,592,000	433,000	4,868,000	4,470,000	6,415,000	4,405,000	2,675,000	2,157,000	1,691,000	3,674,000	3,024,000	7,195,000	586,000	903,000	2,961,000	81,000	945,000	206,000	215,000	261,000	111,000	(44,600)	(194,800)	179,700	(182,000)	(74,300)	(174,400)	(133,400)	(60,700)	(79,800)	(67,500)	(38,000)	(56,100)	(59,300)	(32,700)	(6,300)
Other Income/(Expense), Non-Operating									2,670,000	2,072,000	4,091,000	950,000	565,000	1,176,000	726,000	952,000	519,000	1,267,000	335,000	176,000	368,000	726,000
Total Non-Operating Income/(Expenses), Total									(2,301,000)	(2,543,000)	508,000	(1,791,000)	4,010,000	(3,135,000)	(1,768,000)	(5,359,000)	(4,010,000)	(1,260,000)	(650,000)	(5,832,000)	(5,327,000)	(7,086,000)	(4,892,000)	(1,903,000)	(2,157,000)	(1,691,000)	(3,674,000)	(3,024,000)	(7,195,000)	(586,000)	(903,000)	(2,961,000)	(81,000)	(945,000)	(206,000)	(215,000)	(261,000)	(111,000)	44,600	194,800	(179,700)	182,000	74,300	174,400	133,400	60,700	79,800	67,500	38,000	56,100	59,300	32,700	6,300
Pretax Income									1,058,000	34,729,000	24,311,000	7,036,000	11,321,000	3,594,000	12,305,000	8,351,000	8,965,000	12,240,000	15,716,000	11,242,000	11,481,000	9,471,000	10,827,000	9,694,000	9,278,000	13,028,000	10,800,000	13,403,000	3,263,000	11,796,000	9,984,000	5,781,000	6,945,000	4,395,000	2,857,000	2,522,000	2,292,200	1,856,900	848,800	1,532,100	940,500	1,099,100	912,400	1,100,700	1,007,500	960,700	876,100	800,800	694,600	544,900	431,600	402,900	358,500
Provision for Income Tax									(1,115,000)	3,328,000	1,852,000	370,000	583,000	(266,000)	(9,049,000)	1,123,000	1,990,000	3,120,000	4,306,000	2,221,000	3,621,000	1,153,000	2,197,000	1,645,000	1,023,000	1,992,000	3,178,000	2,460,000	1,614,000	2,599,000	2,433,000	2,049,000	1,968,000	1,163,000	775,000	758,000	738,000	558,500	191,300	438,600	218,400	297,900	231,300	309,400	317,300	300,700	296,400	292,900	247,500	208,600	157,900	149,000	120,600
Net Income from Continuing Operations									2,172,000	31,401,000	22,459,000	6,666,000	10,738,000	3,861,000	21,353,000	7,229,000	6,975,000	9,119,000	11,410,000	9,021,000	7,860,000	8,318,000	8,630,000	8,049,000	8,213,000	11,024,000	7,610,000	10,936,000	1,629,000	9,161,000	7,537,000	3,718,000	4,972,000	3,232,000	2,082,000	1,764,000	1,554,200	1,298,400	657,500	1,093,500	722,100	801,200	681,100	791,300	690,200	660,000	579,700	507,900	447,100	336,300	273,700	253,900	237,900
Discontinued Operations									(15,000)	6,000	(434,000)	2,529,000	5,318,000	7,328,000	2,000	17,000	11,000	48,000	10,662,000	5,577,000	2,189,000	(30,000)	14,000	78,000	(69,000)	8,313,000	498,000	425,000	2,311,000	375,000	251,000	8,000	(20,000)	1,401,000	131,000	165,000	18,700
Extraordinary Items																											(23,000)		(30,000)	(410,000)										(282,600)
Net Income after Extraordinary Items and Discontinued Operations									2,158,000	31,407,000	22,025,000	9,195,000	16,056,000	11,188,000	21,355,000	7,246,000	6,986,000	9,168,000	22,072,000	14,598,000	10,049,000	8,288,000	8,644,000	8,127,000
Non-Controlling/Minority Interests									39,000	35,000	45,000	36,000	29,000	36,000	47,000	31,000	26,000	32,000	69,000	28,000	40,000	31,000	9,000	23,000	42,000	12,000	12,000	7,000	3,000	6,000	14,000	14,000	5,000	2,000	10,000	6,000	7,000	4,600	2,600	2,700	3,200	4,200	4,100
Net Income after Non-Controlling/Minority Interests									2,119,000	31,372,000	21,979,000	9,159,000	16,026,000	11,153,000	21,308,000	7,215,000	6,960,000	9,135,000	22,003,000	14,570,000	10,009,000	8,257,000	8,635,000	8,104,000	8,144,000	19,337,000	8,085,000	11,361,000	3,910,000	9,126,000	7,788,000	3,726,000	4,952,000	4,633,000	2,213,000	1,929,000	1,572,900	1,298,400	657,500	810,900	722,100	801,200	681,100	791,300	690,200	660,000	579,700	507,900	447,100	336,300	273,700	253,900	237,900
Preferred/Other Stock Distribution
Preferred Stock Dividends													1,000	1,000	1,000				2,000	2,000	2,000	2,000			4,000	5,000	6,000	5,000	4,000
Total Preferred/Other Stock Distribution													1,000	1,000	1,000				2,000	2,000	2,000	2,000			4,000	5,000	6,000	5,000	4,000
Other Adjustments to Net Income Available to Common Stockholders																(1,000)	(1,000)	(1,000)	0	0
Net Income Available to Common Stockholders									2,119,000	31,372,000	21,979,000	9,159,000	16,025,000	11,152,000	21,307,000	7,214,000	6,959,000	9,134,000	22,001,000	14,568,000	10,007,000	8,255,000	8,635,000	8,104,000	8,140,000	19,332,000	8,079,000	11,356,000	3,906,000	9,126,000	7,788,000	3,726,000	4,952,000	4,633,000	2,213,000	1,929,000	1,572,900	1,298,400	657,500	810,900	722,100	801,200	681,100	791,300	690,200	660,000	579,700	507,900	447,100	336,300	273,700	253,900	237,900
Dilution to Earnings													1,000		1,000		1,000	1,000	2,000	2,000	2,000
Diluted Net Income Available to Common Stockholders									2,119,000	31,372,000	21,979,000	9,159,000	16,026,000	11,152,000	21,308,000	7,214,000	6,960,000	9,135,000	22,003,000	14,570,000	10,009,000	8,255,000	8,635,000	8,104,000	8,140,000	19,332,000	8,079,000	11,356,000	3,906,000	9,126,000	7,788,000	3,726,000	4,952,000	4,633,000	2,213,000	1,929,000	1,572,900	1,298,400	657,500	810,900	722,100	801,200	681,100	791,300	690,200	660,000	579,700	507,900	447,100	336,300	273,700	253,900	237,900
Basic EPS
Basic EPS from Continuing Operations									0.38	5.59	4.00	1.19	1.92	0.65	3.57	1.18	1.13	1.43	1.67	1.21	1.00	1.03	1.23	1.19	1.19	1.52	1.03	1.45	0.22	1.41	1.14	0.57	0.81	0.18	0.18	0.08	0.41	0.35	0.01	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Basic EPS from Discontinued Operations									0.00	0.00	(0.08)	0.46	0.95	1.25	0.01	0.01	0.01	0.01	1.56	0.75	0.28	(0.01)	0.00	0.01	(0.01)	1.15	0.07	0.06	0.32	0.14	0.11	0.03	0.00	0.08	0.01	0.01	0.01
Total Basic EPS									0.38	5.59	3.92	1.65	2.88	1.90	3.57	1.18	1.13	1.44	3.23	1.96	1.28	1.03	1.23	1.20	1.18	2.67	1.10	1.51	0.54	1.48	1.25	0.60	0.81	0.25	0.19	0.09	0.42	0.35	0.01	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Diluted EPS
Diluted EPS from Continuing Operations									0.37	5.47	3.93	1.18	1.89	0.64	3.52	1.17	1.11	1.41	1.65	1.20	0.99	1.03	1.23	1.19	1.18	1.52	1.02	1.43	0.22	1.39	1.11	0.56	0.79	0.17	0.18	0.08	0.41	0.34	0.01	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Diluted EPS from Discontinued Operations									(0.01)	0.00	(0.08)	0.45	0.94	1.23	0.01	0.01	0.01	0.01	1.54	0.74	0.28	(0.01)	0.00	0.01	(0.01)	1.14	0.07	0.06	0.32	0.14	0.11	0.03	(0.01)	0.07	0.01	0.01	0.01
Total Diluted EPS									0.37	5.47	3.85	1.63	2.82	1.87	3.52	1.17	1.11	1.42	3.19	1.94	1.27	1.02	1.23	1.20	1.17	2.66	1.09	1.49	0.54	1.46	1.22	0.59	0.78	0.24	0.19	0.08	0.42	0.34	0.01	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Basic Weighted Average Shares Outstanding									5,643,000,000	5,608,000,000	5,601,000,000	5,555,000,000	5,569,000,000	5,872,000,000	5,970,000,000	6,089,000,000	6,176,000,000	6,346,000,000	6,813,000,000	7,442,000,000	7,817,000,000	8,036,000,000	7,007,000,000	6,727,000,000	6,917,000,000	7,242,000,000	7,361,000,000	7,531,000,000	7,213,000,000	6,156,000,000	6,239,000,000	6,210,000,000	6,126,000,000	18,360,000,000	3,873,738,384	3,840,287,868	3,774,956,980	3,718,564,469	3,905,592,000	3,955,646,000	3,968,895,000	3,965,736,000	3,971,489,000	3,951,694,000	3,964,138,000	3,936,414,000	3,857,087,000	3,846,300,000	3,833,568,000	3,776,126,000	3,601,303,000	3,530,096,000	3,513,327,000
Diluted Weighted Average Shares Outstanding									5,643,000,000	5,733,000,000	5,708,000,000	5,632,000,000	5,675,000,000	5,977,000,000	6,058,000,000	6,159,000,000	6,257,000,000	6,424,000,000	6,895,000,000	7,508,000,000	7,870,000,000	8,074,000,000	7,045,000,000	6,750,000,000	6,939,000,000	7,274,000,000	7,411,000,000	7,614,000,000	7,286,000,000	6,241,000,000	6,361,000,000	6,368,000,000	6,317,000,000	19,086,000,000	3,873,738,384	3,840,287,868	3,774,956,980	3,854,925,000	3,905,592,000	3,955,646,000	3,968,895,000	3,965,736,000	3,971,489,000	3,951,694,000	3,964,138,000	3,936,414,000	3,857,087,000	3,846,300,000	3,833,568,000	3,776,126,000	3,601,303,000	3,530,096,000	3,513,327,000
Income Statement Supplemental Section
Per Share Calculations
Common Dividend per Share (Paid)												1.53	1.46	1.38	1.30	1.22	1.12	1.04	0.96	0.88	0.80	0.72
Common Dividend per Share (Ex-date)									1.64	1.60	1.56	1.52	1.44	1.36	1.28	1.20	1.12	1.04	0.96	0.88	0.80	0.72	0.80	1.28	1.16	0.96	0.76	0.63	0.60	0.52	0.44	0.36	0.31	0.25	0.23	0.20	0.17	0.16	0.14	0.12	0.11	0.10	0.09	0.08	0.07	0.07	0.00
EBITDA per Share									1.41	7.11	5.39	2.34	3.25	1.79	3.21	2.41	2.37	2.91	3.36	2.67	2.76	2.39	2.28	2.08	2.09	2.52	2.21	2.43	1.00	2.06	1.72	1.06	1.24	0.27	0.85	0.75	0.71	0.56	0.28	0.45	0.30	0.33	0.28	0.33	0.30	0.28	0.26	0.24	0.21	0.17	0.15	0.14	0.12
EBITDAR per Share									1.41	7.11	5.39	2.34	3.25	1.79	3.21	2.41	2.37	2.91	3.36	2.67	2.76	2.39	2.28	2.08	2.09	2.52	2.21	2.43	1.00	2.06	1.72	1.06	1.24	0.27	0.85	0.75	0.71	0.56	0.28	0.45	0.30	0.33	0.28	0.33	0.30	0.28	0.26	0.24	0.21	0.17	0.15	0.14	0.12
Basic EPS (Normalized)									1.86	6.73	4.14	2.25	3.00	1.69	2.69	2.42	2.23	2.29	2.24	2.12	2.19	2.19	1.73	1.57	1.47	1.72	1.38	1.78	0.87	1.48	1.25	0.88	0.82	0.18	0.18	0.08	0.41	0.35	0.01	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Diluted EPS (Normalized)									1.84	6.58	4.06	2.22	2.95	1.66	2.65	2.40	2.20	2.26	2.22	2.10	2.18	2.18	1.73	1.56	1.46	1.72	1.37	1.75	0.86	1.46	1.22	0.86	0.80	0.17	0.18	0.08	0.41	0.34	0.01	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Normalized EBITDA per Share									4.07	8.28	6.13	3.14	3.04	3.07	3.72	3.70	3.27	3.33	2.08	2.61	3.32	3.66	2.90	2.53	2.40	2.75	2.71	2.83	1.99	2.15	1.86	1.52	1.26	0.27	0.85	0.75	0.71	0.56	0.28	0.45	0.30	0.33	0.28	0.33	0.30	0.28	0.26	0.24	0.21	0.17	0.15	0.14	0.12
Normalized EBITDAR per Share									4.07	8.28	6.13	3.14	3.04	3.07	3.72	3.70	3.27	3.33	2.08	2.61	3.32	3.66	2.90	2.53	2.40	2.75	2.71	2.83	1.99	2.15	1.86	1.52	1.26	0.27	0.85	0.75	0.71	0.56	0.28	0.45	0.30	0.33	0.28	0.33	0.30	0.28	0.26	0.24	0.21	0.17	0.15	0.14	0.12
Recommended Normalized Basic EPS									1.86	6.73	4.14	2.25	3.00	1.69	2.69	2.42	2.23	2.29	2.24	2.12	2.19	2.19	1.73	1.57	1.47	1.72	1.38	1.78	0.87	1.48	1.25	0.88	0.82	0.18	0.18	0.08	0.41	0.35	0.01	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Recommended Normalized Diluted EPS									1.84	6.58	4.06	2.22	2.95	1.66	2.65	2.40	2.20	2.26	2.22	2.10	2.18	2.18	1.73	1.56	1.46	1.72	1.37	1.75	0.86	1.46	1.22	0.86	0.80	0.17	0.18	0.08	0.41	0.34	0.01	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Sales per Share									10.37	17.50	14.24	7.40	7.21	6.83	8.67	8.58	7.81	7.72	7.48	7.28	7.76	8.07	7.10	7.15	6.98	6.65	6.40	6.43	6.14	5.17	4.56	4.61	4.33	1.22	2.85	2.57	2.65	2.15	1.91	1.83	1.75	1.62	1.43	1.36	1.24	1.14	1.04	1.00	0.98	0.93	0.90	0.86	0.78
Total Dividend per Share									1.64	1.60	1.56	1.52	1.44	1.36	1.28	1.20	1.12	1.04	0.96	0.88	0.80	0.72	0.80	1.28	1.16	0.96	0.76	0.63	0.60	0.52	0.44	0.36	0.31	0.25	0.23	0.20	0.17	0.16	0.14	0.12	0.11	0.10	0.09	0.08	0.07	0.07	0.00
Reported Normalized and Operating Income/Expense Supplemental Section
Reported Total Revenue									58,496,000	100,330,000	81,288,000	41,651,000	40,905,000	40,825,000	52,546,000	52,824,000	48,851,000	49,605,000	51,584,000	54,657,000	61,035,000	65,165,000	50,009,000	48,296,000	48,418,000	48,371,000	47,405,000	48,988,000	44,736,000	32,294,000	29,024,000	29,355,000	27,376,000	23,231,000	11,055,000	9,864,000	10,021,400	8,281,300	7,477,700	7,230,200	6,950,000	6,406,000	5,671,500	5,385,400	4,919,800	4,476,000	4,024,500	3,854,500	3,750,000	3,496,000	3,249,700	3,029,300	2,746,000
Reported Normalized Income									10,501,000	37,717,000	23,196,000	12,506,000	16,733,000	9,944,000	16,085,000	14,761,000	13,755,000	14,530,000	15,288,000	15,749,000	17,145,000	17,562,000
Reported Normalized Diluted EPS									1.84	6.58	4.06	2.22	2.95	1.66	2.65	2.40	2.20	2.26	2.22	2.10	2.18	2.18
Reported Effective Tax Rate									-105.40%	9.60%	7.60%	6.40%	15.00%	-7.40%	73.50%	13.40%	22.20%	25.50%	27.40%	19.80%	31.50%	12.20%
Profitability Metrics
Unadjusted Profitability Metrics
EBITDA									7,933,000	40,780,000	30,757,000	13,189,000	18,424,000	10,727,000	19,453,000	14,824,000	14,850,000	18,712,000	23,137,000	20,037,000	21,732,000	19,267,000	16,071,000	14,012,000	14,478,000	18,321,000	16,376,000	18,496,000	7,288,000	12,832,000	10,956,000	6,749,000	7,850,000	5,192,000	3,285,000	2,881,000	2,666,200	2,148,900	1,107,000	1,796,000	1,184,600	1,323,900	1,119,500	1,295,200	1,169,500	1,107,800	1,005,600	927,600	809,100	655,100	527,800	489,500	438,500
EBIT									1,643,000	35,716,000	25,566,000	8,412,000	12,669,000	4,577,000	13,184,000	9,067,000	9,693,000	13,175,000	16,727,000	12,382,000	12,706,000	10,868,000	11,314,000	8,922,000	9,278,000	13,028,000	10,800,000	13,403,000	3,263,000	11,796,000	9,984,000	5,781,000	6,945,000	4,395,000	2,857,000	2,522,000	2,292,200	1,856,900	848,800	1,532,100	940,500	1,099,100	912,400	1,100,700	1,007,500	960,700	876,100	800,800	694,600	544,900	431,600	402,900	358,500
EBITDAR									7,933,000	40,780,000	30,757,000	13,189,000	18,424,000	10,727,000	19,453,000	14,824,000	14,850,000	18,712,000	23,137,000	20,037,000	21,732,000	19,267,000	16,071,000	14,012,000	14,478,000	18,321,000	16,376,000	18,496,000	7,288,000	12,832,000	10,956,000	6,749,000	7,850,000	5,192,000	3,285,000	2,881,000	2,666,200	2,148,900	1,107,000	1,796,000	1,184,600	1,323,900	1,119,500	1,295,200	1,169,500	1,107,800	1,005,600	927,600	809,100	655,100	527,800	489,500	438,500
Interest and Dividend Income									1,624,000	251,000	36,000	73,000	225,000	333,000	391,000	470,000	471,000	425,000	403,000	382,000	456,000	400,000	746,000	1,288,000
Tax Effect of Unusual Items									3,154,830	640,224	323,532	285,952	(180,000)	2,065,230	1,235,600	1,065,300	1,240,758	677,790	(2,412,296)	(94,050)	1,385,685	1,258,674	890,610	516,714	237,833	258,556	1,081,109	555,028	2,518,250	129,113	220,052	1,049,488	22,953	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Unusual Items									15,023,000	6,669,000	4,257,000	4,468,000	(1,200,000)	7,649,000	3,089,000	7,950,000	5,589,000	2,658,000	(8,804,000)	(475,000)	4,399,000	10,317,000	4,389,000	3,045,000	2,157,000	1,691,000	3,674,000	3,024,000	7,195,000	586,000	903,000	2,961,000	81,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Unusual Items Excluding Goodwill									15,023,000	6,669,000	4,257,000	4,468,000	(1,200,000)	7,649,000	3,089,000	7,950,000	5,589,000	2,658,000	(8,804,000)	(475,000)	4,399,000	10,317,000	4,389,000	3,045,000	2,157,000	1,691,000	3,674,000	3,024,000	7,195,000	586,000	903,000	2,961,000	81,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue and Operating Expense									55,137,000	63,058,000	57,584,000	32,822,000	33,594,000	34,095,000	38,473,000	39,114,000	35,875,000	36,106,000	35,218,000	37,583,000	44,227,000	48,608,000	34,290,000	36,699,000	38,082,000	34,089,000	33,200,000	32,560,000	34,371,000	20,073,000	18,410,000	20,785,000	20,414,000	17,880,000	7,982,000	7,121,000	7,461,200	6,308,800	6,564,400	5,786,800	5,696,500	5,352,200	4,703,300	4,373,500	3,979,000	3,516,300	3,144,500	3,021,000	2,992,400	2,886,400	2,739,200	2,544,200	2,299,000
Net Operating Profit After Tax (NOPAT)									2,634,150	32,293,248	23,618,620	7,953,936	11,883,800	4,578,590	21,880,400	7,849,056	7,541,384	9,815,575	12,143,986	9,935,280	8,699,125	9,544,566	9,018,179	7,408,003	8,213,000	11,024,000	7,610,000	10,936,000	1,629,000	9,161,000	7,537,000	3,718,000	4,972,000	3,232,000	2,082,000	1,764,000	1,554,200	1,298,400	657,500	1,093,500	722,100	801,200	681,100	791,300	690,200	660,000	579,700	507,900	447,100	336,300	273,700	253,900	237,900
Income After Taxes									2,173,000	31,401,000	22,459,000	6,666,000	10,738,000	3,860,000	21,354,000	7,228,000	6,975,000	9,120,000	11,410,000	9,021,000	7,860,000	8,318,000	8,630,000	8,049,000	8,255,000	11,036,000	7,622,000	10,943,000	1,649,000	9,197,000	7,551,000	3,732,000	4,977,000	3,232,000	2,082,000	1,764,000	1,554,200	1,298,400	657,500	1,093,500	722,100	801,200	681,100	791,300	690,200	660,000	579,700	507,900	447,100	336,300	273,700	253,900	237,900
Normalized Profitability Metrics
EBITDA (Normalized)									22,956,000	47,449,000	35,014,000	17,657,000	17,224,000	18,376,000	22,542,000	22,774,000	20,439,000	21,370,000	14,333,000	19,562,000	26,131,000	29,584,000	20,460,000	17,057,000	16,635,000	20,012,000	20,050,000	21,520,000	14,483,000	13,418,000	11,859,000	9,710,000	7,931,000	5,192,000	3,285,000	2,881,000	2,666,200	2,148,900	1,107,000	1,796,000	1,184,600	1,323,900	1,119,500	1,295,200	1,169,500	1,107,800	1,005,600	927,600	809,100	655,100	527,800	489,500	438,500
EBIT (Normalized)									16,666,000	42,385,000	29,823,000	12,880,000	11,469,000	12,226,000	16,273,000	17,017,000	15,282,000	15,833,000	7,923,000	11,907,000	17,105,000	21,185,000	15,703,000	11,967,000	11,435,000	14,719,000	14,474,000	16,427,000	10,458,000	12,382,000	10,887,000	8,742,000	7,026,000	4,395,000	2,857,000	2,522,000	2,292,200	1,856,900	848,800	1,532,100	940,500	1,099,100	912,400	1,100,700	1,007,500	960,700	876,100	800,800	694,600	544,900	431,600	402,900	358,500
EBITDAR (Normalized)									22,956,000	47,449,000	35,014,000	17,657,000	17,224,000	18,376,000	22,542,000	22,774,000	20,439,000	21,370,000	14,333,000	19,562,000	26,131,000	29,584,000	20,460,000	17,057,000	16,635,000	20,012,000	20,050,000	21,520,000	14,483,000	13,418,000	11,859,000	9,710,000	7,931,000	5,192,000	3,285,000	2,881,000	2,666,200	2,148,900	1,107,000	1,796,000	1,184,600	1,323,900	1,119,500	1,295,200	1,169,500	1,107,800	1,005,600	927,600	809,100	655,100	527,800	489,500	438,500
Net Income (Normalized)									10,501,000	37,717,000	23,196,000	12,506,000	16,733,000	9,944,000	16,085,000	14,761,000	13,755,000	14,530,000	15,288,000	15,749,000	17,145,000	17,562,000	12,128,390	10,577,286	10,132,167	12,456,444	10,202,891	13,404,972	6,305,750	9,617,887	8,219,948	5,629,512	5,030,047	3,232,000	2,082,000	1,764,000	1,554,200	1,298,400	657,500	1,093,500	722,100	801,200	681,100	791,300	690,200	660,000	579,700	507,900	447,100	336,300	273,700	253,900	237,900
Analyst Normalized Profitability Metrics
EBITDA (Analyst Normalized)									13,726,000	45,220,000	29,972,000	21,009,000	18,545,000	19,636,000	27,314,000	25,683,000	24,020,000	26,285,000	28,549,000	31,109,000	34,840,000	27,265,715	25,401,000	25,281,000	20,109,000	18,321,000	16,376,000	18,496,000	7,288,000
EBIT (Analyst Normalized)									12,169,000	43,765,000	28,527,000	16,232,000	12,790,000	13,486,000	21,045,000	19,926,000	18,863,000	20,748,000	22,139,000	23,454,000	25,814,000	18,866,715	20,644,000	20,191,000	14,909,000	13,028,000	10,800,000	13,403,000	3,263,000
Net Income (Analyst Normalized)									10,526,000	37,732,000	23,117,000	12,803,000	15,681,000	17,558,000	16,085,000	14,738,000	13,754,000	14,517,000	15,249,000
EPS (Analyst Normalized)									1.84	6.58	4.07	2.27	2.76	2.94	2.65	2.39	2.20	2.26	2.21	2.10	2.29	2.23	2.02	2.43	2.20	2.08	2.02	2.12	1.75
Data Origination
Preliminary									No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No
Original									No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No
Restated									Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes
Calculated									No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No
© PitchBook Data, Inc. 2024
Public Fundamental Data provided by Morningstar, Inc.

Balance Sheet

Balance Sheet (Fiscal Year)
Downloaded On: 18-Apr-2024	Summary Stats
Company: Pfizer (Pharmaceuticals) (NYS: PFE)	Median	Mean	Min	Max	25th pctile	75th pctile	Std. Dev	Coefficient of Variation	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003	FY 2002	FY 2001	FY 2000	FY 1999	FY 1998	FY 1997	FY 1996	FY 1995	FY 1994	FY 1993	FY 1992	FY 1991	FY 1990	FY 1989	FY 1988	FY 1987	FY 1986	FY 1985	FY 1984	FY 1983	FY 1982	FY 1981	FY 1980	FY 1979
Amounts in Thousands, USD (except Ratios, Multiples & per share items)
									Filed: 22-Feb-2024	Filed: 22-Feb-2024	Filed: 23-Feb-2023	Filed: 24-Feb-2022	Filed: 25-Feb-2021	Filed: 27-Feb-2020	Filed: 28-Feb-2019	Filed: 22-Feb-2018	Filed: 23-Feb-2017	Filed: 29-Feb-2016	Filed: 27-Feb-2015	Filed: 31-Dec-2012	Filed: 31-Dec-2011	Filed: 31-Dec-2010	Filed: 31-Dec-2009	Filed: 31-Dec-2008	Filed: 31-Dec-2007	Filed: 31-Dec-2006	Filed: 31-Dec-2005	Filed: 31-Dec-2004	Filed: 31-Dec-2003	Filed: 31-Dec-2002	Filed: 31-Dec-2001	Filed: 31-Dec-2000	Filed: 31-Dec-1999	Filed: 31-Dec-1998	Filed: 31-Dec-1997	Filed: 31-Dec-1996	Filed: 31-Dec-1995	Filed: 31-Dec-1994	Filed: 31-Dec-1993	Filed: 31-Dec-1992	Filed: 31-Dec-1991	Filed: 31-Dec-1990	Filed: 31-Dec-1989	Filed: 31-Dec-1988	Filed: 31-Dec-1987	Filed: 31-Dec-1986	Filed: 31-Dec-1985	Filed: 31-Dec-1984	Filed: 31-Dec-1983	Filed: 31-Dec-1982	Filed: 31-Dec-1981	Filed: 31-Dec-1980	Filed: 31-Dec-1979
									View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K/A	View 10-K	View 10-K
Assets
Current Assets
Cash, Cash Equivalents and Short Term Investments
Cash and Cash Equivalents									2,853,000	416,000	1,944,000	1,786,000	1,121,000	1,139,000	1,342,000	2,595,000	3,641,000	3,343,000	2,183,000	10,081,000	3,182,000	1,735,000	1,978,000	2,122,000	3,406,000	1,827,000	2,247,000	1,808,000	1,520,000	1,878,000	1,036,000	1,099,000	2,358,000	1,552,000	877,000	1,150,000	403,300	1,458,500	729,400	1,257,100	1,317,600	870,300	825,400	807,500	1,031,100	398,600	412,600	880,900	715,700	611,200	566,900	490,600	478,800
Short Term Investments
Available-for-Sale Securities, Current									4,400,000	18,743,000	22,014,000
Held-to-Maturity Securities, Current									313,000	1,985,000	1,746,000
Other Short Term Investments									5,124,000	1,588,000	5,365,000
Total Short Term Investments									9,837,000	22,316,000	29,125,000	10,437,000	8,525,000	17,694,000	18,650,000	15,255,000	19,649,000	32,779,000	30,225,000	22,318,000	23,270,000	26,277,000	23,991,000	21,609,000	22,069,000	25,886,000	19,979,000	18,085,000	10,432,000	10,673,000	7,579,000	5,764,000	4,028,000
Total Cash, Cash Equivalents and Short Term Investments									12,690,000	22,732,000	31,069,000	12,223,000	9,646,000	18,833,000	19,992,000	17,850,000	23,290,000	36,122,000	32,408,000	32,399,000	26,452,000	28,012,000	25,969,000	23,731,000	25,475,000	27,713,000	22,226,000	19,893,000	11,952,000	12,551,000	8,615,000	6,863,000	6,386,000	1,552,000	877,000	1,150,000	403,300	1,458,500	729,400	1,257,100	1,317,600	870,300	825,400	807,500	1,031,100	398,600	412,600	880,900	715,700	611,200	566,900	490,600	478,800
Inventories
Raw Materials, Consumables and Supplies									1,007,000	859,000	994,000	716,000	672,000	546,000	788,000	793,000	867,000	510,000	505,000	448,000	785,000	912,000	1,378,000	830,000	885,000	1,262,000	1,357,000	1,314,000	1,297,000	403,000	412,000	433,000	464,000
Work-in-Process									5,688,000	5,519,000	4,424,000	4,436,000	4,131,000	4,701,000	3,908,000	3,696,000	3,932,000	3,248,000	3,445,000	3,374,000	3,514,000	3,733,000	5,776,000	1,527,000	2,353,000	3,198,000	2,379,000	2,703,000	2,204,000	1,142,000	1,062,000	1,074,000	977,000
Finished Goods and Merchandise									3,495,000	2,603,000	3,641,000	2,867,000	2,265,000	2,262,000	2,883,000	2,293,000	2,714,000	1,905,000	2,216,000	2,254,000	2,311,000	3,760,000	5,249,000	2,024,000	2,064,000	1,651,000	1,742,000	2,643,000	2,198,000	1,133,000	1,011,000	1,195,000	1,147,000
Total Inventories									10,189,000	8,981,000	9,059,000	8,020,000	7,068,000	7,508,000	7,578,000	6,783,000	7,513,000	5,663,000	6,166,000	6,076,000	6,610,000	8,405,000	12,403,000	4,381,000	5,302,000	6,111,000	5,478,000	6,660,000	5,699,000	2,678,000	2,485,000	2,702,000	2,588,000	1,828,000	1,461,000	1,589,000	1,384,100	1,264,900	1,093,500	1,067,800	1,171,500	1,142,600	1,080,500	1,089,400	1,028,200	889,200	801,400	736,000	733,700	793,700	848,200	891,500	741,900
Trade and Other Receivables, Current
Trade/Accounts Receivable, Current
Gross Trade/Accounts Receivable, Current									11,647,000	11,401,000	11,971,000	8,421,000	7,265,000	8,566,000	8,805,000	8,834,000	8,560,000	8,813,000	9,835,000	10,999,000	13,284,000
Allowance/Adjustments for Trade/Accounts Receivable, Current									(470,000)	(449,000)	(492,000)	(508,000)	(493,000)	(541,000)	(584,000)	(609,000)	(384,000)	(412,000)	(478,000)	(324,000)	(226,000)
Total Trade/Accounts Receivable, Current									11,177,000	10,952,000	11,479,000	7,913,000	6,772,000	8,025,000	8,221,000	8,225,000	8,176,000	8,401,000	9,357,000	10,675,000	13,058,000	14,612,000	14,645,000	8,958,000	9,843,000	9,392,000	9,103,000	9,367,000	8,636,000	5,785,000	4,798,000	5,489,000	5,368,000
Loans Receivable, Current																						467,000	1,195,000	824,000	617,000	514,000	510,000	653,000	391,000	399,000	269,000
Taxes Receivable, Current									3,978,000	3,577,000	4,266,000	3,264,000	2,736,000	3,374,000	3,050,000	3,041,000	2,662,000	2,566,000			9,380,000
Total Trade and Other Receivables, Current									15,155,000	14,529,000	15,745,000	11,177,000	9,508,000	11,399,000	11,271,000	11,266,000	10,838,000	10,967,000	9,357,000	10,675,000	22,438,000	15,079,000	15,840,000	9,782,000	10,460,000	9,906,000	9,613,000	10,020,000	9,027,000	6,184,000	5,067,000	5,489,000	5,368,000	2,914,000	2,220,000	2,252,000	2,024,000	1,665,000	1,468,700	1,400,300	1,403,900	1,377,200	2,064,900	1,167,200	1,184,400	960,900	813,100	682,600	768,900	727,900	750,000	718,300	653,800
Prepayments and Deposits, Current																										3,866,000	2,903,000	2,333,000	2,758,000	1,797,000	1,418,000	1,993,000	1,696,000
Deferred Tax Assets, Current																			4,624,000	6,170,000		8,411,000	6,962,000	5,034,000
Deferred Costs/Assets, Current																						0	0	0
Assets Held for Sale/Discontinued Operations, Current													4,224,000	9,725,000	12,000	801,000	9,000			5,944,000	5,317,000	561,000	496,000	148,000
Other Current Assets									5,299,000	5,017,000	3,820,000	3,646,000	2,357,000	2,461,000	2,289,000	2,249,000	2,154,000	2,843,000	3,689,000	3,567,000					5,612,000	62,000	6,615,000	182,000	1,241,000	1,571,000	1,627,000	140,000	273,000	3,637,000	2,884,000	1,477,000	2,341,000	1,400,000	1,441,600	1,659,600	915,200	1,045,800	534,000	1,030,700	857,000	91,200	130,900	138,900	120,700	90,500	95,000	73,800	53,200
Total Current Assets									43,333,000	51,259,000	59,693,000	35,067,000	32,803,000	49,926,000	41,141,000	38,949,000	43,804,000	55,595,000	56,244,000	64,831,000	60,817,000	60,468,000	61,670,000	43,076,000	46,849,000	47,658,000	46,835,000	39,088,000	30,677,000	24,781,000	19,212,000	17,187,000	16,311,000	9,931,000	7,442,000	6,468,000	6,152,400	5,788,400	4,733,200	5,384,800	4,808,200	4,435,900	4,504,800	4,094,800	4,100,700	2,339,900	2,158,000	2,438,400	2,339,000	2,223,300	2,260,100	2,174,200	1,927,700
Non-Current Assets
Net Property, Plant and Equipment
Gross Property, Plant and Equipment
Properties
Land and Improvements									353,000	368,000	423,000	443,000	495,000	500,000	540,000	530,000	588,000	529,000	557,000	566,000	737,000	803,000	937,000	616,000	718,000	641,000		688,000	521,000	252,000	201,000	200,000	224,000
Buildings and Improvements									9,046,000	8,832,000	9,001,000	8,998,000	9,181,000	9,920,000	10,254,000	9,810,000	9,604,000	9,355,000	10,055,000	10,643,000	12,089,000	13,405,000	14,186,000	8,775,000	10,319,000	9,947,000		9,771,000	9,201,000	5,407,000	4,490,000	3,832,000	3,329,000
Total Properties									9,399,000	9,200,000	9,424,000	9,441,000	9,676,000	10,420,000	10,794,000	10,340,000	10,192,000	9,884,000	10,612,000	11,209,000	12,826,000	14,208,000	15,123,000	9,391,000	11,037,000	10,588,000		10,459,000	9,722,000	5,659,000	4,691,000	4,032,000	3,553,000
Machinery, Furniture and Equipment
Plant and Machinery									14,263,000	12,881,000	12,252,000	11,000,000	10,648,000	11,871,000	11,902,000	11,248,000	10,933,000	9,671,000	10,050,000	9,939,000	10,882,000
Furniture, Fixtures and Office Equipment									5,399,000	4,491,000	4,457,000	4,484,000	4,840,000	4,693,000	4,661,000	4,410,000	4,351,000	4,162,000	3,914,000	3,860,000	4,235,000
Total Machinery, Furniture and Equipment									19,662,000	17,372,000	16,709,000	15,484,000	15,488,000	16,564,000	16,563,000	15,658,000	15,284,000	13,833,000	13,964,000	13,799,000	15,117,000	17,055,000	16,835,000	13,933,000	15,308,000	14,613,000		14,065,000	12,870,000	9,000,000	7,785,000	8,236,000	7,675,000
Construction in Progress and Advance Payments									5,925,000	4,875,000	3,822,000	3,481,000	2,794,000	2,992,000	2,680,000	2,127,000	1,791,000	1,271,000	1,102,000	957,000	1,294,000	1,035,000	1,966,000	1,804,000	1,758,000	1,862,000		2,395,000	2,480,000	1,484,000	1,896,000	1,866,000	1,963,000
Total Gross Property, Plant and Equipment									34,985,000	31,448,000	29,955,000	28,406,000	27,959,000	29,977,000	30,037,000	28,125,000	27,268,000	24,988,000	25,678,000	25,965,000	29,237,000	32,298,000	33,924,000	25,128,000	28,103,000	27,063,000	25,760,000	26,919,000	25,072,000	16,143,000	14,372,000	14,134,000	13,191,000	6,844,000	5,867,000	6,005,000	5,463,400	4,992,900	4,300,700	3,816,400	4,007,500	3,616,300	3,252,500	3,153,600	2,875,900	2,541,900	2,303,300	2,045,900	1,983,500	2,947,900	1,743,800	1,498,000	1,364,800
Accumulated Depreciation and Impairment
Accumulated Depreciation									(16,045,000)	(15,174,000)	(15,074,000)	(14,661,000)	(14,990,000)	(16,591,000)	(16,172,000)	(14,807,000)	(13,502,000)	(13,226,000)	(13,281,000)	(12,752,000)	(13,316,000)	(13,175,000)	(11,144,000)	(11,841,000)	(12,369,000)	(10,431,000)	(9,527,000)	(8,534,000)	(6,916,000)	(5,431,000)	(4,589,000)	(4,709,000)	(4,506,000)	(2,429,000)	(2,074,000)	(2,155,000)	(1,990,800)	(1,919,700)	(1,668,200)	(1,511,300)	(1,626,500)	(1,506,500)	(1,468,400)	(1,498,500)	(1,370,000)	(1,190,600)	(1,035,000)	(890,300)	(826,500)	(1,809,400)	(745,600)	(673,000)	(605,500)
Total Accumulated Depreciation and Impairment									(16,045,000)	(15,174,000)	(15,074,000)	(14,661,000)	(14,990,000)	(16,591,000)	(16,172,000)	(14,807,000)	(13,502,000)	(13,226,000)	(13,281,000)	(12,752,000)	(13,316,000)	(13,175,000)	(11,144,000)	(11,841,000)	(12,369,000)	(10,431,000)	(9,527,000)	(8,534,000)	(6,916,000)	(5,431,000)	(4,589,000)	(4,709,000)	(4,506,000)	(2,429,000)	(2,074,000)	(2,155,000)	(1,990,800)	(1,919,700)	(1,668,200)	(1,511,300)	(1,626,500)	(1,506,500)	(1,468,400)	(1,498,500)	(1,370,000)	(1,190,600)	(1,035,000)	(890,300)	(826,500)	(1,809,400)	(745,600)	(673,000)	(605,500)
Total Net Property, Plant and Equipment									18,940,000	16,274,000	14,882,000	13,745,000	12,969,000	13,385,000	13,865,000	13,318,000	13,766,000	11,762,000	12,397,000	13,213,000	15,921,000	19,123,000	22,780,000	13,287,000	15,734,000	16,632,000	16,233,000	18,385,000	18,156,000	10,712,000	9,783,000	9,425,000	8,685,000	4,415,000	3,793,000	3,850,000	3,472,600	3,073,200	2,632,500	2,305,100	2,381,000	2,109,800	1,784,100	1,655,100	1,505,900	1,351,300	1,268,300	1,155,600	1,157,000	1,138,500	998,200	825,000	759,300
Net Intangible Assets
Gross Goodwill and Other Intangible Assets
Goodwill									67,783,000	51,375,000	49,208,000	49,556,000	48,202,000	53,411,000	55,952,000	54,449,000	48,242,000	42,069,000	42,519,000	43,661,000	44,569,000	43,947,000	42,376,000	21,464,000	21,382,000	20,876,000	20,985,000
Intangibles other than Goodwill
Trademarks and Patents									1,749,000	1,749,000	1,749,000	1,749,000	1,749,000	2,914,000	9,063,000	8,975,000	8,994,000	9,224,000	9,127,000	9,443,000	9,444,000
Licenses and Rights									102,786,000	88,812,000	76,143,000	75,905,000	75,209,000	90,869,000	91,461,000	85,259,000	79,232,000	71,937,000	72,934,000	73,263,000	73,726,000
Research and Development									23,193,000	11,357,000	3,092,000	3,175,000	5,919,000	2,171,000	5,249,000	10,101,000	1,171,000	387,000	443,000	669,000	1,200,000
Other Intangible Assets																				1,000		57,558,000	68,015,000	17,721,000	20,498,000	24,350,000	26,244,000	57,007,000	57,856,000	1,200,000	1,689,000	1,791,000	1,870,000	813,000	989,000	1,424,000	1,243,000	325,700	231,100	368,200	383,600	498,700	430,000	419,400	237,900	217,000	121,400	119,400	106,100	104,200	102,900	116,400	103,800
Total Intangibles other than Goodwill									127,728,000	101,918,000	80,984,000	80,829,000	82,877,000	95,954,000	105,773,000	104,335,000	89,397,000	81,548,000	82,504,000	83,376,000	84,370,000	57,558,000	68,015,000	17,721,000	20,498,000	24,350,000	26,244,000	57,007,000	57,856,000	1,200,000	1,689,000	1,791,000	1,870,000	813,000	989,000	1,424,000	1,243,000	325,700	231,100	368,200	383,600	498,700	430,000	419,400	237,900	217,000	121,400	119,400	106,100	104,200	102,900	116,400	103,800
Total Gross Goodwill and Other Intangible Assets									195,511,000	153,293,000	130,192,000	130,385,000	131,079,000	149,365,000	161,725,000	158,784,000	137,639,000	123,617,000	125,023,000	127,037,000	128,939,000	101,505,000	110,391,000	39,185,000	41,880,000	45,226,000	47,229,000	57,007,000	57,856,000	1,200,000	1,689,000	1,791,000	1,870,000	813,000	989,000	1,424,000	1,243,000	325,700	231,100	368,200	383,600	498,700	430,000	419,400	237,900	217,000	121,400	119,400	106,100	104,200	102,900	116,400	103,800
Accumulated Amortization and Impairment
Accumulated Amortization of Intangible Assets
Accumulated Amortization of Intangibles other than Goodwill
Accumulated Amortization of Trademarks and Patents									(877,000)	(844,000)	(807,000)	(774,000)	(741,000)	(708,000)	(1,152,000)	(1,032,000)	(928,000)	(855,000)	(773,000)	(693,000)	(687,000)
Accumulated Amortization of Licences and Rights									(61,951,000)	(57,704,000)	(55,031,000)	(51,719,000)	(48,200,000)	(60,035,000)	(55,881,000)	(50,655,000)	(48,111,000)	(45,526,000)	(42,346,000)	(37,537,000)	(32,499,000)
Accumulated Amortization of Research and Development																	0	0	0	0	0
Total Accumulated Amortization of Intangibles other than Goodwill									(62,828,000)	(58,548,000)	(55,838,000)	(52,493,000)	(48,941,000)	(60,743,000)	(57,033,000)	(51,687,000)	(49,039,000)	(46,381,000)	(43,119,000)	(38,230,000)	(33,186,000)
Total Accumulated Amortization of Intangible Assets									(62,828,000)	(58,548,000)	(55,838,000)	(52,493,000)	(48,941,000)	(60,743,000)	(57,033,000)	(51,687,000)	(49,039,000)	(46,381,000)	(43,119,000)	(38,230,000)	(33,186,000)
Total Accumulated Amortization and Impairment									(62,828,000)	(58,548,000)	(55,838,000)	(52,493,000)	(48,941,000)	(60,743,000)	(57,033,000)	(51,687,000)	(49,039,000)	(46,381,000)	(43,119,000)	(38,230,000)	(33,186,000)
Total Net Intangible Assets									132,683,000	94,745,000	74,354,000	77,892,000	82,138,000	88,622,000	104,692,000	107,097,000	88,600,000	77,236,000	81,904,000	88,807,000	95,753,000	101,505,000	110,391,000	39,185,000	41,880,000	45,226,000	47,229,000	57,007,000	57,856,000	1,200,000	1,689,000	1,791,000	1,870,000	813,000	989,000	1,424,000	1,243,000	325,700	231,100	368,200	383,600	498,700	430,000	419,400	237,900	217,000	121,400	119,400	106,100	104,200	102,900	116,400	103,800
Long Term Investments
Long Term Equity Investments									11,637,000	11,033,000	16,472,000	16,856,000	17,133,000	181,000
Investment in Financial Assets, Non-Current
Equity Securities/Shares, Non-Current									3,534,000	3,636,000	4,499,000
Financial Investment Securities, Available-for-Sale & Held-to-Maturity, Non-Current
Available-for-Sale Securities, Non-Current									150,000	352,000	521,000
Held-to-Maturity Securities, Non-Current									47,000	48,000	34,000
Total Financial Investment Securities, Available-for-Sale & Held-to-Maturity, Non-Current									197,000	400,000	555,000
Total Investment in Financial Assets, Non-Current									3,731,000	4,036,000	5,054,000
Other Investments, Non-Current												3,406,000	3,014,000	2,586,000
Total Long Term Investments									15,368,000	15,069,000	21,526,000	20,262,000	20,147,000	2,767,000	7,015,000	7,116,000	15,999,000	17,518,000	16,406,000	14,149,000	9,814,000	9,748,000	13,122,000	11,478,000
Trade and Other Receivables, Non-Current
Taxes Receivable, Non-Current																					5,697,000
Total Trade and Other Receivables, Non-Current																					5,697,000
Deferred Tax Assets, Non-Current									3,706,000	6,693,000	3,341,000	2,383,000	1,911,000	1,924,000	1,855,000	1,812,000	1,794,000	1,944,000	1,554,000	1,565,000				4,122,000
Deferred Costs/Assets, Non-Current																								0
Assets Held for Sale/Discontinued Operations, Non-Current													13,427,000
Other Non-Current Assets									12,471,000	13,163,000	7,679,000	4,879,000	4,199,000	2,799,000	3,227,000	3,323,000	3,420,000	3,513,000	3,596,000	3,233,000		4,170,000	4,986,000		10,805,000	6,030,000	6,673,000	8,598,000	10,086,000	9,663,000	8,469,000	5,107,000	4,506,000	3,143,000	2,767,000	2,925,000	1,861,300	1,911,200	1,734,100	1,532,000	2,061,800	2,007,600	1,605,900	1,468,300	1,078,100	1,255,500	915,200	333,700	334,000	315,000	285,900	248,100	258,300
Total Non-Current Assets									183,168,000	145,944,000	121,782,000	119,161,000	134,791,000	109,497,000	130,654,000	132,666,000	123,579,000	111,973,000	115,857,000	120,967,000	127,185,000	134,546,000	151,279,000	68,072,000	68,419,000	67,888,000	70,135,000	83,990,000	86,098,000	21,575,000	19,941,000	16,323,000	15,061,000	8,371,000	7,549,000	8,199,000	6,576,900	5,310,100	4,597,700	4,205,300	4,826,400	4,616,100	3,820,000	3,542,800	2,821,900	2,823,800	2,304,900	1,608,700	1,597,100	1,557,700	1,387,000	1,189,500	1,121,400
Total Assets									226,501,000	197,205,000	181,476,000	154,229,000	167,594,000	159,422,000	171,797,000	171,615,000	167,381,000	167,566,000	172,101,000	185,798,000	188,002,000	195,014,000	212,949,000	111,148,000	115,268,000	115,546,000	116,970,000	123,078,000	116,775,000	46,356,000	39,153,000	33,510,000	31,372,000	18,302,000	14,991,000	14,667,000	12,729,300	11,098,500	9,330,900	9,590,100	9,634,600	9,052,000	8,324,800	7,637,600	6,922,600	5,163,700	4,462,900	4,047,100	3,936,100	3,781,000	3,647,100	3,363,700	3,049,100
Liabilities
Current Liabilities
Payables and Accrued Expenses, Current
Trade and Other Payables, Current
Trade/Accounts Payable, Current									6,710,000	6,809,000	5,578,000	4,283,000	3,887,000	4,674,000	4,656,000	4,536,000	3,620,000	3,210,000	3,234,000	2,921,000	3,678,000	4,026,000	4,370,000	1,751,000	2,270,000	2,019,000	2,073,000	2,672,000	2,587,000	1,620,000	1,411,000	1,719,000	1,889,000	971,000	660,000	913,000	715,300	524,900	479,100	456,400	462,900	450,300	401,400
Dividends Payable, Current									2,372,000	2,303,000	2,249,000	2,162,000	2,104,000	2,047,000	2,029,000	1,944,000	1,852,000	1,711,000	1,663,000	1,733,000	1,796,000	1,601,000	1,454,000	2,159,000
Taxes Payable, Current
Income Tax Payable, Current									2,349,000	1,587,000	1,266,000	1,049,000	980,000	1,265,000	477,000	437,000	418,000	531,000	678,000	979,000	1,009,000	946,000	10,107,000	656,000
Other Tax Payable, Current																						0	0	0
Total Taxes Payable, Current									2,349,000	1,587,000	1,266,000	1,049,000	980,000	1,265,000	477,000	437,000	418,000	531,000	678,000	979,000	1,009,000	946,000	10,107,000	656,000
Total Trade and Other Payables, Current									11,431,000	10,699,000	9,093,000	7,494,000	6,971,000	7,986,000	7,162,000	6,917,000	5,890,000	5,452,000	5,575,000	5,633,000	6,483,000	6,573,000	15,931,000	4,566,000	2,270,000	2,019,000	2,073,000	2,672,000	2,587,000	1,620,000	1,411,000	1,719,000	1,889,000	971,000	660,000	913,000	715,300	524,900	479,100	456,400	462,900	450,300	401,400
Accrued Expenses, Current																						2,108,000	2,242,000	1,667,000	1,974,000	1,903,000	1,602,000	1,939,000	3,142,000	1,084,000	1,026,000	982,000
Total Payables and Accrued Expenses, Current									11,431,000	10,699,000	9,093,000	7,494,000	6,971,000	7,986,000	7,162,000	6,917,000	5,890,000	5,452,000	5,575,000	5,633,000	6,483,000	8,681,000	18,173,000	6,233,000	4,244,000	3,922,000	3,675,000	4,611,000	5,729,000	2,704,000	2,437,000	2,701,000	1,889,000	971,000	660,000	913,000	715,300	524,900	479,100	456,400	462,900	450,300	401,400
Financial Liabilities, Current
Current Debt and Capital Lease Obligation
Current Debt
Commercial Paper									7,965,000	0		556,000	13,915,000	3,100,000	6,100,000	5,800,000
Other Loans, Current Debt									252,000	385,000	605,000	145,000	860,000	966,000	320,000	673,000
Total Current Debt									8,217,000	385,000	605,000	701,000	14,775,000	4,066,000	6,420,000	6,473,000	6,440,000	2,130,000	3,967,000	3,975,000	4,010,000	5,623,000	5,469,000	9,320,000	5,825,000	2,434,000	11,589,000	11,266,000	8,818,000	8,669,000	6,263,000	4,289,000	5,299,000	2,729,000	2,251,000	2,235,000	2,035,500	2,220,000	1,178,800	1,252,300	1,691,100	1,499,300	1,526,300	967,700	714,900	271,300	185,900	298,900	317,600	401,700	474,700	452,000	353,100
Current Portion of Long Term Debt and Capital Lease
Current Portion of Long Term Debt
Other Current Portion of LT Debt									2,129,000	2,549,000	1,636,000	2,002,000	1,415,000	4,770,000	3,520,000	4,190,000	3,719,000	3,011,000	2,060,000	2,449,000	6,000
Total Current Portion of Long Term Debt									2,129,000	2,549,000	1,636,000	2,002,000	1,415,000	4,770,000	3,520,000	4,190,000	3,719,000	3,011,000	2,060,000	2,449,000	6,000
Total Current Portion of Long Term Debt and Capital Lease									2,129,000	2,549,000	1,636,000	2,002,000	1,415,000	4,770,000	3,520,000	4,190,000	3,719,000	3,011,000	2,060,000	2,449,000	6,000
Total Current Debt and Capital Lease Obligation									10,346,000	2,934,000	2,241,000	2,703,000	16,190,000	8,836,000	9,940,000	10,663,000	10,159,000	5,141,000	6,027,000	6,424,000	4,016,000	5,623,000	5,469,000	9,320,000	5,825,000	2,434,000	11,589,000	11,266,000	8,818,000	8,669,000	6,263,000	4,289,000	5,299,000	2,729,000	2,251,000	2,235,000	2,035,500	2,220,000	1,178,800	1,252,300	1,691,100	1,499,300	1,526,300	967,700	714,900	271,300	185,900	298,900	317,600	401,700	474,700	452,000	353,100
Derivative and Hedging Liabilities, Current									5,000	11,000			5,000	(5,000)	14,000	24,000
Total Financial Liabilities, Current									10,351,000	2,945,000	2,241,000	2,703,000	16,195,000	8,831,000	9,954,000	10,687,000	10,159,000	5,141,000	6,027,000	6,424,000	4,016,000	5,623,000	5,469,000	9,320,000	5,825,000	2,434,000	11,589,000	11,266,000	8,818,000	8,669,000	6,263,000	4,289,000	5,299,000	2,729,000	2,251,000	2,235,000	2,035,500	2,220,000	1,178,800	1,252,300	1,691,100	1,499,300	1,526,300	967,700	714,900	271,300	185,900	298,900	317,600	401,700	474,700	452,000	353,100
Provisions, Current
Provision for Employee Entitlements, Current									2,776,000	3,407,000	3,332,000	3,049,000	2,390,000	2,397,000	2,196,000	2,487,000	2,359,000	1,841,000	1,792,000	1,875,000	2,120,000
Total Provisions, Current									2,776,000	3,407,000	3,332,000	3,049,000	2,390,000	2,397,000	2,196,000	2,487,000	2,359,000	1,841,000	1,792,000	1,875,000	2,120,000
Tax Liabilities, Current
Deferred Tax Liabilities, Current																								11,456,000
Total Liabilities, Current																								11,456,000
Deferred Liabilities, Current
Deferred Income/Customer Advances/Billings in Excess of Cost, Current									2,700,000	2,520,000	3,067,000	1,113,000
Total Deferred Liabilities, Current									2,700,000	2,520,000	3,067,000	1,113,000
Liabilities Held for Sale/Discontinued Operations, Current													2,413,000	1,890,000	0					1,442,000	1,224,000
Other Current Liabilities									20,537,000	22,568,000	24,939,000	11,561,000	9,334,000	10,753,000	11,115,000	11,023,000	10,990,000	9,153,000	9,972,000	13,812,000	15,066,000	14,305,000	13,583,000		11,766,000	15,743,000	13,148,000	10,581,000	9,362,000	7,182,000	5,029,000	4,991,000	4,708,000	3,492,000	2,083,000	2,492,000	2,436,400	2,081,000	1,785,700	1,508,700	1,266,500	1,167,300	983,900	1,376,600	1,241,700	899,300	773,800	784,700	809,400	703,800	649,100	644,800	601,500
Total Current Liabilities									47,794,000	42,138,000	42,671,000	25,920,000	37,304,000	31,858,000	30,427,000	31,115,000	29,399,000	21,587,000	23,366,000	29,186,000	28,909,000	28,609,000	37,225,000	27,009,000	21,835,000	22,099,000	28,412,000	26,458,000	23,909,000	18,555,000	13,729,000	11,981,000	11,896,000	7,192,000	4,994,000	5,640,000	5,187,200	4,825,900	3,443,600	3,217,400	3,420,500	3,116,900	2,911,600	2,344,300	1,956,600	1,170,600	959,700	1,083,600	1,127,000	1,105,500	1,123,800	1,096,800	954,600
Non-Current Liabilities
Financial Liabilities, Non-Current
Long Term Debt and Capital Lease Obligation
Long Term Debt
Notes Payables, Non-Current									60,982,000	32,080,000	34,948,000	35,774,000	34,821,000	32,902,000	32,783,000	30,520,000	8,442,000	12,406,000	9,121,000	6,428,000	6,602,000
Other Loans, Non-Current									(483,000)	(155,000)	(191,000)	(203,000)	(171,000)	7,000	(117,000)	(121,000)	20,298,000	19,135,000	21,341,000	24,608,000	28,324,000
Total Long Term Debt									60,499,000	31,925,000	34,757,000	35,571,000	34,650,000	32,909,000	32,666,000	30,399,000	28,740,000	31,541,000	30,462,000	31,036,000	34,926,000	38,410,000	43,193,000	7,963,000	7,314,000	5,546,000	6,347,000	7,279,000	5,755,000	3,140,000	2,609,000	1,123,000	1,774,000	527,000	725,000	687,000	833,000	604,200	570,500	571,300	396,600	193,300	190,600	226,900	248,900	285,400	323,500	338,300	483,700	520,500	690,000	583,100	565,500
Total Long Term Debt and Capital Lease Obligation									60,499,000	31,925,000	34,757,000	35,571,000	34,650,000	32,909,000	32,666,000	30,399,000	28,740,000	31,541,000	30,462,000	31,036,000	34,926,000	38,410,000	43,193,000	7,963,000	7,314,000	5,546,000	6,347,000	7,279,000	5,755,000	3,140,000	2,609,000	1,123,000	1,774,000	527,000	725,000	687,000	833,000	604,200	570,500	571,300	396,600	193,300	190,600	226,900	248,900	285,400	323,500	338,300	483,700	520,500	690,000	583,100	565,500
Derivative and Hedging Liabilities, Non-Current									1,039,000	959,000	1,438,000	1,562,000	1,305,000		872,000	998,000
Total Financial Liabilities, Non-Current									61,538,000	32,884,000	36,195,000	37,133,000	35,955,000	32,909,000	33,538,000	31,397,000	28,740,000	31,541,000	30,462,000	31,036,000	34,926,000	38,410,000	43,193,000	7,963,000	7,314,000	5,546,000	6,347,000	7,279,000	5,755,000	3,140,000	2,609,000	1,123,000	1,774,000	527,000	725,000	687,000	833,000	604,200	570,500	571,300	396,600	193,300	190,600	226,900	248,900	285,400	323,500	338,300	483,700	520,500	690,000	583,100	565,500
Provisions, Non-Current
Provision for Employee Entitlements, Non-Current
Pension and Other Post-Retirement Benefit Plans, Non-Current									2,167,000	2,250,000	3,724,000	5,411,000	6,217,000	6,610,000	7,430,000	8,172,000	8,119,000	10,264,000	7,303,000	11,273,000	9,699,000	9,236,000	9,635,000	5,839,000
Total Provision for Employee Entitlements, Non-Current									2,167,000	2,250,000	3,724,000	5,411,000	6,217,000	6,610,000	7,430,000	8,172,000	8,119,000	10,264,000	7,303,000	11,273,000	9,699,000	9,236,000	9,635,000	5,839,000
Total Provisions, Non-Current									2,167,000	2,250,000	3,724,000	5,411,000	6,217,000	6,610,000	7,430,000	8,172,000	8,119,000	10,264,000	7,303,000	11,273,000	9,699,000	9,236,000	9,635,000	5,839,000
Tax Liabilities, Non-Current
Deferred Tax Liabilities, Non-Current									640,000	1,023,000	349,000	4,063,000	5,652,000	3,700,000	3,900,000	30,753,000	26,877,000	23,317,000	25,590,000	21,193,000	18,861,000	18,648,000	17,839,000	2,959,000	7,696,000	8,015,000	9,707,000	12,026,000	13,012,000	364,000	398,000	380,000	485,000	197,000	127,000	253,000	166,100	211,700	189,400	146,900	284,800	351,800	311,600	312,700	317,700	203,600	170,000	67,800	71,500	77,000	59,700	44,300	46,600
Total Tax Liabilities, Non-Current									640,000	1,023,000	349,000	4,063,000	5,652,000	3,700,000	3,900,000	30,753,000	26,877,000	23,317,000	25,590,000	21,193,000	18,861,000	18,648,000	17,839,000	2,959,000	7,696,000	8,015,000	9,707,000	12,026,000	13,012,000	364,000	398,000	380,000	485,000	197,000	127,000	253,000	166,100	211,700	189,400	146,900	284,800	351,800	311,600	312,700	317,700	203,600	170,000	67,800	71,500	77,000	59,700	44,300	46,600
Payables and Accrued Expenses, Non-Current
Trade and Other Payables, Non-Current
Taxes Payable, Non-Current									8,534,000	9,812,000	11,331,000	11,560,000	12,126,000	14,737,000	18,697,000	4,000,000	3,992,000	4,353,000	3,993,000	6,581,000	6,886,000	6,245,000	9,000,000	6,568,000
Total Trade and Other Payables, Non-Current									8,534,000	9,812,000	11,331,000	11,560,000	12,126,000	14,737,000	18,697,000	4,000,000	3,992,000	4,353,000	3,993,000	6,581,000	6,886,000	6,245,000	9,000,000	6,568,000
Total Payables and Accrued Expenses, Non-Current									8,534,000	9,812,000	11,331,000	11,560,000	12,126,000	14,737,000	18,697,000	4,000,000	3,992,000	4,353,000	3,993,000	6,581,000	6,886,000	6,245,000	9,000,000	6,568,000
Other Non-Current Liabilities									16,539,000	13,180,000	9,743,000	6,669,000	6,894,000	5,850,000	6,149,000	6,337,000	5,257,000	4,883,000	4,767,000	4,851,000	6,100,000	5,601,000	5,611,000	3,070,000	13,299,000	8,454,000	6,740,000	9,037,000	8,722,000	4,347,000	4,124,000	3,950,000	3,267,000	1,576,000	1,212,000	1,083,000	989,800	1,094,000	1,222,600	901,000	472,000	269,300	351,100	452,600	517,000	88,800	82,400	72,900	73,100	81,400	76,000	75,600	68,500
Total Non-Current Liabilities									89,419,000	59,151,000	61,343,000	64,836,000	66,843,000	63,806,000	69,714,000	80,660,000	72,984,000	74,357,000	72,115,000	74,934,000	76,472,000	78,140,000	85,278,000	26,399,000	28,309,000	22,015,000	22,794,000	28,342,000	27,489,000	7,851,000	7,131,000	5,453,000	5,526,000	2,300,000	2,064,000	2,023,000	1,988,900	1,909,900	1,982,500	1,619,200	1,153,400	814,400	853,300	992,200	1,083,600	577,800	575,900	479,000	628,300	678,900	825,700	703,000	680,600
Total Liabilities									137,213,000	101,289,000	104,014,000	90,756,000	104,147,000	95,664,000	100,141,000	111,775,000	102,383,000	95,944,000	95,481,000	104,120,000	105,381,000	106,749,000	122,503,000	53,408,000	50,144,000	44,114,000	51,206,000	54,800,000	51,398,000	26,406,000	20,860,000	17,434,000	17,422,000	9,492,000	7,058,000	7,663,000	7,176,100	6,735,800	5,426,100	4,836,600	4,573,900	3,931,300	3,764,900	3,336,500	3,040,200	1,748,400	1,535,600	1,562,600	1,755,300	1,784,400	1,949,500	1,799,800	1,635,200
Equity
Equity Attributable to Parent Stockholders
Paid in Capital
Capital Stock
Common Stock									478,000	476,000	473,000	470,000	468,000	467,000	464,000	461,000	459,000	455,000	453,000	448,000	445,000	444,000	443,000	443,000	442,000	441,000	439,000	438,000	435,000	341,000	340,000	337,000	332,000
Preferred Stock									0	0	0	0	17,000	19,000	21,000	24,000	26,000	29,000	33,000	39,000	45,000	52,000	61,000	73,000	93,000	141,000	169,000	193,000	219,000
Additional Paid in Capital/Share Premium									92,631,000	91,802,000	90,591,000	88,674,000	87,428,000	86,253,000	84,278,000	82,685,000	81,016,000	78,977,000	77,283,000	72,608,000	71,423,000	70,760,000	70,497,000	70,283,000	69,913,000	69,104,000	67,759,000	67,098,000	66,396,000	9,368,000	9,300,000	8,895,000	5,943,000
Total Capital Stock									93,109,000	92,278,000	91,064,000	89,144,000	87,913,000	86,739,000	84,763,000	83,170,000	81,501,000	79,461,000	77,769,000	73,095,000	71,913,000	71,256,000	71,001,000	70,799,000	70,448,000	69,686,000	68,367,000	67,729,000	67,050,000	9,709,000	9,640,000	9,232,000	6,275,000
Treasury Stock									(114,487,000)	(113,969,000)	(111,361,000)	(110,988,000)	(110,801,000)	(101,610,000)	(89,425,000)	(84,364,000)	(79,252,000)	(73,021,000)	(67,923,000)	(40,122,000)	(31,801,000)	(22,712,000)	(21,632,000)	(57,391,000)	(56,847,000)	(46,740,000)	(39,767,000)	(35,992,000)	(29,352,000)	(16,341,000)	(11,378,000)	(7,858,000)	(6,851,000)
Total Paid in Capital									(21,378,000)	(21,691,000)	(20,297,000)	(21,844,000)	(22,888,000)	(14,871,000)	(4,662,000)	(1,194,000)	2,249,000	6,440,000	9,846,000	32,973,000	40,112,000	48,544,000	49,369,000	13,408,000	13,601,000	22,946,000	28,600,000	31,737,000	37,698,000	(6,632,000)	(1,738,000)	1,374,000	(576,000)
Retained Earnings/Accumulated Deficit									118,353,000	125,656,000	103,394,000	90,392,000	97,670,000	89,554,000	85,291,000	71,774,000	71,993,000	72,176,000	69,732,000	54,240,000	46,210,000	42,716,000	40,426,000	49,142,000	49,660,000	49,669,000	37,608,000	35,492,000	29,382,000	30,243,000	24,430,000	19,599,000	18,459,000	11,439,000	9,349,000	8,017,000	6,858,900	5,944,500	5,240,700	5,119,300	4,794,900	4,509,900	4,105,400	3,697,400	3,327,100	2,933,700	2,543,400	2,197,300	1,848,200	1,591,800	1,396,800	1,328,500	1,188,400
Reserves/Accumulated Comprehensive Income/Losses
Other Reserves/Accum. Comp. Inc									(217,000)	(412,000)	119,000	(5,310,000)	(11,640,000)	(11,275,000)	(9,321,000)	(11,036,000)	(9,522,000)	(7,316,000)	(3,271,000)	(5,953,000)	(4,129,000)				(2,123,000)	(3,484,000)			(2,335,000)	(2,223,000)	(2,876,000)	(3,411,000)	(2,905,000)
Cumulative Foreign Exchange Translation Reserves/Accum. Comp. Inc									(7,863,000)	(8,360,000)	(6,172,000)														3,872,000	2,227,000			632,000	(1,438,000)	(1,523,000)	(1,486,000)	(1,028,000)
Available for Sale Financial Investments Reserves/Accum. Comp. Inc									(9,000)	220,000	(220,000)
Pension and Other Post-Retirement Benefit Plans Reserves/Accum. Comp. Inc									128,000	248,000	377,000
Total Reserves/Accumulated Comprehensive Income/Losses									(7,961,000)	(8,304,000)	(5,896,000)	(5,310,000)	(11,640,000)	(11,275,000)	(9,321,000)	(11,036,000)	(9,522,000)	(7,316,000)	(3,271,000)	(5,953,000)	(4,129,000)	(3,440,000)	552,000	(4,569,000)	1,749,000	(1,257,000)	(444,000)	1,049,000	(1,703,000)	(3,661,000)	(4,399,000)	(4,897,000)	(3,933,000)
Other Equity Interest																					(3,000)	(7,000)	(333,000)	(425,000)										(2,629,000)	(1,416,000)	(1,063,000)	(1,352,300)	(1,620,600)	(1,375,200)	(400,700)	231,400	582,100	430,400	603,700	555,300	481,600	383,900	287,200	332,600	404,800	300,800	235,400	225,500
Total Equity Attributable to Parent Stockholders									89,014,000	95,661,000	77,201,000	63,238,000	63,143,000	63,407,000	71,308,000	59,544,000	64,720,000	71,301,000	76,307,000	81,260,000	82,190,000	87,813,000	90,014,000	57,556,000	65,010,000	71,358,000	65,764,000	68,278,000	65,377,000	19,950,000	18,293,000	16,076,000	13,950,000	8,810,000	7,933,000	6,954,000	5,506,600	4,323,900	3,865,500	4,718,600	5,026,300	5,092,000	4,535,800	4,301,100	3,882,400	3,415,300	2,927,300	2,484,500	2,180,800	1,996,600	1,697,600	1,563,900	1,413,900
Non-Controlling/Minority Interests									274,000	256,000	262,000	235,000	303,000	351,000	348,000	296,000	278,000	321,000	313,000	418,000	431,000	452,000	432,000	184,000	114,000	74,000										50,000	46,600	38,800	39,300	34,900	34,400	28,700	24,100
Total Equity									89,288,000	95,916,000	77,462,000	63,473,000	63,447,000	63,758,000	71,656,000	59,840,000	64,998,000	71,622,000	76,620,000	81,678,000	82,621,000	88,265,000	90,446,000	57,740,000	65,124,000	71,432,000	65,764,000	68,278,000	65,377,000	19,950,000	18,293,000	16,076,000	13,950,000	8,810,000	7,933,000	7,004,000	5,553,200	4,362,700	3,904,800	4,753,500	5,060,700	5,120,700	4,559,900	4,301,100	3,882,400	3,415,300	2,927,300	2,484,500	2,180,800	1,996,600	1,697,600	1,563,900	1,413,900
Balance Sheet Supplemental Section
Common Shares Issued
Common Shares Outstanding									5,646,000,000	5,616,000,000	5,620,000,000	5,567,000,000	5,534,000,000	5,717,000,000	5,979,000,000	6,070,000,000	6,175,000,000	6,291,000,000	6,399,000,000	7,276,000,000	7,575,000,000	8,012,000,000	8,070,000,000	6,742,935,405	6,761,000,000	7,124,000,000	7,361,000,000	7,473,000,000	7,629,000,000	6,162,000,000	6,277,000,000	6,314,000,000	3,847,000,000	3,882,006,108	3,882,006,108	3,870,006,120	3,823,601,568	3,774,492,000	3,854,925,000	3,905,604,000	3,959,730,000	3,974,517,000	3,971,477,000	3,973,483,000	3,951,694,000	3,964,138,000	3,936,414,000	3,862,204,000	3,833,568,000	3,776,126,000	3,601,303,000	3,530,096,000	3,513,327,000
Common Shares Treasury									3,916,000,000	3,903,000,000	3,851,000,000	3,840,000,000	3,835,000,000	3,615,000,000	3,296,000,000	3,160,000,000	3,003,000,000	2,819,000,000	2,652,000,000	1,680,000,000	1,327,000,000	864,000,000	799,000,000
Total Common Shares Issued									9,562,000,000	9,519,000,000	9,471,000,000	9,407,000,000	9,369,000,000	9,332,000,000	9,275,000,000	9,230,000,000	9,178,000,000	9,110,000,000	9,051,000,000	8,956,000,000	8,902,000,000	8,876,000,000	8,869,000,000	6,742,935,405	6,761,000,000	7,124,000,000	7,361,000,000	7,473,000,000	7,629,000,000	6,162,000,000	6,277,000,000	6,314,000,000	3,847,000,000	3,882,006,108	3,882,006,108	3,870,006,120	3,823,601,568	3,774,492,000	3,854,925,000	3,905,604,000	3,959,730,000	3,974,517,000	3,971,477,000	3,973,483,000	3,951,694,000	3,964,138,000	3,936,414,000	3,862,204,000	3,833,568,000	3,776,126,000	3,601,303,000	3,530,096,000	3,513,327,000
Preferred Shares Issued
Preferred Shares Outstanding																		717,000,000	829,000,000	967,000,000	1,112,000,000	1,279,000,000	1,511,000,000	1,804,000,000
Total Preferred Shares Issued																		717,000,000	829,000,000	967,000,000	1,112,000,000	1,279,000,000	1,511,000,000	1,804,000,000
Total Maturity Schedule
Debt Maturity Schedule
Debt due in Year 1												2,703,000	16,195,000	8,831,000	3,546,000	10,688,000	10,160,000	5,141,000	6,027,000	6,424,000	4,018,000
Debt due in Year 2																3,567,000	4,412,000	3,990,000	3,040,000	3,922,000	3,964,000
Debt due in Year 3												4,346,000	4,769,000	5,935,000	6,388,000	3,350,000	2,400,000	3,963,000	4,412,000	3,065,000	3,987,000
Debt due in Year 4																360,000	4,807,000	2,399,000	2,660,000	4,449,000	3,074,000
Debt due in Year 5												3,068,000	5,274,000	4,067,000	4,732,000	4,241,000	364,000	4,771,000	2,413,000	1,907,000	4,500,000
Debt due Beyond												29,719,000	25,912,000	22,907,000	22,418,000	19,879,000	16,835,000	16,418,000	17,937,000	17,693,000	19,406,000
Total Debt Maturity Schedule												39,836,000	52,150,000	41,740,000	37,084,000	42,085,000	38,978,000	36,682,000	36,489,000	37,460,000	38,949,000
Operating Lease Obligation Maturity Schedule
Operating Lease due in year 1									639,000	662,000	520,000	357,000	323,000	300,000	209,000	220,000	202,000	183,000	204,000	184,000
Operating Lease due in year 2									474,000	489,000	417,000	299,000	286,000	252,000	172,000	188,000	196,000	159,000	168,000	162,000
Operating Lease due in year 3									387,000	356,000	322,000	250,000	220,000	210,000	150,000	163,000	170,000	151,000	130,000	132,000
Operating Lease due in year 4									319,000	300,000	279,000	167,000	180,000	267,000	136,000	138,000	143,000	112,000	98,000	85,000
Operating Lease due in year 5									262,000	246,000	217,000	137,000	97,000	248,000	123,000	125,000	119,000	88,000	80,000	74,000
Operating Lease due Beyond									1,743,000	1,791,000	1,865,000	408,000	424,000	2,040,000	891,000	967,000	1,002,000	774,000	771,000	618,000
Operating Lease - Interests Charges and Other Adjustments									(671,000)	(627,000)	(661,000)	(183,000)	(206,000)
Operating Lease Obligation Maturity Schedule Total									3,153,000	3,217,000	2,959,000	1,435,000	1,324,000	3,317,000	1,681,000	1,801,000	1,832,000	1,467,000	1,451,000	1,255,000
Other Contractual Obligations Maturity Schedule
Other Contractual Obligations due in year 1												3,362,000	3,271,000	27,024,000	2,781,000	2,944,000	2,703,000	2,923,000	3,182,000	3,548,000
Other Contractual Obligations due in year 3												6,367,000	5,929,000	6,198,000	6,614,000	4,197,000	3,876,000	4,391,000	4,738,000	5,013,000
Other Contractual Obligations due in year 5												7,469,000	5,804,000	4,991,000	6,224,000	3,927,000	3,325,000	3,482,000	3,618,000	3,306,000
Other Contractual Obligations due Beyond												18,828,000	21,445,000	23,032,000	26,434,000	16,589,000	14,230,000	13,985,000	13,910,000	14,761,000
Other Contractual Obligations - Interest Charges and Other Adjustments													(2,000)
Other Contractual Obligations Maturity Schedule Total												36,026,000	36,447,000	61,245,000	42,053,000	27,657,000	24,134,000	24,781,000	25,448,000	26,628,000
Lease Liability
Total Lease Liability - Due in year 1									639,000	662,000	520,000	357,000	323,000	300,000	209,000	220,000	202,000	183,000	204,000	184,000
Total Lease Liability - Due in year 2									474,000	489,000	417,000	299,000	286,000	252,000	172,000	188,000	196,000	159,000	168,000	162,000
Total Lease Liability - Due in year 3									387,000	356,000	322,000	250,000	220,000	210,000	150,000	163,000	170,000	151,000	130,000	132,000
Total Lease Liability - Due in year 4									319,000	300,000	279,000	167,000	180,000	267,000	136,000	138,000	143,000	112,000	98,000	85,000
Total Lease Liability - Due in year 5									262,000	246,000	217,000	137,000	97,000	248,000	123,000	125,000	119,000	88,000	80,000	74,000
Total Lease Liability - Beyond									1,743,000	1,791,000	1,865,000	408,000	424,000	2,040,000	891,000	967,000	1,002,000	774,000	771,000	618,000
Total Lease Liability - Interest Charges and Other Adjustments									(671,000)	(627,000)	(661,000)	(183,000)	(206,000)
Total Lease Liability									3,153,000	3,217,000	2,959,000	1,435,000	1,324,000	3,317,000	1,681,000	1,801,000	1,832,000	1,467,000	1,451,000	1,255,000
Contractual Obligations
Total Contractual Obligations due in year 1									639,000	662,000	520,000	6,422,000	3,594,000	27,324,000	6,536,000	13,852,000	2,905,000	8,247,000	9,413,000	10,156,000	4,018,000
Total Contractual Obligations due in year 2									474,000	489,000	417,000	299,000	286,000	252,000	172,000	3,755,000	196,000	4,149,000	3,208,000	4,084,000	3,964,000
Total Contractual Obligations due in year 3									387,000	356,000	322,000	10,963,000	6,149,000	6,408,000	13,152,000	7,710,000	4,046,000	8,505,000	9,280,000	8,210,000	3,987,000
Total Contractual Obligations due in year 4									319,000	300,000	279,000	167,000	180,000	267,000	136,000	498,000	143,000	2,511,000	2,758,000	4,534,000	3,074,000
Total Contractual Obligations due in year 5									262,000	246,000	217,000	10,674,000	5,901,000	5,239,000	11,079,000	8,293,000	3,444,000	8,341,000	6,111,000	5,287,000	4,500,000
Total Contractual Obligations due Beyond									1,743,000	1,791,000	1,865,000	48,955,000	21,869,000	25,072,000	49,743,000	37,435,000	15,232,000	31,177,000	32,618,000	33,072,000	19,406,000
Total Contractual Obligations - Interests Charges and Other Adjustments									(671,000)	(627,000)	(661,000)	(183,000)	(208,000)
Total Contractual Obligations									3,153,000	3,217,000	2,959,000	77,297,000	37,771,000	64,562,000	80,818,000	71,543,000	25,966,000	62,930,000	63,388,000	65,343,000	38,949,000
Financial Health Metrics
Total Debt									70,845,000	34,859,000	36,998,000	38,274,000	50,840,000	41,745,000	42,606,000	41,062,000	38,899,000	36,682,000	36,489,000	37,460,000	38,942,000	44,033,000	48,662,000	17,283,000	13,139,000	7,980,000	17,936,000	18,545,000	14,573,000	11,809,000	8,872,000	5,412,000	7,073,000	3,256,000	2,976,000	2,922,000	2,868,500	2,824,200	1,749,300	1,823,600	2,087,700	1,692,600	1,716,900	1,194,600	963,800	556,700	509,400	637,200	801,300	922,200	1,164,700	1,035,100	918,600
Net Debt									58,155,000	12,127,000	5,929,000	26,051,000	41,194,000	22,912,000	22,614,000	23,212,000	15,609,000	560,000	4,081,000	5,061,000	12,490,000	16,021,000	22,693,000	(6,448,000)	(12,336,000)	(19,733,000)	(4,290,000)	(1,348,000)	2,621,000	(742,000)	257,000	(1,451,000)	687,000	1,704,000	2,099,000	1,772,000	2,465,200	1,365,700	1,019,900	566,500	770,100	822,300	891,500	387,100	(67,300)	158,100	96,800	(243,700)	85,600	311,000	597,800	544,500	439,800
Common Equity Book Value									89,014,000	95,661,000	77,201,000	63,238,000	63,126,000	63,388,000	71,287,000	59,520,000	64,694,000	71,272,000	76,274,000	81,221,000	82,145,000	87,761,000	89,953,000	57,483,000	64,917,000	71,217,000	65,595,000	68,085,000	65,158,000	19,950,000	18,293,000	16,076,000	13,950,000	8,810,000	7,933,000	6,954,000	5,506,600	4,323,900	3,865,500	4,718,600	5,026,300	5,092,000	4,535,800	4,301,100	3,882,400	3,415,300	2,927,300	2,484,500	2,180,800	1,996,600	1,697,600	1,563,900	1,413,900
Total Liabilities & Equity									226,501,000	197,205,000	181,476,000	154,229,000	167,594,000	159,422,000	171,797,000	171,615,000	167,381,000	167,566,000	172,101,000	185,798,000	188,002,000	195,014,000	212,949,000	111,148,000	115,268,000	115,546,000	116,970,000	123,078,000	116,775,000	46,356,000	39,153,000	33,510,000	31,372,000	18,302,000	14,991,000	14,667,000	12,729,300	11,098,500	9,330,900	9,590,100	9,634,600	9,052,000	8,324,800	7,637,600	6,922,600	5,163,700	4,462,900	4,047,100	3,936,100	3,781,000	3,647,100	3,363,700	3,049,100
Net Tangible Assets									93,818,000	102,460,000	107,122,000	76,337,000	85,456,000	70,800,000	67,105,000	64,518,000	78,781,000	90,330,000	90,197,000	96,991,000	92,249,000	93,509,000	102,558,000	71,963,000	73,388,000	70,320,000	69,741,000	66,071,000	58,919,000	45,156,000	37,464,000	31,719,000	29,502,000	17,489,000	14,002,000	13,243,000	11,486,300	10,772,800	9,099,800	9,221,900	9,251,000	8,553,300	7,894,800	7,218,200	6,684,700	4,946,700	4,341,500	3,927,700	3,830,000	3,676,800	3,544,200	3,247,300	2,945,300
Tangible Book Value									(43,395,000)	1,171,000	3,108,000	(14,419,000)	(18,691,000)	(24,864,000)	(33,036,000)	(47,257,000)	(23,602,000)	(5,614,000)	(5,284,000)	(7,129,000)	(13,132,000)	(13,240,000)	(19,945,000)	18,555,000	23,244,000	26,206,000	18,535,000	11,271,000	7,521,000	18,750,000	16,604,000	14,285,000	12,080,000	7,997,000	6,944,000	5,580,000	4,310,200	4,037,000	3,673,700	4,385,300	4,677,100	4,622,000	4,129,900	3,881,700	3,644,500	3,198,300	2,805,900	2,365,100	2,074,700	1,892,400	1,594,700	1,447,500	1,310,100
Working Capital									(4,461,000)	9,121,000	17,022,000	9,147,000	(4,501,000)	18,068,000	10,714,000	7,834,000	14,405,000	34,008,000	32,878,000	35,645,000	31,908,000	31,859,000	24,445,000	16,067,000	25,014,000	25,559,000	18,423,000	12,630,000	6,768,000	6,226,000	5,483,000	5,206,000	4,415,000	2,739,000	2,448,000	828,000	965,200	962,500	1,289,600	2,167,400	1,387,700	1,319,000	1,593,200	1,750,500	2,144,100	1,169,300	1,198,300	1,354,800	1,212,000	1,117,800	1,136,300	1,077,400	973,100
Invested Capital									160,133,000	130,775,000	114,460,000	101,747,000	114,287,000	105,503,000	114,262,000	100,902,000	103,897,000	108,304,000	113,109,000	119,138,000	121,563,000	132,298,000	139,108,000	75,023,000	78,263,000	79,412,000	83,700,000	86,823,000	79,950,000	31,759,000	27,165,000	21,488,000	21,023,000	12,066,000	10,909,000	9,926,000	8,421,700	7,186,900	5,654,100	6,577,100	7,148,400	6,813,300	6,276,800	5,495,700	4,846,200	3,972,000	3,436,700	3,121,700	2,982,100	2,918,800	2,862,300	2,599,000	2,332,500
Total Shares Outstanding (TSO)									5,646,413,292	5,613,314,537	5,620,000,000	5,567,000,000	5,534,000,000	5,717,000,000	5,960,707,317	6,068,355,132	6,175,000,000	6,291,000,000	6,399,000,000	7,276,000,000	7,686,966,786	8,012,000,000	8,070,000,000	6,742,935,405	6,761,000,000	7,210,444,662	7,371,396,380	7,473,000,000	7,629,000,000	6,162,000,000	6,277,000,000	6,309,039,330	3,847,000,000	3,882,006,108	3,882,006,108	3,870,006,120	3,816,930,252	3,781,123,000	3,854,925,000	3,905,604,000	3,959,730,000	3,974,517,000	3,971,489,000	3,951,694,000	3,951,694,000	3,964,138,000	3,936,414,000	3,862,204,000	3,776,126,000	3,776,126,000	3,601,303,000	3,530,096,000	3,513,327,000
Number of Employees									83,000	79,000	79,000	78,500	88,300	92,400	96,500	97,900	97,900	78,300	77,700	91,500	110,600	110,600	116,500	81,800	86,600	106,000	115,000	115,000	122,000	98,000	90,000	50,900	50,900	46,400	49,200	46,500	40,800	40,500	40,500	40,700	44,100	42,500
Per Share Calculations
Book Value per Share									15.77	17.03	13.74	11.36	11.41	11.09	11.92	9.81	10.48	11.33	11.92	11.16	10.84	10.95	11.15	8.52	9.60	10.00	8.91	9.11	8.54	3.24	2.91	2.55	3.63	2.27	2.04	1.80	1.44	1.15	1.00	1.21	1.27	1.28	1.14	1.08	0.98	0.86	0.74	0.64	0.57	0.53	0.47	0.44	0.40
Cash And Cash Equivalents per Share									0.51	0.07	0.35	0.32	0.20	0.20	0.22	0.43	0.59	0.53	0.34	1.39	0.42	0.22	0.25	0.31	0.50	0.26	0.31	0.24	0.20	0.30	0.17	0.17	0.61	0.40	0.23	0.30	0.11	0.39	0.19	0.32	0.33	0.22	0.21	0.20	0.26	0.10	0.10	0.23	0.19	0.16	0.16	0.14	0.14
Cash, Cash Equivalents And Short Term Investments per Share									2.25	4.05	5.53	2.20	1.74	3.29	3.34	2.94	3.77	5.74	5.06	4.45	3.49	3.50	3.22	3.52	3.77	3.89	3.02	2.66	1.57	2.04	1.37	1.09	1.66	0.40	0.23	0.30	0.11	0.39	0.19	0.32	0.33	0.22	0.21	0.20	0.26	0.10	0.10	0.23	0.19	0.16	0.16	0.14	0.14
Net Intangible Assets per Share									23.50	16.87	13.23	13.99	14.84	15.50	17.51	17.64	14.35	12.28	12.80	12.21	12.64	12.67	13.68	5.81	6.19	6.35	6.42	7.63	7.58	0.19	0.27	0.28	0.49	0.21	0.25	0.37	0.33	0.09	0.06	0.09	0.10	0.13	0.11	0.11	0.06	0.05	0.03	0.03	0.03	0.03	0.03	0.03	0.03
Total Asset per Share									40.12	35.11	32.29	27.70	30.28	27.89	28.73	28.27	27.11	26.64	26.89	25.54	24.82	24.34	26.39	16.48	17.05	16.22	15.89	16.47	15.31	7.52	6.24	5.31	8.15	4.71	3.86	3.79	3.33	2.94	2.42	2.46	2.43	2.28	2.10	1.92	1.75	1.30	1.13	1.05	1.03	1.00	1.01	0.95	0.87
Data Origination
Preliminary									No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No
Original									No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No
Restated									Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes
Calculated									No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No
© PitchBook Data, Inc. 2024
Public Fundamental Data provided by Morningstar, Inc.

Cash Flow

Cash Flow (Fiscal Year)
Downloaded On: 18-Apr-2024	Summary Stats
Company: Pfizer (Pharmaceuticals) (NYS: PFE)	Median	Mean	Min	Max	25th pctile	75th pctile	Std. Dev	Coefficient of Variation	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003	FY 2002	FY 2001	FY 2000	FY 1999	FY 1998	FY 1997	FY 1996	FY 1995	FY 1994	FY 1993	FY 1992	FY 1991	FY 1990	FY 1989	FY 1988	FY 1987	FY 1986	FY 1985	FY 1984	FY 1983	FY 1982	FY 1981	FY 1980	FY 1979
Amounts in Thousands, USD (except Ratios, Multiples & per share items)
									Filed: 22-Feb-2024	Filed: 22-Feb-2024	Filed: 22-Feb-2024	Filed: 24-Feb-2022	Filed: 24-Feb-2022	Filed: 25-Feb-2021	Filed: 27-Feb-2020	Filed: 28-Feb-2019	Filed: 22-Feb-2018	Filed: 23-Feb-2017	Filed: 29-Feb-2016	Filed: 31-Dec-2012	Filed: 31-Dec-2011	Filed: 31-Dec-2010	Filed: 31-Dec-2009	Filed: 31-Dec-2008	Filed: 31-Dec-2007	Filed: 31-Dec-2006	Filed: 31-Dec-2005	Filed: 31-Dec-2004	Filed: 31-Dec-2003	Filed: 31-Dec-2002	Filed: 31-Dec-2001	Filed: 31-Dec-2000	Filed: 31-Dec-1999	Filed: 31-Dec-1998	Filed: 31-Dec-1997	Filed: 31-Dec-1996	Filed: 31-Dec-1995	Filed: 31-Dec-1994	Filed: 31-Dec-1993	Filed: 31-Dec-1992	Filed: 31-Dec-1991	Filed: 31-Dec-1990	Filed: 31-Dec-1989	Filing not available	Filing not available	Filing not available	Filing not available	Filing not available	Filing not available	Filing not available	Filing not available	Filing not available	Filing not available
									View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K	View 10-K/A	View 10-K	View 10-K
Cash Flow from Operating Activities, Indirect
Net Cash Flow from Continuing Operating Activities, Indirect
Cash Generated from Operating Activities
Income/(Loss) before Non-Cash Adjustment									2,172,000	31,401,000	22,459,000	7,021,000	10,738,000	3,861,000	21,355,000	7,246,000	6,986,000	9,168,000	22,072,000	14,598,000	10,049,000	8,288,000	8,644,000	8,127,000	8,144,000	19,337,000	8,085,000	11,361,000	3,910,000	9,126,000	7,788,000	3,718,000	4,972,000	4,633,000	2,213,000	1,929,000	1,572,900	1,298,400	657,500	1,093,500	722,100	801,200	681,100
Adjustments for Non-Cash Items
Depreciation, Amortization and Depletion, Non-Cash Adjustment
Depreciation and Amortization, Non-Cash Adjustment									6,290,000	5,064,000	5,191,000	4,777,000	5,755,000	6,150,000	6,269,000	5,757,000	5,157,000	5,537,000	6,410,000	7,655,000	9,026,000	8,399,000	4,757,000	5,090,000	5,200,000	5,293,000	5,576,000	5,093,000	4,025,000	1,036,000	972,000	968,000	905,000	797,000	428,000	359,000	374,000	292,000	258,200	263,900	244,100	224,800	207,100
Total Depreciation, Amortization and Depletion, Non-Cash Adjustment									6,290,000	5,064,000	5,191,000	4,777,000	5,755,000	6,150,000	6,269,000	5,757,000	5,157,000	5,537,000	6,410,000	7,655,000	9,026,000	8,399,000	4,757,000	5,090,000	5,200,000	5,293,000	5,576,000	5,093,000	4,025,000	1,036,000	972,000	968,000	905,000	797,000	428,000	359,000	374,000	292,000	258,200	263,900	244,100	224,800	207,100
Stock-Based Compensation, Non-Cash Adjustment									525,000	872,000	1,182,000	756,000	687,000	923,000	840,000	691,000	669,000	586,000	523,000	481,000	419,000	405,000	349,000	384,000
Taxes, Non-Cash Adjustment									(3,442,000)	(3,764,000)	(4,293,000)	(1,468,000)	561,000	(2,204,000)	(2,410,000)	(700,000)	(20,000)	317,000	1,703,000	2,198,000	454,000	1,953,000	(9,582,000)	(1,331,000)	(2,788,000)	(1,945,000)	(1,457,000)	(1,594,000)	631,000	(385,000)	193,000	(265,000)	213,000	(164,000)	13,000	80,000	(12,900)	32,600	(336,100)
Net Investment (Income)/Loss, Non-Cash Adjustment
Share of (Profit)/Loss from Associates, Joint Ventures and other Equity Investments, Non-Cash Adjustment												(6,000)	(8,254,000)	0	0
Net Foreign Exchange (Gain)/Loss, Non-Cash Adjustment																	806,000	0
(Gain)/Loss on Other Investments, Non-Cash Adjustment																			(459,000)	0	0
Total Net Investment (Income)/Loss, Non-Cash Adjustment												(6,000)	(8,254,000)	0	0		806,000	0	(459,000)	0	0
Irregular (Income)/Loss, Non-Cash Adjustment
(Gain)/Loss on Disposals, Non-Cash Adjustment
(Gain)/Loss on Disposal/Sale of Fixed Assets, Non-Cash Adjustment																							(670,000)	(14,000)
(Gain)/Loss on Disposal/Sale of Business, Non-Cash Adjustment																		(51,000)	(10,446,000)	(7,123,000)	(1,688,000)	11,000
(Gain)/Loss on Disposal/Sale of Other Assets, Non-Cash Adjustment																1,712,000	0
Total (Gain)/Loss on Disposals, Non-Cash Adjustment																1,712,000	0	(51,000)	(10,446,000)	(7,123,000)	(1,688,000)	11,000	(670,000)	(14,000)
Impairment/Write Off/Write Down of Capital Assets Loss/Reversal, Non-Cash Adjustment																							305,000	0
Impairment/Write Off/Write Down of Other Assets, Non-Cash Adjustment									9,607,000	1,733,000	276,000	2,049,000	2,889,000	3,398,000	634,000	1,613,000	1,119,000	531,000	1,145,000	1,299,000	1,198,000	3,486,000
Total Irregular (Income)/Loss, Non-Cash Adjustment									9,607,000	1,733,000	276,000	2,049,000	2,889,000	3,398,000	634,000	3,325,000	1,119,000	480,000	(9,301,000)	(5,824,000)	(490,000)	3,497,000	(365,000)	(14,000)
Other Operating (Gain)/Loss, Non-Cash Adjustment																								627,000	(326,000)	(280,000)	(172,000)	1,761,000	3,833,000	84,000	(443,000)	(29,000)	310,000	(1,043,000)	(131,000)	(165,000)	77,200	(5,900)	763,000	(179,800)	224,100	(106,100)	(9,300)
Other Non-Cash Items									(3,492,000)	758,000	(1,573,000)	(478,000)	(1,403,000)	(1,862,000)	(10,261,000)	487,000	(152,000)	(430,000)	(182,000)	(130,000)	18,000	(49,000)	812,000	496,000	3,755,000	2,416,000	3,575,000	558,000	588,000								(112,200)
Total Adjustments for Non-Cash Items									9,488,000	4,663,000	783,000	5,630,000	235,000	6,405,000	(4,928,000)	9,560,000	7,579,000	6,490,000	(1,306,000)	4,380,000	9,427,000	14,205,000	(4,029,000)	5,252,000	5,841,000	5,484,000	7,522,000	5,818,000	9,077,000	735,000	722,000	674,000	1,428,000	(410,000)	310,000	274,000	326,100	318,700	685,100	84,100	468,200	118,700	197,800
Changes in Operating Capital
Change in Inventories									(1,169,000)	(591,000)	(1,125,000)	(736,000)	(1,071,000)	(432,000)	(357,000)	365,000	(199,000)	175,000	(538,000)	(631,000)	1,084,000	2,917,000	1,631,000	294,000	720,000	118,000	72,000	(542,000)	(200,000)	(129,000)	(110,000)	(436,000)	(278,000)	(566,000)	(350,000)	(140,000)	(24,600)	(110,800)	(142,300)	(116,100)	(118,000)	(38,800)	(77,100)
Change in Trade and Other Receivables
Change in Trade/Accounts Receivable									347,000	261,000	(3,811,000)	(1,249,000)	(1,124,000)	(458,000)	259,000	(134,000)	21,000	148,000	940,000	367,000	140,000	(608,000)	252,000	195,000
Total Change in Trade and Other Receivables									347,000	261,000	(3,811,000)	(1,249,000)	(1,124,000)	(458,000)	259,000	(134,000)	21,000	148,000	940,000	367,000	140,000	(608,000)	252,000	195,000	(320,000)	(172,000)	(803,000)	(465,000)	207,000	(963,000)	81,000	(498,000)	(1,274,000)	(902,000)	(477,000)	(259,000)	(290,200)	(160,700)	(160,800)	(193,800)	(101,800)	(62,700)	(221,700)
Change in Prepayments and Deposits																											615,000	(640,000)	(918,000)	(1,423,000)	106,000	365,000	(127,000)
Change in Other Current Assets									(663,000)	(4,506,000)	(1,057,000)	(146,000)	847,000	(52,000)	7,000	(47,000)	236,000	1,161,000	(822,000)	(434,000)	186,000	(818,000)	(867,000)	(538,000)										(486,000)	(128,000)	(174,000)	(170,700)	(11,500)	(44,800)	(343,700)	(206,300)	(88,700)	(154,000)
Change in Payables and Accrued Expenses
Change in Trade and Other Payables
Change in Trade/Accounts Payable									(300,000)	1,191,000	1,242,000	353,000	(341,000)	404,000	46,000	871,000	254,000	297,000	382,000	579,000	(367,000)	(301,000)
Change in Taxes Payable																							9,454,000	647,000
Change in Other Payables																							1,502,000	3,797,000
Total Change in Trade and Other Payables									(300,000)	1,191,000	1,242,000	353,000	(341,000)	404,000	46,000	871,000	254,000	297,000	382,000	579,000	(367,000)	(301,000)	10,956,000	4,444,000
Total Change in Payables and Accrued Expenses									(300,000)	1,191,000	1,242,000	353,000	(341,000)	404,000	46,000	871,000	254,000	297,000	382,000	579,000	(367,000)	(301,000)	10,956,000	4,444,000	1,509,000	(450,000)	(1,054,000)	(704,000)	909,000	461,000	(412,000)	807,000	378,000	970,000	(63,000)	25,000	407,900	167,900	30,500	69,700	74,300	70,900	184,800
Change in Other Current Liabilities									595,000	(1,449,000)	18,721,000	2,741,000	861,000	367,000	(67,000)	(223,000)	664,000	(650,000)	(3,117,000)	(2,738,000)	1,508,000	1,114,000		464,000	(2,002,000)	2,909,000	254,000	1,512,000	(1,258,000)	2,057,000	686,000	1,565,000	394,000	1,938,000	(83,000)	173,000		(13,500)	237,800	213,300	9,100	59,900	44,900
Change in Other Operating Capital									(982,000)	(545,000)	(1,166,000)	(1,238,000)	(3,074,000)	(163,000)	1,446,000	(734,000)	(235,000)	492,000	(223,000)	490,000	(18,000)	(12,666,000)			(707,000)	611,000	119,000
Total Changes in Operating Capital									(2,172,000)	(5,639,000)	12,804,000	(275,000)	(3,902,000)	(334,000)	1,334,000	98,000	741,000	1,623,000	(3,378,000)	(2,367,000)	2,533,000	(10,362,000)	11,972,000	4,859,000	(800,000)	3,016,000	(797,000)	(839,000)	(1,260,000)	3,000	351,000	1,803,000	(907,000)	954,000	(1,101,000)	(375,000)	(77,600)	(128,600)	(79,600)	(370,600)	(342,700)	(59,400)	(223,100)
Total Cash Generated from Operating Activities									9,488,000	30,425,000	36,046,000	12,376,000	7,071,000	9,932,000	17,761,000	16,904,000	15,306,000	17,281,000	17,388,000	16,611,000	22,009,000	12,131,000	16,587,000	18,238,000	13,185,000	27,837,000	14,810,000	16,340,000	11,727,000	9,864,000	8,861,000	6,195,000	5,493,000	5,177,000	1,422,000	1,828,000	1,821,400	1,488,500	1,263,000	807,000	847,600	860,500	655,800
Other Operating Cash Flow									(787,000)	(1,158,000)	(3,123,000)	(1,790,000)	(55,000)	(1,057,000)	(961,000)	(712,000)	(617,000)	(199,000)	296,000	135,000	(1,769,000)	(677,000)
Total Net Cash Flow from Continuing Operating Activities, Indirect									8,701,000	29,267,000	32,923,000	10,586,000	7,016,000	8,875,000	16,800,000	16,192,000	14,689,000	17,082,000	17,684,000	16,746,000	20,240,000	11,454,000	16,587,000	18,238,000	13,185,000	27,837,000	14,810,000	16,340,000	11,727,000	9,864,000	8,861,000	6,195,000	5,493,000	5,177,000	1,422,000	1,828,000	1,821,400	1,488,500	1,263,000	807,000	847,600	860,500	655,800
Net Cash Flow from Discontinued Operating Activities									0	0	(343,000)	3,817,000	5,572,000	6,952,000											168,000	(10,243,000)	(77,000)			319,000	313,000		(20,000)	4,000	118,000	134,000
Total Cash Flow from Operating Activities, Indirect									8,700,000	29,267,000	32,580,000	14,403,000	12,588,000	15,827,000	16,802,000	16,192,000	14,688,000	17,084,000	17,684,000	16,746,000	20,240,000	11,454,000	16,587,000	18,238,000	13,353,000	17,594,000	14,733,000	16,340,000	11,727,000	10,183,000	9,174,000	6,195,000	5,473,000	5,181,000	1,540,000	1,962,000	1,821,400	1,488,500	1,263,000	807,000	847,600	860,500	655,800
Cash Flow from Investing Activities
Cash Flow from Continuing Investing Activities
(Purchase)/Sale and Disposal of Property, Plant and Equipment, Net
Purchase of Property, Plant and Equipment									(3,907,000)	(3,236,000)	(2,711,000)	(2,226,000)	(2,046,000)	(1,984,000)	(1,956,000)	(1,823,000)	(1,397,000)	(1,199,000)	(1,206,000)	(1,327,000)	(1,660,000)	(1,513,000)	(1,205,000)	(1,701,000)	(1,991,000)	(2,203,000)	(2,106,000)	(2,601,000)	(2,629,000)	(1,758,000)	(2,105,000)	(2,191,000)	(2,493,000)	(1,951,000)	(878,000)	(1,141,000)	(696,300)	(671,500)	(634,200)	(674,200)	(593,800)	(547,500)	(456,500)
Sale and Disposal of Property, Plant and Equipment																											127,000	1,276,000	5,602,000	220,000	8,000	468,000	109,000	3,302,000	68,000	451,000				896,600	212,300	351,800	10,800
Total (Purchase)/Sale and Disposal of Property, Plant and Equipment, Net									(3,907,000)	(3,236,000)	(2,711,000)	(2,226,000)	(2,046,000)	(1,984,000)	(1,956,000)	(1,823,000)	(1,397,000)	(1,199,000)	(1,206,000)	(1,327,000)	(1,660,000)	(1,513,000)	(1,205,000)	(1,701,000)	(1,991,000)	(2,203,000)	(1,979,000)	(1,325,000)	2,973,000	(1,538,000)	(2,097,000)	(1,723,000)	(2,384,000)	1,351,000	(810,000)	(690,000)	(696,300)	(671,500)	(634,200)	222,400	(381,500)	(195,700)	(445,700)
(Purchase)/Sale of Intangibles, Net
Purchase of Intangibles														(152,000)	(261,000)	(176,000)	(99,000)	(384,000)	(259,000)	(92,000)	(222,000)
Total (Purchase)/Sale of Intangibles, Net														(152,000)	(261,000)	(176,000)	(99,000)	(384,000)	(259,000)	(92,000)	(222,000)
(Purchase)/Sale of Business, Net
Purchase/Acquisition of Business									(43,430,000)	(22,997,000)	0	0	(10,861,000)	0	(1,000,000)	(18,368,000)	(16,466,000)	(195,000)	(15,000)	(1,050,000)	(3,282,000)	(273,000)	(43,123,000)	(1,184,000)
Sale of Business																				11,850,000	2,376,000	0
Total (Purchase)/Sale of Business, Net									(43,430,000)	(22,997,000)	0	0	(10,861,000)	0	(1,000,000)	(18,368,000)	(16,466,000)	(195,000)	(15,000)	10,800,000	(906,000)	(273,000)	(43,123,000)	(1,184,000)	(440,000)	(2,120,000)	(2,104,000)	(2,263,000)
(Purchase)/Sale of Investments, Net
Purchase of Investments									(31,178,000)	(38,780,000)	(47,613,000)	(14,402,000)	(7,036,000)	(13,474,000)	(18,133,000)	(23,968,000)	(38,123,000)	(61,672,000)	(58,058,000)	(35,163,000)	(23,067,000)	(15,210,000)	(42,219,000)	(45,062,000)	(27,061,000)	(11,522,000)	(28,727,000)	(18,828,000)	(11,814,000)	(15,529,000)	(17,926,000)	(8,820,000)	(9,270,000)	(5,965,000)	(221,000)	(2,850,000)	(2,610,400)	(1,355,900)	(760,900)	(535,700)	(210,600)	(89,600)	(526,900)
Sale of Investments									46,417,000	45,462,000	28,096,000	12,730,000	16,340,000	19,908,000	15,939,000	36,464,000	52,761,000	57,449,000	48,682,000	31,751,000	27,197,000	16,386,000	54,643,000	36,805,000	30,460,000	21,004,000	28,088,000	13,293,000	12,416,000	13,258,000	12,888,000	6,592,000	7,785,000	4,328,000	28,000	3,490,000	2,184,600	1,288,200	846,800	510,800	242,400	197,200	449,800
Total (Purchase)/Sale of Investments, Net									15,239,000	6,682,000	(19,517,000)	(1,672,000)	9,304,000	6,434,000	(2,194,000)	12,496,000	14,638,000	(4,223,000)	(9,376,000)	(3,412,000)	4,130,000	1,176,000	12,424,000	(8,257,000)	3,399,000	9,482,000	(639,000)	(5,535,000)	602,000	(2,271,000)	(5,038,000)	(2,228,000)	(1,485,000)	(1,637,000)	(193,000)	640,000	(425,800)	(67,700)	85,900	(24,900)	31,800	107,600	(77,100)
Dividends Received/(Paid), CFI									0	3,960,000	0
Other Investing Cash Flow									(179,000)	(192,000)	(305,000)	(265,000)	(223,000)	287,000	671,000	80,000	344,000	347,000	312,000	185,000	501,000	118,000	632,000	(1,693,000)	(173,000)	(58,000)	(350,000)	(299,000)	1,275,000	(529,000)		198,000	(37,000)	(482,000)	40,000	(800,000)	(1,220,700)	(101,100)	351,400	192,400	224,500	(240,900)	(104,000)
Total Cash Flow from Continuing Investing Activities									(32,277,000)	(15,783,000)	(22,533,000)	(4,163,000)	(3,826,000)	4,585,000	(4,740,000)	(7,791,000)	(2,980,000)	(5,654,000)	(10,544,000)	6,154,000	1,843,000	(492,000)	(31,272,000)	(12,835,000)	795,000	5,101,000	(5,072,000)	(9,422,000)	4,850,000	(4,338,000)	(7,135,000)	(3,753,000)	(3,906,000)	(768,000)	(963,000)	(850,000)	(2,342,800)	(840,300)	(196,900)	389,900	(125,200)	(329,000)	(626,800)
Net Cash Flow from Discontinued Investing Activities									0	0	(12,000)	(109,000)	(120,000)	(60,000)
Total Cash Flow from Investing Activities									(32,278,000)	(15,783,000)	(22,546,000)	(4,271,000)	(3,945,000)	4,525,000	(4,740,000)	(7,791,000)	(2,980,000)	(5,654,000)	(10,544,000)	6,154,000	1,843,000	(492,000)	(31,272,000)	(12,835,000)	795,000	5,101,000	(5,072,000)	(9,422,000)	4,850,000	(4,338,000)	(7,135,000)	(3,753,000)	(3,906,000)	(768,000)	(963,000)	(850,000)	(2,342,800)	(840,300)	(196,900)	389,900	(125,200)	(329,000)	(626,800)
Cash Flow from Financing Activities
Cash Flow from Continuing Financing Activities
Issuance of/(Payments for) Common Stock, Net
Proceeds from Issuance of Common Stock																									459,000	732,000	451,000	1,012,000	1,072,000	660,000	773,000	1,188,000	636,000	526,000	411,000	280,000	205,000	64,200
Payments for Common Stock									0	(2,000,000)	0	0	(8,865,000)	(12,198,000)	(5,000,000)	(5,000,000)	(6,160,000)	(5,000,000)	(16,290,000)	(8,228,000)	(9,000,000)	(1,000,000)	0	(500,000)	(9,994,000)	(6,979,000)	(3,797,000)	(6,659,000)	(13,037,000)	(4,996,000)	(3,665,000)	(1,005,000)	(2,542,000)	(2,177,000)	(586,000)	(27,000)	(108,500)	(511,200)	(1,019,600)	(665,100)	(463,900)	(132,200)	(154,700)
Total Issuance of/(Payments for) Common Stock, Net									0	(2,000,000)	0	0	(8,865,000)	(12,198,000)	(5,000,000)	(5,000,000)	(6,160,000)	(5,000,000)	(16,290,000)	(8,228,000)	(9,000,000)	(1,000,000)	0	(500,000)	(9,535,000)	(6,247,000)	(3,346,000)	(5,647,000)	(11,965,000)	(4,336,000)	(2,892,000)	183,000	(1,906,000)	(1,651,000)	(175,000)	253,000	96,500	(447,000)	(1,019,600)	(665,100)	(463,900)	(132,200)	(154,700)
Issuance of/(Repayments for) Debt, Net
Issuance of/(Repayments for) Short Term Debt, Net
Proceeds from Issuance of Short Term Debt									7,686,000	3,891,000	0	12,352,000	19,006,000	3,711,000	8,464,000	7,472,000	5,557,000	13,000	7,798,000	7,995,000	14,720,000	6,400,000	32,033,000	40,119,000
Repayments for Short Term Debt									(3,000)	(4,109,000)	(96,000)	(26,326,000)	(8,378,000)	(6,054,000)	(8,525,000)	(8,153,000)	(1,248,000)	(1,851,000)	(4,234,000)	(8,207,000)	(13,276,000)	(10,546,000)	(34,969,000)	(37,264,000)
Total Issuance of/(Repayments for) Short Term Debt, Net									7,683,000	(218,000)	(96,000)	(13,974,000)	10,628,000	(2,343,000)	(61,000)	(681,000)	4,309,000	(1,838,000)	3,564,000	(212,000)	1,444,000	(4,146,000)	(2,936,000)	2,855,000
Issuance of/(Repayments for) Long Term Debt, Net
Proceeds from Issuance of Long Term Debt									30,831,000	0	997,000	5,222,000	4,942,000	4,974,000	5,274,000	10,976,000	0	4,491,000	6,618,000	0	0		24,023,000	605,000
Repayments for Long Term Debt									(2,569,000)	(3,298,000)	(2,004,000)	(4,003,000)	(6,806,000)	(3,566,000)	(6,154,000)	(7,689,000)	(2,990,000)	(2,110,000)	(4,146,000)	(1,513,000)	(6,986,000)	(6,000)	(967,000)	(1,053,000)
Total Issuance of/(Repayments for) Long Term Debt, Net									28,262,000	(3,298,000)	(1,007,000)	1,219,000	(1,864,000)	1,408,000	(880,000)	3,287,000	(2,990,000)	2,381,000	2,472,000	(1,513,000)	(6,986,000)	(6,000)	23,056,000	(448,000)
Total Issuance of/(Repayments for) Debt, Net									35,945,000	(3,516,000)	(1,103,000)	(12,755,000)	8,764,000	(935,000)	(941,000)	2,606,000	1,319,000	543,000	6,036,000	(1,725,000)	(5,542,000)	(4,152,000)	20,120,000	2,407,000	4,900,000	(9,934,000)	(321,000)	4,100,000	(591,000)	2,505,000	3,511,000	(1,691,000)	2,099,000	(489,000)	183,000	107,000	58,000	1,070,600	(63,700)	(141,700)	459,100	(36,600)	614,000
Cash Dividends and Interest Paid
Cash Dividends Paid									(9,247,000)	(8,983,000)	(8,729,000)	(8,440,000)	(8,043,000)	(7,978,000)	(7,659,000)	(7,317,000)	(6,940,000)	(6,609,000)	(6,580,000)	(6,534,000)	(6,234,000)	(6,088,000)	(5,548,000)	(8,541,000)	(7,975,000)	(6,919,000)	(5,555,000)	(5,082,000)	(4,353,000)	(3,168,000)	(2,715,000)	(2,197,000)	(1,820,000)	(1,501,000)	(881,000)	(771,000)	(658,500)	(594,600)	(536,100)	(486,500)	(437,100)	(396,700)	(364,000)
Total Cash Dividends and Interest Paid									(9,247,000)	(8,983,000)	(8,729,000)	(8,440,000)	(8,043,000)	(7,978,000)	(7,659,000)	(7,317,000)	(6,940,000)	(6,609,000)	(6,580,000)	(6,534,000)	(6,234,000)	(6,088,000)	(5,548,000)	(8,541,000)	(7,975,000)	(6,919,000)	(5,555,000)	(5,082,000)	(4,353,000)	(3,168,000)	(2,715,000)	(2,197,000)	(1,820,000)	(1,501,000)	(881,000)	(771,000)	(658,500)	(594,600)	(536,100)	(486,500)	(437,100)	(396,700)	(364,000)
Proceeds from Issuance/Exercising of Stock Options/Warrants														1,259,000	862,000	1,019,000	1,263,000	1,002,000	1,750,000	568,000	153,000
Other Financing Cash Flow									(631,000)	(335,000)	16,000	(444,000)	(342,000)	(588,000)	(611,000)	(536,000)	109,000	(123,000)	109,000	(80,000)	16,000	66,000	(91,000)	74,000											50,000	44,000	(15,100)	32,900	52,400	65,300	179,300	65,600	43,500
Total Cash Flow from Continuing Financing Activities									26,067,000	(14,834,000)	(9,816,000)	(21,639,000)	(8,486,000)	(20,440,000)	(13,349,000)	(9,228,000)	(10,409,000)	(10,187,000)	(14,975,000)	(15,999,000)	(20,607,000)	(11,174,000)	14,481,000	(6,560,000)	(12,610,000)	(23,100,000)	(9,222,000)	(6,629,000)	(16,909,000)	(4,999,000)	(2,096,000)	(3,705,000)	(1,627,000)	(3,641,000)	(823,000)	(367,000)	(519,100)	61,900	(1,567,000)	(1,228,000)	(262,600)	(499,900)	138,800
Net Cash Flow from Discontinued Financing Activities												11,991,000	0	0
Total Cash Flow from Financing Activities									26,066,000	(14,834,000)	(9,816,000)	(9,649,000)	(8,485,000)	(20,441,000)	(13,350,000)	(9,228,000)	(10,409,000)	(10,187,000)	(14,975,000)	(15,999,000)	(20,607,000)	(11,174,000)	14,481,000	(6,560,000)	(12,610,000)	(23,100,000)	(9,222,000)	(6,629,000)	(16,909,000)	(4,999,000)	(2,096,000)	(3,705,000)	(1,627,000)	(3,641,000)	(823,000)	(367,000)	(519,100)	61,900	(1,567,000)	(1,228,000)	(262,600)	(499,900)	138,800
Cash and Cash Equivalents, End of Period
Change in Cash									2,488,000	(1,350,000)	218,000	483,000	158,000	(89,000)	(1,288,000)	(827,000)	1,299,000	1,243,000	(7,835,000)	6,901,000	1,476,000	(212,000)	(204,000)	(1,157,000)	1,538,000	(405,000)	439,000	289,000	(332,000)	846,000	(57,000)	(1,263,000)	(60,000)	772,000	(246,000)	745,000	(1,040,500)	710,100	(500,900)	(31,100)	459,800	31,600	167,800
Effect of Exchange Rate Changes									(40,000)	(165,000)	(59,000)	(8,000)	(32,000)	(116,000)	53,000	(215,000)	(1,000,000)	(83,000)	(63,000)	(2,000)	(29,000)	(31,000)	60,000	(127,000)	41,000	(15,000)		(1,000)	(26,000)	(4,000)	(6,000)	4,000	11,000	21,000	(27,000)	2,000	(14,700)	19,000	(26,800)	(29,400)	(12,500)	13,300	(9,000)
Other Changes																																				(1,150,000)	(403,300)	(1,458,500)	(729,400)	(1,257,100)	(1,317,600)	(870,300)	(825,400)
Cash and Cash Equivalents, Beginning of Period									468,000	1,983,000	1,825,000	1,350,000	1,225,000	1,431,000	2,666,000	3,707,000	3,343,000	2,183,000	10,081,000	3,182,000	1,735,000	1,978,000	2,122,000	3,406,000	1,827,000	2,247,000	1,808,000	1,520,000	1,878,000	1,036,000	1,099,000	2,358,000	2,407,000	1,614,000	1,150,000	403,000	1,458,500	729,400	1,257,100	1,317,600	870,300	825,400	666,600
Total Cash and Cash Equivalents, End of Period									2,917,000	468,000	1,983,000	1,825,000	1,350,000	1,225,000	1,431,000	2,666,000	3,641,000	3,343,000	2,183,000	10,081,000	3,182,000	1,735,000	1,978,000	2,122,000	3,406,000	1,827,000	2,247,000	1,808,000	1,520,000	1,878,000	1,036,000	1,099,000	2,358,000	2,407,000	877,000	0	0	0	0	0	0	0	0
Cash Flow Supplemental Section
Change in Cash As Reported, Supplemental									2,448,000	(1,515,000)	159,000	475,000	125,000	(205,000)	(1,235,000)	(1,041,000)	298,000	1,160,000	(7,898,000)	6,899,000	1,447,000	(243,000)	(144,000)	(1,284,000)	1,579,000	(420,000)	439,000	288,000	(358,000)	842,000	(63,000)	(1,259,000)	(49,000)	793,000	(273,000)	747,000	(1,055,200)	729,100	(527,700)	(60,500)	447,300	44,900	158,800
Income Tax Paid, Supplemental									(3,147,000)	(7,867,000)	(7,427,000)	(3,153,000)	(3,664,000)	(3,655,000)	(2,489,000)	(2,521,000)	(2,383,000)	(2,100,000)	(2,874,000)	(2,409,000)	(2,927,000)	(11,775,000)	(2,300,000)	(2,252,000)
Interest Paid, Supplemental									(2,215,000)	(1,442,000)	(1,467,000)	(1,641,000)	(1,587,000)	(1,311,000)	(1,518,000)	(1,451,000)	(1,302,000)	(1,550,000)	(1,729,000)	(1,873,000)	(2,085,000)	(2,155,000)	(935,000)	(782,000)
Cash Flow Metrics
FCF to Firm (FCFF)									8,711,110	32,789,152	18,600,884	9,991,264	10,209,050	8,033,680	14,011,000	15,122,076	13,384,822	14,889,200	20,623,564	18,914,644	16,976,485	21,880,766	4,392,801	12,106,439	11,994,000	22,618,000	13,501,000	14,578,000	10,358,000	8,103,000	6,405,000	2,201,000	3,907,000	2,272,000	1,645,000	1,062,000	1,202,700	945,600	708,400	503,400	596,500	372,400	422,400
FCF to Equityholders (FCFE)									6,966,000	31,670,000	17,408,000	8,635,000	8,872,000	7,073,000	13,249,000	14,095,000	12,452,000	13,876,000	19,597,000	17,694,000	15,825,000	20,303,000	3,410,000	11,678,000	11,994,000	22,618,000	13,501,000	14,578,000	10,358,000	8,103,000	6,405,000	2,201,000	3,907,000	2,272,000	1,645,000	1,062,000	1,202,700	945,600	708,400	503,400	596,500	372,400	422,400
Issuance of Capital Stock									0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	459,000	732,000	451,000	1,012,000	1,072,000	660,000	773,000	1,188,000	636,000	526,000	411,000	280,000	205,000	64,200	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Issuance of Debt									38,517,000	3,891,000	997,000	17,574,000	23,948,000	8,685,000	13,738,000	18,448,000	5,557,000	4,504,000	14,416,000	7,995,000	14,720,000	6,400,000	56,056,000	40,724,000	4,900,000	0	0	4,100,000	0	2,505,000	3,511,000	0	2,099,000	0	183,000	107,000	58,000	1,070,600	0	0	459,100	0	614,000	0	0	0	0	0	0	0	0	0	0
Repayment of Debt									(2,572,000)	(7,407,000)	(2,100,000)	(30,329,000)	(15,184,000)	(9,620,000)	(14,679,000)	(15,842,000)	(4,238,000)	(3,961,000)	(8,380,000)	(9,720,000)	(20,262,000)	(10,552,000)	(35,936,000)	(38,317,000)	0	(9,934,000)	(321,000)	0	(591,000)	0	0	(1,691,000)	0	(489,000)	0	0	0	0	(63,700)	(141,700)	0	(36,600)	0	0	0	0	0	0	0	0	0	0	0
Repurchase of Capital Stock									0	(2,000,000)	0	0	(8,865,000)	(12,198,000)	(5,000,000)	(5,000,000)	(6,160,000)	(5,000,000)	(16,290,000)	(8,228,000)	(9,000,000)	(1,000,000)	0	(500,000)	(9,994,000)	(6,979,000)	(3,797,000)	(6,659,000)	(13,037,000)	(4,996,000)	(3,665,000)	(1,005,000)	(2,542,000)	(2,177,000)	(586,000)	(27,000)	(108,500)	(511,200)	(1,019,600)	(665,100)	(463,900)	(132,200)	(154,700)	0	0	0	0	0	0	0	0	0	0
FCF to CFO Ratio									[$-en-US]0.64	[$-en-US]0.91	[$-en-US]0.87	[$-en-US]0.80	[$-en-US]0.81	[$-en-US]0.77	[$-en-US]0.86	[$-en-US]0.88	[$-en-US]0.89	[$-en-US]0.90	[$-en-US]0.93	[$-en-US]0.93	[$-en-US]0.89	[$-en-US]0.93	[$-en-US]0.74	[$-en-US]0.87	[$-en-US]0.86	[$-en-US]0.91	[$-en-US]0.87	[$-en-US]0.85	[$-en-US]0.80	[$-en-US]0.82	[$-en-US]0.75	[$-en-US]0.50	[$-en-US]0.61	[$-en-US]0.54	[$-en-US]0.65	[$-en-US]0.48	[$-en-US]0.63	[$-en-US]0.58	[$-en-US]0.53	[$-en-US]0.43	[$-en-US]0.50	[$-en-US]0.40	[$-en-US]0.48
Per Share Calculations
Free Cash Flow per Share									1.23	5.52	3.05	1.53	1.56	1.18	2.19	2.29	1.99	2.16	2.84	2.36	2.01	2.51	0.48	1.73	1.73	3.11	1.82	1.91	1.42	1.30	1.01	0.35	0.62	0.12	0.42	0.28	0.32	0.25	0.18	0.13	0.15	0.09	0.11
Operating Cash Flow per Share									1.93	6.09	3.52	1.93	1.92	1.54	2.55	2.61	2.23	2.41	3.05	2.55	2.25	2.70	0.66	1.98	2.02	3.41	2.11	2.26	1.78	1.58	1.34	0.69	1.01	0.22	0.65	0.57	0.50	0.42	0.34	0.30	0.30	0.23	0.22
Data Origination
Preliminary									No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No
Original									No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No
Restated									Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes
Calculated									No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No	No
© PitchBook Data, Inc. 2024
Public Fundamental Data provided by Morningstar, Inc.

Segments

Segments (Fiscal Year)
Downloaded On: 18-Apr-2024
Company: Pfizer (Pharmaceuticals) (NYS: PFE)	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Amounts in Thousands, USD (except Ratios, Multiples & per share items)
	Filed: 22-Feb-2024	Filed: 22-Feb-2024	Filed: 22-Feb-2024	Filed: 24-Feb-2022	Filed: 24-Feb-2022	Filed: 28-Feb-2019	Filed: 22-Feb-2018	Filed: 23-Feb-2017
Amount in thousands
Business Unit
Revenue
Biopharma	57,186,000	98,988,000	79,557,000	40,724,000	38,013,000
Other business activities	1,310,000	1,342,000	1,731,000	926,000	2,892,000
Innovative Health						33,426,000	31,422,000	29,197,000
Essential Health						20,221,000	21,124,000	23,627,000
Total Revenue	58,496,000	100,330,000	81,288,000	41,650,000	40,905,000	53,647,000	52,546,000	52,824,000
Region
Revenue
United States	27,088,000	42,473,000	29,746,000			25,329,000	26,026,000	26,369,000
Emerging Markets	11,996,000	20,097,000	20,701,000
Developed Europe	11,650,000	21,982,000	18,336,000			9,116,000	8,508,000	9,306,000
Developed Rest of World	4,251,240
Japan	3,509,760	8,026,400	7,315,920			4,291,760	4,203,680
Developed Rest of World	4,251,240
Emerging Markets	11,996,000	20,097,000	20,701,000
China						4,291,760	3,678,220
Total Revenue	58,495,000	100,330,000	81,289,000			53,647,000	52,545,000	52,824,000
Product/Services
Revenue
GLOBAL BIOPHARMACEUTICALS BUSINESS (BIOPHARMA)	57,186,000	98,988,000	79,557,000	40,724,000	38,013,000
Primary Care	30,589,000	73,023,000	52,029,000
Specialty Care	14,970,000	13,833,000	15,194,000
All other Specialty Care	2,244,000	2,350,000	2,830,000
All other Anti-infectives	1,092,000	1,171,000	1,572,000
Sulperazon	757,000	786,000	683,000	618,000	684,000
Immunoglobulin (Ig) portfolio	584,000	491,000	430,000
Zavicefta	511,000	412,000	413,000	212,000	108,000
Zithromax	406,000	331,000	278,000	276,000	336,000
Vyndaqel family	3,321,000	2,447,000	2,015,000	1,288,000	473,000
Xeljanz	1,703,000	1,796,000	2,455,000	2,437,000	2,242,000
Enbrel (Outside the U.S. and Canada)	830,000	1,003,000	1,185,000	1,350,000	1,699,000
Genotropin	539,000	360,000	389,000	427,000	498,000
Inflectra	490,000	532,000	657,000	659,000	625,000
BeneFIX	424,000	425,000	438,000	454,000	488,000
Somavert	267,000	268,000	277,000	277,000	264,000
Refacto AF/Xyntha	230,000	239,000	304,000	370,000	426,000
Medrol	339,000	328,000	432,000	402,000	469,000
Oxbryta	328,000	73,000
Fragmin	238,000	269,000	305,000	252,000	253,000
Cresemba	195,000	155,000	142,000
Vfend	187,000	225,000	267,000	270,000	346,000
Bicillin	158,000	146,000	120,000
Cibinqo	128,000	27,000
Oncology	11,627,000	12,132,000	12,333,000	10,867,000	9,014,000
Ibrance	4,753,000	5,120,000	5,437,000	5,392,000	4,961,000
Xtandi alliance revenues	1,191,000	1,198,000	1,185,000	1,024,000	838,000
Inlyta	1,036,000	1,003,000	1,002,000	787,000	477,000
Bosulif	645,000	575,000	540,000	450,000	365,000
Lorbrena	539,000	343,000	266,000	204,000	115,000
All other Oncology	433,000	357,000	238,000	137,000	122,000
Zirabev	424,000	562,000	444,000	143,000	1,000
Ruxience	390,000	458,000	491,000	170,000	(1,000)
Xalkori	374,000	465,000	493,000	544,000	530,000
Retacrit	340,000	394,000	444,000	386,000	225,000
Aromasin	301,000	248,000	211,000	148,000	136,000
Besponsa	236,000	219,000	192,000	182,000	157,000
Braftovi	213,000	194,000	187,000	160,000	48,000
Bavencio alliance revenues	190,000	271,000	178,000	80,000	49,000
Sutent	180,000	347,000	673,000	819,000	936,000
Mektovi	174,000	176,000	155,000	142,000	49,000
Trazimera	91,000	203,000	197,000	98,000	6,000
Padcev	52,000
Adcetris	46,000
Tukysa	17,000
Tivdak	4,000
Hospital				6,777,000	6,695,000
Inflammation & Immunology (I&I)				4,567,000	4,733,000
All other Inflammation & Immunology (I&I)				121,000	167,000
Rare Disease				2,936,000	2,278,000
All other Rare Disease				120,000	129,000
Tygacil				160,000	197,000
All other Hospital				2,435,000	2,225,000
All other Anti-infectives				1,294,000	1,396,000
IVIg Products				376,000	275,000
Precedex				260,000	155,000
Zyvox				222,000	251,000
Eliquis alliance revenues and direct sales	6,747,000	6,480,000	5,970,000	4,949,000	4,220,000
All other Primary Care	1,777,000	1,932,000	2,604,000
Paxlovid	1,279,000	18,933,000	76,000
Nurtec oral disintegrating tablet (ODT)/Vydura	928,000	213,000
Abrysvo	890,000
Premarin family	397,000	455,000	563,000	680,000	734,000
BMP2	338,000	277,000	266,000	274,000	287,000
Comirnaty direct sales and alliance revenues	11,220,000	37,806,000	36,781,000	154,000
Prevnar family	6,440,000	6,337,000	5,272,000
FSME/IMMUN-TicoVac	268,000	200,000	185,000	196,000	220,000
Nimenrix	179,000	268,000	193,000	221,000	230,000
Trumenba	126,000	123,000	118,000	112,000	135,000
Internal Medicine				9,003,000	8,790,000
Vaccines				6,575,000	6,504,000
Prevnar 13/Prevenar 13				5,850,000	5,847,000
All other Vaccines				42,000	73,000
All other Internal Medicine				1,758,000	2,016,000
Chantix/Champix				919,000	1,107,000
Toviaz				252,000	250,000
Pristiq				171,000	176,000
BUSINESS INNOVATION	1,310,000	1,342,000	1,731,000
Pfizer CentreOne	1,265,000	1,335,000	1,731,000	926,000	810,000
Pfizer Ignite	44,000	7,000
Consumer Healthcare Business					2,082,000
Total Revenue	58,496,000	100,330,000	81,288,000	41,650,000	40,905,000
Percents of total
Business Unit
Revenue
Biopharma	97.76%	98.66%	97.87%	97.78%	92.93%
Other business activities	2.24%	1.34%	2.13%	2.22%	7.07%
Innovative Health						62.31%	59.80%	55.27%
Essential Health						37.69%	40.20%	44.73%
Region
Revenue
United States	46.31%	42.33%	36.59%			47.21%	49.53%	49.92%
Emerging Markets	20.51%	20.03%	25.47%
Developed Europe	19.92%	21.91%	22.56%			16.99%	16.19%	17.62%
Developed Rest of World	7.27%
Japan	6.00%	8.00%	9.00%			8.00%	8.00%
Developed Rest of World	7.27%
Emerging Markets	20.51%	20.03%	25.47%
China						8.00%	7.00%
Product/Services
Revenue
GLOBAL BIOPHARMACEUTICALS BUSINESS (BIOPHARMA)	97.76%	98.66%	97.87%	97.78%	92.93%
Primary Care	52.29%	72.78%	64.01%
Specialty Care	25.59%	13.79%	18.69%
All other Specialty Care	3.84%	2.34%	3.48%
All other Anti-infectives	1.87%	1.17%	1.93%
Sulperazon	1.29%	0.78%	0.84%	1.48%	1.67%
Immunoglobulin (Ig) portfolio	1.00%	0.49%	0.53%
Zavicefta	0.87%	0.41%	0.51%	0.51%	0.26%
Zithromax	0.69%	0.33%	0.34%	0.66%	0.82%
Vyndaqel family	5.68%	2.44%	2.48%	3.09%	1.16%
Xeljanz	2.91%	1.79%	3.02%	5.85%	5.48%
Enbrel (Outside the U.S. and Canada)	1.42%	1.00%	1.46%	3.24%	4.15%
Genotropin	0.92%	0.36%	0.48%	1.03%	1.22%
Inflectra	0.84%	0.53%	0.81%	1.58%	1.53%
BeneFIX	0.72%	0.42%	0.54%	1.09%	1.19%
Somavert	0.46%	0.27%	0.34%	0.67%	0.65%
Refacto AF/Xyntha	0.39%	0.24%	0.37%	0.89%	1.04%
Medrol	0.58%	0.33%	0.53%	0.97%	1.15%
Oxbryta	0.56%	0.10%
Fragmin	0.41%	0.27%	0.38%	0.61%	0.62%
Cresemba	0.33%	0.15%	0.17%
Vfend	0.32%	0.22%	0.33%	0.65%	0.85%
Bicillin	0.27%	0.15%	0.15%
Cibinqo	0.22%	0.10%
Oncology	19.88%	12.09%	15.17%	26.09%	22.04%
Ibrance	8.13%	5.10%	6.69%	12.95%	12.13%
Xtandi alliance revenues	2.04%	1.19%	1.46%	2.46%	2.05%
Inlyta	1.77%	1.00%	1.23%	1.89%	1.17%
Bosulif	1.10%	0.57%	0.66%	1.08%	0.89%
Lorbrena	0.92%	0.34%	0.33%	0.49%	0.28%
All other Oncology	0.74%	0.36%	0.29%	0.33%	0.30%
Zirabev	0.72%	0.56%	0.55%	0.34%	0.10%
Ruxience	0.67%	0.46%	0.60%	0.41%	-0.10%
Xalkori	0.64%	0.46%	0.61%	1.31%	1.30%
Retacrit	0.58%	0.39%	0.55%	0.93%	0.55%
Aromasin	0.51%	0.25%	0.26%	0.36%	0.33%
Besponsa	0.40%	0.22%	0.24%	0.44%	0.38%
Braftovi	0.36%	0.19%	0.23%	0.38%	0.12%
Bavencio alliance revenues	0.32%	0.27%	0.22%	0.19%	0.12%
Sutent	0.31%	0.35%	0.83%	1.97%	2.29%
Mektovi	0.30%	0.18%	0.19%	0.34%	0.12%
Trazimera	0.16%	0.20%	0.24%	0.24%	0.10%
Padcev	0.10%
Adcetris	0.10%
Tukysa	0.10%
Tivdak	0.10%
Hospital				16.27%	16.37%
Inflammation & Immunology (I&I)				10.97%	11.57%
All other Inflammation & Immunology (I&I)				0.29%	0.41%
Rare Disease				7.05%	5.57%
All other Rare Disease				0.29%	0.32%
Tygacil				0.38%	0.48%
All other Hospital				5.85%	5.44%
All other Anti-infectives				3.11%	3.41%
IVIg Products				0.90%	0.67%
Precedex				0.62%	0.38%
Zyvox				0.53%	0.61%
Eliquis alliance revenues and direct sales	11.53%	6.46%	7.34%	11.88%	10.32%
All other Primary Care	3.04%	1.93%	3.20%
Paxlovid	2.19%	18.87%	0.10%
Nurtec oral disintegrating tablet (ODT)/Vydura	1.59%	0.21%
Abrysvo	1.52%
Premarin family	0.68%	0.45%	0.69%	1.63%	1.79%
BMP2	0.58%	0.28%	0.33%	0.66%	0.70%
Comirnaty direct sales and alliance revenues	19.18%	37.68%	45.25%	0.37%
Prevnar family	11.01%	6.32%	6.49%
FSME/IMMUN-TicoVac	0.46%	0.20%	0.23%	0.47%	0.54%
Nimenrix	0.31%	0.27%	0.24%	0.53%	0.56%
Trumenba	0.22%	0.12%	0.15%	0.27%	0.33%
Internal Medicine				21.62%	21.49%
Vaccines				15.79%	15.90%
Prevnar 13/Prevenar 13				14.05%	14.29%
All other Vaccines				0.10%	0.18%
All other Internal Medicine				4.22%	4.93%
Chantix/Champix				2.21%	2.71%
Toviaz				0.61%	0.61%
Pristiq				0.41%	0.43%
BUSINESS INNOVATION	2.24%	1.34%	2.13%
Pfizer CentreOne	2.16%	1.33%	2.13%	2.22%	1.98%
Pfizer Ignite	0.10%	0.10%
Consumer Healthcare Business					5.09%
Data Origination
Original	No	No	No	No	No	Yes	No	No
Restated	Yes	Yes	Yes	Yes	Yes	No	Yes	Yes
© PitchBook Data, Inc. 2024
Public Fundamental Data provided by Morningstar, Inc.

Ratios

Ratios (Fiscal Year)
Downloaded On: 18-Apr-2024	Summary Stats
Company: Pfizer (Pharmaceuticals) (NYS: PFE)	Median	Mean	Min	Max	25th pctile	75th pctile	Std. Dev	Coefficient of Variation	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003	FY 2002	FY 2001	FY 2000	FY 1999	FY 1998	FY 1997	FY 1996	FY 1995	FY 1994	FY 1993	FY 1992	FY 1991	FY 1990	FY 1989	FY 1988	FY 1987	FY 1986	FY 1985	FY 1984	FY 1983	FY 1982	FY 1981	FY 1980	FY 1979
Amounts in Thousands, USD (except Ratios, Multiples & per share items)
Profitability
Return on Invested Capital (ROIC)									1.75%	26.12%	21.64%	6.75%	10.83%	4.07%	20.82%	7.51%	7.20%	8.66%	10.36%	8.24%	6.71%	7.12%	8.47%	9.14%	10.55%	13.79%	9.17%	12.82%	2.55%	30.14%	30.29%	18.21%	32.77%	27.60%	19.53%	18.89%	18.79%	20.56%	10.03%	15.73%	10.59%	12.72%	11.57%	15.30%	15.65%	17.82%	17.68%	16.64%	15.15%	11.63%	10.02%	10.30%	10.20%
Normalized Return on Invested Capital									7.28%	31.23%	22.32%	11.71%	16.29%	9.49%	15.81%	14.72%	13.66%	13.44%	13.67%	13.82%	13.88%	14.02%	11.76%	12.26%	13.02%	15.58%	12.29%	15.71%	9.88%	31.65%	33.03%	27.57%	33.15%	27.60%	19.53%	18.89%	18.79%	20.56%	10.03%	15.73%	10.59%	12.72%	11.57%	15.30%	15.65%	17.82%	17.68%	16.64%	15.15%	11.63%	10.02%	10.30%	10.20%
Return on Equity (ROE)									2.25%	36.08%	31.65%	10.38%	17.32%	5.58%	34.63%	11.54%	10.35%	12.00%	14.40%	11.06%	8.97%	9.42%	12.78%	12.44%	11.97%	16.02%	11.43%	16.24%	3.28%	47.86%	42.42%	26.05%	50.49%	38.58%	28.43%	28.54%	31.54%	32.57%	15.60%	21.60%	14.33%	16.65%	15.41%	19.34%	18.92%	20.81%	21.42%	21.77%	21.41%	18.21%	16.78%	17.05%	16.83%
Normalized Return on Equity									10.90%	43.34%	32.69%	19.48%	26.99%	14.37%	26.09%	23.56%	20.41%	19.13%	19.30%	19.31%	19.56%	19.90%	17.96%	16.35%	14.77%	18.10%	15.33%	19.90%	12.70%	50.25%	46.27%	39.45%	51.07%	38.58%	28.43%	28.54%	31.54%	32.57%	15.60%	21.60%	14.33%	16.65%	15.41%	19.34%	18.92%	20.81%	21.42%	21.77%	21.41%	18.21%	16.78%	17.05%	16.83%
Forward ROE									13.06%	29.03%	42.31%	24.31%	23.18%	25.24%
Return on Asset (ROA)									1.03%	16.47%	13.31%	3.94%	6.64%	2.33%	12.52%	4.25%	4.22%	5.33%	6.34%	4.88%	4.05%	4.22%	5.93%	6.98%	7.32%	9.75%	6.50%	9.05%	1.77%	21.38%	20.53%	12.34%	22.90%	19.25%	13.74%	12.82%	12.51%	12.84%	6.77%	11.30%	7.96%	9.55%	8.53%	10.87%	11.42%	13.71%	13.62%	12.72%	11.59%	9.05%	7.81%	7.92%	7.80%
Normalized Return on Assets									4.98%	19.79%	13.75%	7.40%	10.34%	6.00%	9.43%	8.67%	8.31%	8.49%	8.49%	8.51%	8.84%	8.91%	8.33%	9.17%	9.03%	11.01%	8.71%	11.09%	6.85%	22.44%	22.39%	18.69%	23.16%	19.25%	13.74%	12.82%	12.51%	12.84%	6.77%	11.30%	7.96%	9.55%	8.53%	10.87%	11.42%	13.71%	13.62%	12.72%	11.59%	9.05%	7.81%	7.92%	7.80%
Forward ROA									5.89%	13.77%	17.87%	8.86%	8.85%	10.72%
Efficiency
Cash to Assets									[$-en-US]0.06	[$-en-US]0.12	[$-en-US]0.17	[$-en-US]0.08	[$-en-US]0.06	[$-en-US]0.12	[$-en-US]0.12	[$-en-US]0.10	[$-en-US]0.14	[$-en-US]0.22	[$-en-US]0.19	[$-en-US]0.17	[$-en-US]0.14	[$-en-US]0.14	[$-en-US]0.12	[$-en-US]0.21	[$-en-US]0.22	[$-en-US]0.24	[$-en-US]0.19	[$-en-US]0.16	[$-en-US]0.10	[$-en-US]0.27	[$-en-US]0.22	[$-en-US]0.20	[$-en-US]0.20	[$-en-US]0.08	[$-en-US]0.06	[$-en-US]0.08	[$-en-US]0.03	[$-en-US]0.13	[$-en-US]0.08	[$-en-US]0.13	[$-en-US]0.14	[$-en-US]0.10	[$-en-US]0.10	[$-en-US]0.11	[$-en-US]0.15	[$-en-US]0.08	[$-en-US]0.09	[$-en-US]0.22	[$-en-US]0.18	[$-en-US]0.16	[$-en-US]0.16	[$-en-US]0.15	[$-en-US]0.16
Cash Turnover									[$-en-US]2.03	[$-en-US]3.41	[$-en-US]3.75	[$-en-US]3.85	[$-en-US]3.29	[$-en-US]2.52	[$-en-US]3.14	[$-en-US]2.75	[$-en-US]1.77	[$-en-US]1.46	[$-en-US]1.54	[$-en-US]2.10	[$-en-US]2.30	[$-en-US]2.88	[$-en-US]1.35	[$-en-US]1.86	[$-en-US]2.01	[$-en-US]2.60	[$-en-US]2.58	[$-en-US]2.99	[$-en-US]3.18	[$-en-US]2.94	[$-en-US]3.47	[$-en-US]4.85	[$-en-US]8.98	[$-en-US]15.92	[$-en-US]9.27	[$-en-US]11.50	[$-en-US]11.97	[$-en-US]8.84	[$-en-US]6.93	[$-en-US]6.38	[$-en-US]8.38	[$-en-US]11.47	[$-en-US]6.95	[$-en-US]5.86	[$-en-US]6.88	[$-en-US]11.04	[$-en-US]6.22	[$-en-US]4.83	[$-en-US]5.65	[$-en-US]5.93	[$-en-US]6.15	[$-en-US]6.25	[$-en-US]5.74
Inventory Turnover									[$-en-US]2.53	[$-en-US]3.58	[$-en-US]3.57	[$-en-US]1.03	[$-en-US]1.03	[$-en-US]1.14	[$-en-US]1.51	[$-en-US]1.67	[$-en-US]1.49	[$-en-US]1.57	[$-en-US]1.50	[$-en-US]1.43	[$-en-US]1.54	[$-en-US]1.50	[$-en-US]1.42	[$-en-US]1.63	[$-en-US]2.00	[$-en-US]1.24	[$-en-US]1.14	[$-en-US]1.05	[$-en-US]1.96	[$-en-US]1.47	[$-en-US]1.38	[$-en-US]2.05	[$-en-US]2.44	[$-en-US]2.44	[$-en-US]0.83	[$-en-US]0.89	[$-en-US]1.30	[$-en-US]1.35	[$-en-US]1.35	[$-en-US]1.52	[$-en-US]1.66	[$-en-US]1.77	[$-en-US]1.71	[$-en-US]1.72	[$-en-US]1.81	[$-en-US]1.86	[$-en-US]1.84	[$-en-US]1.90	[$-en-US]1.87	[$-en-US]1.76	[$-en-US]1.67	[$-en-US]1.67	[$-en-US]1.68
Receivable Turnover									[$-en-US]5.25	[$-en-US]7.50	[$-en-US]7.86	[$-en-US]4.76	[$-en-US]4.69	[$-en-US]4.48	[$-en-US]5.86	[$-en-US]5.95	[$-en-US]5.55	[$-en-US]5.22	[$-en-US]4.63	[$-en-US]4.32	[$-en-US]4.14	[$-en-US]4.58	[$-en-US]4.61	[$-en-US]4.89	[$-en-US]4.93	[$-en-US]5.11	[$-en-US]5.02	[$-en-US]5.21	[$-en-US]5.79	[$-en-US]5.49	[$-en-US]5.34	[$-en-US]5.41	[$-en-US]5.10	[$-en-US]8.29	[$-en-US]4.55	[$-en-US]4.56	[$-en-US]5.15	[$-en-US]5.25	[$-en-US]5.05	[$-en-US]4.93	[$-en-US]4.86	[$-en-US]4.29	[$-en-US]3.51	[$-en-US]4.58	[$-en-US]4.59	[$-en-US]5.05	[$-en-US]5.38	[$-en-US]5.31	[$-en-US]5.01	[$-en-US]4.73	[$-en-US]4.43	[$-en-US]4.42	[$-en-US]4.20
Payable Turnover									[$-en-US]2.56	[$-en-US]3.31	[$-en-US]3.70	[$-en-US]1.22	[$-en-US]1.11	[$-en-US]1.17	[$-en-US]1.84	[$-en-US]2.12	[$-en-US]1.79	[$-en-US]2.02	[$-en-US]2.06	[$-en-US]1.69	[$-en-US]1.96	[$-en-US]2.03	[$-en-US]1.49	[$-en-US]3.29	[$-en-US]5.37	[$-en-US]4.04	[$-en-US]3.30	[$-en-US]2.55	[$-en-US]4.94	[$-en-US]2.61	[$-en-US]2.48	[$-en-US]3.42	[$-en-US]4.68	[$-en-US]5.29	[$-en-US]1.66	[$-en-US]1.84	[$-en-US]2.83	[$-en-US]3.52	[$-en-US]3.61	[$-en-US]3.92	[$-en-US]4.54	[$-en-US]5.04	[$-en-US]4.62
Fixed Asset Turnover									[$-en-US]3.34	[$-en-US]6.52	[$-en-US]5.70	[$-en-US]3.01	[$-en-US]3.05	[$-en-US]2.95	[$-en-US]3.90	[$-en-US]3.91	[$-en-US]3.93	[$-en-US]4.08	[$-en-US]4.01	[$-en-US]3.66	[$-en-US]3.40	[$-en-US]3.16	[$-en-US]3.32	[$-en-US]3.28	[$-en-US]2.99	[$-en-US]2.92	[$-en-US]2.70	[$-en-US]2.75	[$-en-US]2.94	[$-en-US]3.06	[$-en-US]2.97	[$-en-US]3.51	[$-en-US]4.99	[$-en-US]5.63	[$-en-US]2.84	[$-en-US]2.73	[$-en-US]2.94	[$-en-US]2.93	[$-en-US]3.04	[$-en-US]2.98	[$-en-US]3.14	[$-en-US]3.26	[$-en-US]3.30	[$-en-US]3.41	[$-en-US]3.44	[$-en-US]3.42	[$-en-US]3.32	[$-en-US]3.33	[$-en-US]3.27	[$-en-US]3.27	[$-en-US]3.56	[$-en-US]3.82	[$-en-US]3.62
Total Asset Turnover									[$-en-US]0.28	[$-en-US]0.53	[$-en-US]0.48	[$-en-US]0.25	[$-en-US]0.25	[$-en-US]0.25	[$-en-US]0.31	[$-en-US]0.31	[$-en-US]0.30	[$-en-US]0.29	[$-en-US]0.29	[$-en-US]0.30	[$-en-US]0.31	[$-en-US]0.33	[$-en-US]0.34	[$-en-US]0.42	[$-en-US]0.43	[$-en-US]0.43	[$-en-US]0.40	[$-en-US]0.41	[$-en-US]0.49	[$-en-US]0.75	[$-en-US]0.79	[$-en-US]0.97	[$-en-US]1.26	[$-en-US]1.38	[$-en-US]0.73	[$-en-US]0.72	[$-en-US]0.81	[$-en-US]0.82	[$-en-US]0.77	[$-en-US]0.75	[$-en-US]0.77	[$-en-US]0.76	[$-en-US]0.71	[$-en-US]0.74	[$-en-US]0.81	[$-en-US]0.93	[$-en-US]0.95	[$-en-US]0.97	[$-en-US]0.97	[$-en-US]0.94	[$-en-US]0.93	[$-en-US]0.94	[$-en-US]0.90
Equity Turnover									[$-en-US]0.61	[$-en-US]1.15	[$-en-US]1.14	[$-en-US]0.65	[$-en-US]0.66	[$-en-US]0.59	[$-en-US]0.85	[$-en-US]0.84	[$-en-US]0.72	[$-en-US]0.65	[$-en-US]0.65	[$-en-US]0.67	[$-en-US]0.69	[$-en-US]0.73	[$-en-US]0.74	[$-en-US]0.74	[$-en-US]0.70	[$-en-US]0.70	[$-en-US]0.71	[$-en-US]0.73	[$-en-US]0.90	[$-en-US]1.69	[$-en-US]1.63	[$-en-US]2.06	[$-en-US]2.78	[$-en-US]2.77	[$-en-US]1.50	[$-en-US]1.58	[$-en-US]2.02	[$-en-US]2.06	[$-en-US]1.76	[$-en-US]1.42	[$-en-US]1.37	[$-en-US]1.32	[$-en-US]1.28	[$-en-US]1.32	[$-en-US]1.35	[$-en-US]1.41	[$-en-US]1.49	[$-en-US]1.65	[$-en-US]1.80	[$-en-US]1.89	[$-en-US]1.99	[$-en-US]2.03	[$-en-US]1.94
Days In Sales									[$-en-US]69.57	[$-en-US]48.67	[$-en-US]46.46	[$-en-US]76.60	[$-en-US]77.86	[$-en-US]81.53	[$-en-US]62.26	[$-en-US]61.37	[$-en-US]65.73	[$-en-US]69.90	[$-en-US]78.77	[$-en-US]84.57	[$-en-US]88.26	[$-en-US]79.74	[$-en-US]79.11	[$-en-US]74.64	[$-en-US]74.07	[$-en-US]71.38	[$-en-US]72.70	[$-en-US]70.00	[$-en-US]63.01	[$-en-US]66.48	[$-en-US]68.35	[$-en-US]67.50	[$-en-US]71.57	[$-en-US]44.05	[$-en-US]80.30	[$-en-US]80.10	[$-en-US]70.94	[$-en-US]69.59	[$-en-US]72.33	[$-en-US]74.05	[$-en-US]75.10	[$-en-US]85.06	[$-en-US]104.00	[$-en-US]79.69	[$-en-US]79.58	[$-en-US]72.33	[$-en-US]67.83	[$-en-US]68.72	[$-en-US]72.84	[$-en-US]77.15	[$-en-US]82.46	[$-en-US]82.66	[$-en-US]86.90
Days In Inventory									[$-en-US]144.00	[$-en-US]102.00	[$-en-US]102.23	[$-en-US]355.97	[$-en-US]354.03	[$-en-US]320.79	[$-en-US]242.41	[$-en-US]219.17	[$-en-US]245.42	[$-en-US]232.48	[$-en-US]244.00	[$-en-US]255.64	[$-en-US]236.55	[$-en-US]242.98	[$-en-US]257.02	[$-en-US]224.55	[$-en-US]182.20	[$-en-US]294.40	[$-en-US]320.23	[$-en-US]347.91	[$-en-US]185.83	[$-en-US]247.83	[$-en-US]264.35	[$-en-US]178.22	[$-en-US]149.71	[$-en-US]149.79	[$-en-US]440.17	[$-en-US]411.45	[$-en-US]280.28	[$-en-US]271.07	[$-en-US]269.69	[$-en-US]240.76	[$-en-US]219.59	[$-en-US]205.68	[$-en-US]213.46	[$-en-US]211.69	[$-en-US]201.70	[$-en-US]196.11	[$-en-US]198.12	[$-en-US]192.00	[$-en-US]195.08	[$-en-US]207.50	[$-en-US]218.24	[$-en-US]218.80	[$-en-US]217.71
Days In Payment									[$-en-US]142.71	[$-en-US]110.23	[$-en-US]98.74	[$-en-US]298.56	[$-en-US]329.17	[$-en-US]311.42	[$-en-US]198.62	[$-en-US]172.01	[$-en-US]203.71	[$-en-US]180.58	[$-en-US]177.49	[$-en-US]215.43	[$-en-US]186.47	[$-en-US]179.59	[$-en-US]245.27	[$-en-US]110.89	[$-en-US]68.00	[$-en-US]90.45	[$-en-US]110.57	[$-en-US]143.32	[$-en-US]73.85	[$-en-US]139.98	[$-en-US]147.45	[$-en-US]106.72	[$-en-US]77.96	[$-en-US]69.03	[$-en-US]220.14	[$-en-US]198.47	[$-en-US]129.05	[$-en-US]103.80	[$-en-US]101.06	[$-en-US]93.01	[$-en-US]80.33	[$-en-US]72.46	[$-en-US]78.97
Cash Conversion Cycle									[$-en-US]70.87	[$-en-US]40.43	[$-en-US]49.95	[$-en-US]134.01	[$-en-US]102.72	[$-en-US]90.89	[$-en-US]106.06	[$-en-US]108.53	[$-en-US]107.44	[$-en-US]121.80	[$-en-US]145.28	[$-en-US]124.78	[$-en-US]138.34	[$-en-US]143.13	[$-en-US]90.86	[$-en-US]188.30	[$-en-US]188.27	[$-en-US]275.33	[$-en-US]282.36	[$-en-US]274.60	[$-en-US]175.00	[$-en-US]174.32	[$-en-US]185.25	[$-en-US]139.00	[$-en-US]143.32	[$-en-US]124.81	[$-en-US]300.33	[$-en-US]293.08	[$-en-US]222.18	[$-en-US]236.85	[$-en-US]240.96	[$-en-US]221.80	[$-en-US]214.36	[$-en-US]218.28	[$-en-US]238.49
Sales Per Full Time Employee									665	1,209	1,029	531	463	442	583	547	499	634	664	597	589	589	429	590	559	494	447	426	367	330	322	326	538	501	225	212	246	203	185	178	158	151	139
Net Income per Full Time Employee									25	378	284	85	122	42	237	75	71	116	147	99	76	75	74	98	95	112	72	95	13	93	84	41	98	70	42	38	38	32	16	27	16	19	17
Margins
Gross Margin									57.34%	65.77%	62.08%	79.63%	80.31%	77.99%	78.63%	76.67%	80.25%	80.69%	81.42%	82.03%	79.52%	77.31%	82.23%	83.20%	76.79%	84.21%	84.74%	86.95%	78.57%	87.57%	86.83%	82.94%	82.97%	81.86%	87.81%	86.46%	82.14%	80.36%	79.76%	75.65%	71.85%	68.24%	67.29%	66.10%	64.74%	64.85%	64.81%	63.76%	61.90%	58.69%	55.23%	55.03%	54.71%
Selling, General and Admin Expense Margin									25.25%	13.63%	15.63%	27.84%	31.11%	30.89%	28.17%	28.10%	30.31%	28.42%	27.83%	27.76%	28.80%	29.12%	29.74%	30.10%	32.27%	32.23%	32.30%	31.24%	33.77%	33.53%	33.48%	38.23%	39.49%	41.16%	39.81%	39.12%	52.86%	53.01%	64.09%	52.04%	50.30%	48.28%	46.57%	43.70%	42.32%	40.12%	39.73%	38.84%	38.64%	38.10%	36.56%	36.15%	35.51%
EBITDAR Margin									13.56%	40.65%	37.84%	31.67%	45.04%	26.28%	37.02%	28.06%	30.40%	37.72%	44.85%	36.66%	35.61%	29.57%	32.14%	29.01%	29.90%	37.88%	34.54%	37.76%	16.29%	39.73%	37.75%	22.99%	28.67%	22.35%	29.72%	29.21%	26.61%	25.95%	14.80%	24.84%	17.04%	20.67%	19.74%	24.05%	23.77%	24.75%	24.99%	24.07%	21.58%	18.74%	16.24%	16.16%	15.97%
Normalized EBITDAR Margin									39.24%	47.29%	43.07%	42.39%	42.11%	45.01%	42.90%	43.11%	41.84%	43.08%	27.79%	35.79%	42.81%	45.40%	40.91%	35.32%	34.36%	41.37%	42.30%	43.93%	32.37%	41.55%	40.86%	33.08%	28.97%	22.35%	29.72%	29.21%	26.61%	25.95%	14.80%	24.84%	17.04%	20.67%	19.74%	24.05%	23.77%	24.75%	24.99%	24.07%	21.58%	18.74%	16.24%	16.16%	15.97%
EBITDA Margin									13.56%	40.65%	37.84%	31.67%	45.04%	26.28%	37.02%	28.06%	30.40%	37.72%	44.85%	36.66%	35.61%	29.57%	32.14%	29.01%	29.90%	37.88%	34.54%	37.76%	16.29%	39.73%	37.75%	22.99%	28.67%	22.35%	29.72%	29.21%	26.61%	25.95%	14.80%	24.84%	17.04%	20.67%	19.74%	24.05%	23.77%	24.75%	24.99%	24.07%	21.58%	18.74%	16.24%	16.16%	15.97%
Normalized EBITDA Margin									39.24%	47.29%	43.07%	42.39%	42.11%	45.01%	42.90%	43.11%	41.84%	43.08%	27.79%	35.79%	42.81%	45.40%	40.91%	35.32%	34.36%	41.37%	42.30%	43.93%	32.37%	41.55%	40.86%	33.08%	28.97%	22.35%	29.72%	29.21%	26.61%	25.95%	14.80%	24.84%	17.04%	20.67%	19.74%	24.05%	23.77%	24.75%	24.99%	24.07%	21.58%	18.74%	16.24%	16.16%	15.97%
Operating Margin									5.74%	37.15%	29.16%	21.20%	17.87%	16.48%	26.78%	25.95%	26.56%	27.21%	31.73%	31.24%	27.54%	25.41%	31.43%	24.01%	21.35%	29.53%	29.97%	33.53%	23.17%	37.84%	36.57%	29.19%	25.43%	23.03%	27.80%	27.81%	25.55%	23.82%	12.21%	19.96%	18.04%	16.45%	17.07%	18.79%	19.12%	21.44%	21.87%	21.62%	20.20%	17.44%	15.71%	16.01%	16.28%
EBIT Margin									2.81%	35.60%	31.45%	20.20%	30.97%	11.21%	25.09%	17.16%	19.84%	26.56%	32.43%	22.65%	20.82%	16.68%	22.62%	18.47%	19.16%	26.93%	22.78%	27.36%	7.29%	36.53%	34.40%	19.69%	25.37%	18.92%	25.84%	25.57%	22.87%	22.42%	11.35%	21.19%	13.53%	17.16%	16.09%	20.44%	20.48%	21.46%	21.77%	20.78%	18.52%	15.59%	13.28%	13.30%	13.06%
Normalized EBIT Margin									28.49%	42.25%	36.69%	30.92%	28.04%	29.95%	30.97%	32.21%	31.28%	31.92%	15.36%	21.78%	28.02%	32.51%	31.40%	24.78%	23.62%	30.43%	30.53%	33.53%	23.38%	38.34%	37.51%	29.78%	25.66%	18.92%	25.84%	25.57%	22.87%	22.42%	11.35%	21.19%	13.53%	17.16%	16.09%	20.44%	20.48%	21.46%	21.77%	20.78%	18.52%	15.59%	13.28%	13.30%	13.06%
EBT Margin									1.81%	34.61%	29.91%	16.89%	27.68%	8.80%	23.42%	15.81%	18.35%	24.67%	30.47%	20.57%	18.81%	14.53%	21.65%	20.07%	19.16%	26.93%	22.78%	27.36%	7.29%	36.53%	34.40%	19.69%	25.37%	18.92%	25.84%	25.57%	22.87%	22.42%	11.35%	21.19%	13.53%	17.16%	16.09%	20.44%	20.48%	21.46%	21.77%	20.78%	18.52%	15.59%	13.28%	13.30%	13.06%
Net Profit Margin									3.71%	31.30%	27.63%	16.00%	26.25%	9.46%	40.64%	13.69%	14.28%	18.38%	22.12%	16.50%	12.88%	12.76%	17.26%	16.67%	16.96%	22.79%	16.05%	22.32%	3.64%	28.37%	25.97%	12.67%	18.16%	13.91%	18.83%	17.88%	15.51%	15.68%	8.79%	15.12%	10.39%	12.51%	12.01%	14.69%	14.03%	14.75%	14.40%	13.18%	11.92%	9.62%	8.42%	8.38%	8.66%
Normalized Net Profit Margin									17.95%	37.59%	28.54%	30.03%	40.91%	24.36%	30.61%	27.94%	28.16%	29.29%	29.64%	28.81%	28.09%	26.95%	24.25%	21.90%	20.93%	25.75%	21.52%	27.36%	14.10%	29.78%	28.32%	19.18%	18.37%	13.91%	18.83%	17.88%	15.51%	15.68%	8.79%	15.12%	10.39%	12.51%	12.01%	14.69%	14.03%	14.75%	14.40%	13.18%	11.92%	9.62%	8.42%	8.38%	8.66%
Growth Rates
Revenue % Growth									-41.70%	23.43%	95.16%	1.82%	0.20%	-22.31%	-0.53%	8.13%	-1.52%	-3.84%	-5.62%	-10.45%	-6.34%	30.31%	3.55%	-0.25%	0.10%	2.04%	-3.23%	9.50%	38.53%	11.27%	-1.13%	7.23%	17.84%	110.14%	12.07%	-1.57%	21.01%	10.75%	3.42%	4.03%	8.49%	12.95%	5.31%	9.46%	9.92%	11.22%	4.41%	2.79%	7.27%	7.58%	7.28%	10.32%
EBITDA % Growth									-80.55%	32.59%	133.20%	-28.41%	71.75%	-44.86%	31.23%	-0.18%	-20.64%	-19.13%	15.47%	-7.80%	12.79%	19.89%	14.69%	-3.22%	-20.98%	11.88%	-11.46%	153.79%	-43.20%	17.12%	62.34%	-14.03%	51.19%	58.05%	14.02%	8.06%	24.07%	94.12%	-38.36%	51.61%	-10.52%	18.26%	-13.57%	10.75%	5.57%	10.16%	8.41%	14.65%	23.51%	24.12%	7.82%	11.63%
EBIT % Growth									-95.40%	39.70%	203.92%	-33.60%	176.80%	-65.28%	45.41%	-6.46%	-26.43%	-21.24%	35.09%	-2.55%	16.91%	-3.94%	26.81%	-3.84%	-28.78%	20.63%	-19.42%	310.76%	-72.34%	18.15%	72.70%	-16.76%	58.02%	53.83%	13.28%	10.03%	23.44%	118.77%	-44.60%	62.90%	-14.43%	20.46%	-17.11%	9.25%	4.87%	9.66%	9.40%	15.29%	27.47%	26.25%	7.12%	12.38%
Net Income % Growth									-93.25%	42.74%	139.97%	-42.85%	43.69%	-47.66%	195.33%	3.66%	-23.81%	-58.48%	51.02%	45.57%	21.22%	-4.38%	6.55%	-0.49%	-57.88%	139.17%	-28.84%	190.56%	-57.16%	17.18%	109.02%	-24.76%	6.89%	109.35%	14.72%	22.64%	21.14%	97.48%	-18.92%	12.30%	-9.87%	17.63%	-13.93%	14.65%	4.58%	13.85%	14.14%	13.60%	32.95%	22.87%	7.80%	6.73%
Leverage
Degree of Operational Leverage (TTM)									[$-en-US]5.82	[$-en-US]8.21	[$-en-US]0.79	(1,282.69)	[$-en-US]7.65	[$-en-US]2.93	[$-en-US]11.21	(17.87)	(9.51)	[$-en-US]9.94	(9.42)	[$-en-US]1.70	(0.39)	(6.22)	(0.13)	[$-en-US]24.12	[$-en-US]28.24	(85.28)	[$-en-US]0.94	(3.36)	(3.67)	[$-en-US]1.03	(0.50)	(1.10)	[$-en-US]0.06	[$-en-US]0.58	[$-en-US]0.65	[$-en-US]0.49	[$-en-US]0.96	[$-en-US]1.26	(2.58)	[$-en-US]29.49	(22.09)	(8.17)	(7.54)	[$-en-US]5.26	[$-en-US]2.09	[$-en-US]4.02	[$-en-US]4.04
Degree of Combined Leverage (TTM)									[$-en-US]5.41	[$-en-US]10.49	[$-en-US]0.83	[$-en-US]187.28	[$-en-US]11.88	[$-en-US]3.56	[$-en-US]820.42	(18.76)	(8.74)	[$-en-US]14.89	(17.53)	[$-en-US]1.90	[$-en-US]3.86	(22.64)	[$-en-US]0.71	[$-en-US]21.94	[$-en-US]31.52	(79.05)	[$-en-US]0.68	(4.09)	(4.74)	[$-en-US]1.03	(0.69)	(0.85)	[$-en-US]0.13	[$-en-US]0.61	[$-en-US]0.61	[$-en-US]0.39	[$-en-US]1.04	[$-en-US]0.92	(2.18)	[$-en-US]27.35	(18.64)	[$-en-US]1.94	(3.27)	[$-en-US]0.36	(1.31)	[$-en-US]1.24	[$-en-US]0.75
Debt to Equity									[$-en-US]0.68	[$-en-US]0.33	[$-en-US]0.45	[$-en-US]0.56	[$-en-US]0.55	[$-en-US]0.52	[$-en-US]0.46	[$-en-US]0.51	[$-en-US]0.44	[$-en-US]0.44	[$-en-US]0.40	[$-en-US]0.38	[$-en-US]0.42	[$-en-US]0.44	[$-en-US]0.48	[$-en-US]0.14	[$-en-US]0.11	[$-en-US]0.08	[$-en-US]0.10	[$-en-US]0.11	[$-en-US]0.09	[$-en-US]0.16	[$-en-US]0.14	[$-en-US]0.07	[$-en-US]0.13	[$-en-US]0.06	[$-en-US]0.09	[$-en-US]0.10	[$-en-US]0.15	[$-en-US]0.14	[$-en-US]0.15	[$-en-US]0.12	[$-en-US]0.08	[$-en-US]0.04	[$-en-US]0.04	[$-en-US]0.05	[$-en-US]0.06	[$-en-US]0.08	[$-en-US]0.11	[$-en-US]0.14	[$-en-US]0.22	[$-en-US]0.26	[$-en-US]0.41	[$-en-US]0.37	[$-en-US]0.40
Total Debt to Equity									[$-en-US]0.79	[$-en-US]0.36	[$-en-US]0.48	[$-en-US]0.60	[$-en-US]0.80	[$-en-US]0.65	[$-en-US]0.59	[$-en-US]0.69	[$-en-US]0.60	[$-en-US]0.51	[$-en-US]0.48	[$-en-US]0.46	[$-en-US]0.47	[$-en-US]0.50	[$-en-US]0.54	[$-en-US]0.30	[$-en-US]0.20	[$-en-US]0.11	[$-en-US]0.27	[$-en-US]0.27	[$-en-US]0.22	[$-en-US]0.59	[$-en-US]0.48	[$-en-US]0.34	[$-en-US]0.51	[$-en-US]0.37	[$-en-US]0.38	[$-en-US]0.42	[$-en-US]0.52	[$-en-US]0.65	[$-en-US]0.45	[$-en-US]0.38	[$-en-US]0.41	[$-en-US]0.33	[$-en-US]0.38	[$-en-US]0.28	[$-en-US]0.25	[$-en-US]0.16	[$-en-US]0.17	[$-en-US]0.26	[$-en-US]0.37	[$-en-US]0.46	[$-en-US]0.69	[$-en-US]0.66	[$-en-US]0.65
Long Term Debt to Assets									[$-en-US]0.27	[$-en-US]0.16	[$-en-US]0.19	[$-en-US]0.23	[$-en-US]0.21	[$-en-US]0.21	[$-en-US]0.19	[$-en-US]0.18	[$-en-US]0.17	[$-en-US]0.19	[$-en-US]0.18	[$-en-US]0.17	[$-en-US]0.19	[$-en-US]0.20	[$-en-US]0.20	[$-en-US]0.07	[$-en-US]0.06	[$-en-US]0.05	[$-en-US]0.05	[$-en-US]0.06	[$-en-US]0.05	[$-en-US]0.07	[$-en-US]0.07	[$-en-US]0.03	[$-en-US]0.06	[$-en-US]0.03	[$-en-US]0.05	[$-en-US]0.05	[$-en-US]0.07	[$-en-US]0.05	[$-en-US]0.06	[$-en-US]0.06	[$-en-US]0.04	[$-en-US]0.02	[$-en-US]0.02	[$-en-US]0.03	[$-en-US]0.04	[$-en-US]0.06	[$-en-US]0.07	[$-en-US]0.08	[$-en-US]0.12	[$-en-US]0.14	[$-en-US]0.19	[$-en-US]0.17	[$-en-US]0.19
Debt to Assets									[$-en-US]0.31	[$-en-US]0.18	[$-en-US]0.20	[$-en-US]0.25	[$-en-US]0.30	[$-en-US]0.26	[$-en-US]0.25	[$-en-US]0.24	[$-en-US]0.23	[$-en-US]0.22	[$-en-US]0.21	[$-en-US]0.20	[$-en-US]0.21	[$-en-US]0.23	[$-en-US]0.23	[$-en-US]0.16	[$-en-US]0.11	[$-en-US]0.07	[$-en-US]0.15	[$-en-US]0.15	[$-en-US]0.12	[$-en-US]0.25	[$-en-US]0.23	[$-en-US]0.16	[$-en-US]0.23	[$-en-US]0.18	[$-en-US]0.20	[$-en-US]0.20	[$-en-US]0.23	[$-en-US]0.25	[$-en-US]0.19	[$-en-US]0.19	[$-en-US]0.22	[$-en-US]0.19	[$-en-US]0.21	[$-en-US]0.16	[$-en-US]0.14	[$-en-US]0.11	[$-en-US]0.11	[$-en-US]0.16	[$-en-US]0.20	[$-en-US]0.24	[$-en-US]0.32	[$-en-US]0.31	[$-en-US]0.30
Long Term Debt to Invested Capital									[$-en-US]0.38	[$-en-US]0.24	[$-en-US]0.30	[$-en-US]0.35	[$-en-US]0.30	[$-en-US]0.31	[$-en-US]0.29	[$-en-US]0.30	[$-en-US]0.28	[$-en-US]0.29	[$-en-US]0.27	[$-en-US]0.26	[$-en-US]0.29	[$-en-US]0.29	[$-en-US]0.31	[$-en-US]0.11	[$-en-US]0.09	[$-en-US]0.07	[$-en-US]0.08	[$-en-US]0.08	[$-en-US]0.07	[$-en-US]0.10	[$-en-US]0.10	[$-en-US]0.05	[$-en-US]0.08	[$-en-US]0.04	[$-en-US]0.07	[$-en-US]0.07	[$-en-US]0.10	[$-en-US]0.08	[$-en-US]0.10	[$-en-US]0.09	[$-en-US]0.06	[$-en-US]0.03	[$-en-US]0.03	[$-en-US]0.04	[$-en-US]0.05	[$-en-US]0.07	[$-en-US]0.09	[$-en-US]0.11	[$-en-US]0.16	[$-en-US]0.18	[$-en-US]0.24	[$-en-US]0.22	[$-en-US]0.24
Total Debt to Invested Capital									[$-en-US]0.44	[$-en-US]0.27	[$-en-US]0.32	[$-en-US]0.38	[$-en-US]0.44	[$-en-US]0.40	[$-en-US]0.37	[$-en-US]0.41	[$-en-US]0.37	[$-en-US]0.34	[$-en-US]0.32	[$-en-US]0.31	[$-en-US]0.32	[$-en-US]0.33	[$-en-US]0.35	[$-en-US]0.23	[$-en-US]0.17	[$-en-US]0.10	[$-en-US]0.21	[$-en-US]0.21	[$-en-US]0.18	[$-en-US]0.37	[$-en-US]0.33	[$-en-US]0.25	[$-en-US]0.34	[$-en-US]0.27	[$-en-US]0.27	[$-en-US]0.29	[$-en-US]0.34	[$-en-US]0.39	[$-en-US]0.31	[$-en-US]0.28	[$-en-US]0.29	[$-en-US]0.25	[$-en-US]0.27	[$-en-US]0.22	[$-en-US]0.20	[$-en-US]0.14	[$-en-US]0.15	[$-en-US]0.20	[$-en-US]0.27	[$-en-US]0.32	[$-en-US]0.41	[$-en-US]0.40	[$-en-US]0.39
Equity Multiplier									[$-en-US]2.54	[$-en-US]2.06	[$-en-US]2.34	[$-en-US]2.43	[$-en-US]2.64	[$-en-US]2.50	[$-en-US]2.40	[$-en-US]2.87	[$-en-US]2.58	[$-en-US]2.34	[$-en-US]2.25	[$-en-US]2.27	[$-en-US]2.28	[$-en-US]2.21	[$-en-US]2.35	[$-en-US]1.92	[$-en-US]1.77	[$-en-US]1.62	[$-en-US]1.78	[$-en-US]1.80	[$-en-US]1.79	[$-en-US]2.32	[$-en-US]2.14	[$-en-US]2.08	[$-en-US]2.25	[$-en-US]2.08	[$-en-US]1.89	[$-en-US]2.09	[$-en-US]2.29	[$-en-US]2.54	[$-en-US]2.39	[$-en-US]2.02	[$-en-US]1.90	[$-en-US]1.77	[$-en-US]1.83	[$-en-US]1.78	[$-en-US]1.78	[$-en-US]1.51	[$-en-US]1.52	[$-en-US]1.63	[$-en-US]1.80	[$-en-US]1.89	[$-en-US]2.15	[$-en-US]2.15	[$-en-US]2.16
Financial Health
Current Ratio									[$-en-US]0.91	[$-en-US]1.22	[$-en-US]1.40	[$-en-US]1.35	[$-en-US]0.88	[$-en-US]1.57	[$-en-US]1.35	[$-en-US]1.25	[$-en-US]1.49	[$-en-US]2.58	[$-en-US]2.41	[$-en-US]2.22	[$-en-US]2.10	[$-en-US]2.11	[$-en-US]1.66	[$-en-US]1.59	[$-en-US]2.15	[$-en-US]2.16	[$-en-US]1.65	[$-en-US]1.48	[$-en-US]1.28	[$-en-US]1.34	[$-en-US]1.40	[$-en-US]1.43	[$-en-US]1.37	[$-en-US]1.38	[$-en-US]1.49	[$-en-US]1.15	[$-en-US]1.19	[$-en-US]1.20	[$-en-US]1.37	[$-en-US]1.67	[$-en-US]1.41	[$-en-US]1.42	[$-en-US]1.55	[$-en-US]1.75	[$-en-US]2.10	[$-en-US]2.00	[$-en-US]2.25	[$-en-US]2.25	[$-en-US]2.08	[$-en-US]2.01	[$-en-US]2.01	[$-en-US]1.98	[$-en-US]2.02
Quick Ratio									[$-en-US]0.58	[$-en-US]0.88	[$-en-US]1.10	[$-en-US]0.90	[$-en-US]0.51	[$-en-US]0.95	[$-en-US]1.03	[$-en-US]0.94	[$-en-US]1.16	[$-en-US]2.18	[$-en-US]1.79	[$-en-US]1.48	[$-en-US]1.69	[$-en-US]1.51	[$-en-US]1.12	[$-en-US]1.24	[$-en-US]1.65	[$-en-US]1.70	[$-en-US]1.12	[$-en-US]1.13	[$-en-US]0.88	[$-en-US]1.01	[$-en-US]1.00	[$-en-US]1.03	[$-en-US]0.99	[$-en-US]0.62	[$-en-US]0.62	[$-en-US]0.60	[$-en-US]0.47	[$-en-US]0.65	[$-en-US]0.64	[$-en-US]0.83	[$-en-US]0.80	[$-en-US]0.72	[$-en-US]0.99	[$-en-US]0.84	[$-en-US]1.13	[$-en-US]1.16	[$-en-US]1.28	[$-en-US]1.44	[$-en-US]1.32	[$-en-US]1.21	[$-en-US]1.17	[$-en-US]1.10	[$-en-US]1.19
Cash Ratio									[$-en-US]0.27	[$-en-US]0.54	[$-en-US]0.73	[$-en-US]0.47	[$-en-US]0.26	[$-en-US]0.59	[$-en-US]0.66	[$-en-US]0.57	[$-en-US]0.79	[$-en-US]1.67	[$-en-US]1.39	[$-en-US]1.11	[$-en-US]0.92	[$-en-US]0.98	[$-en-US]0.70	[$-en-US]0.88	[$-en-US]1.17	[$-en-US]1.25	[$-en-US]0.78	[$-en-US]0.75	[$-en-US]0.50	[$-en-US]0.68	[$-en-US]0.63	[$-en-US]0.57	[$-en-US]0.54	[$-en-US]0.22	[$-en-US]0.18	[$-en-US]0.20	[$-en-US]0.08	[$-en-US]0.30	[$-en-US]0.21	[$-en-US]0.39	[$-en-US]0.39	[$-en-US]0.28	[$-en-US]0.28	[$-en-US]0.34	[$-en-US]0.53	[$-en-US]0.34	[$-en-US]0.43	[$-en-US]0.81	[$-en-US]0.64	[$-en-US]0.55	[$-en-US]0.50	[$-en-US]0.45	[$-en-US]0.50
Cash Flow to Debt									[$-en-US]0.20	[$-en-US]0.96	[$-en-US]0.53	[$-en-US]0.20	[$-en-US]0.23	[$-en-US]0.22	[$-en-US]0.36	[$-en-US]0.39	[$-en-US]0.38	[$-en-US]0.42	[$-en-US]0.56	[$-en-US]0.50	[$-en-US]0.43	[$-en-US]0.48	[$-en-US]0.12	[$-en-US]0.83	[$-en-US]1.54	[$-en-US]2.27	[$-en-US]0.96	[$-en-US]0.97	[$-en-US]0.93	[$-en-US]0.88	[$-en-US]1.20	[$-en-US]0.71	[$-en-US]1.20	[$-en-US]1.27	[$-en-US]0.76	[$-en-US]0.71	[$-en-US]0.58	[$-en-US]0.71	[$-en-US]0.58	[$-en-US]0.63	[$-en-US]0.68	[$-en-US]0.63	[$-en-US]0.60
Free Cash Flow to Debt									[$-en-US]0.13	[$-en-US]0.87	[$-en-US]0.46	[$-en-US]0.16	[$-en-US]0.19	[$-en-US]0.17	[$-en-US]0.31	[$-en-US]0.34	[$-en-US]0.34	[$-en-US]0.37	[$-en-US]0.52	[$-en-US]0.46	[$-en-US]0.38	[$-en-US]0.45	[$-en-US]0.09	[$-en-US]0.73	[$-en-US]1.32	[$-en-US]2.06	[$-en-US]0.83	[$-en-US]0.82	[$-en-US]0.74	[$-en-US]0.72	[$-en-US]0.90	[$-en-US]0.36	[$-en-US]0.73	[$-en-US]0.68	[$-en-US]0.50	[$-en-US]0.34	[$-en-US]0.36	[$-en-US]0.41	[$-en-US]0.31	[$-en-US]0.27	[$-en-US]0.34	[$-en-US]0.25	[$-en-US]0.29
Total Debt to EBITDA									[$-en-US]6.80	[$-en-US]0.89	[$-en-US]1.23	[$-en-US]4.04	[$-en-US]2.57	[$-en-US]3.99	[$-en-US]2.21	[$-en-US]2.80	[$-en-US]2.50	[$-en-US]1.98	[$-en-US]1.62	[$-en-US]1.93	[$-en-US]1.91	[$-en-US]2.35	[$-en-US]2.42	[$-en-US]1.15	[$-en-US]0.63	[$-en-US]0.60	[$-en-US]0.99	[$-en-US]0.96	[$-en-US]1.92	[$-en-US]0.88	[$-en-US]0.65	[$-en-US]0.91	[$-en-US]0.68	[$-en-US]0.64	[$-en-US]1.00	[$-en-US]1.08	[$-en-US]1.24	[$-en-US]1.07	[$-en-US]2.08	[$-en-US]1.03	[$-en-US]1.48	[$-en-US]1.10	[$-en-US]1.30	[$-en-US]0.83	[$-en-US]0.65	[$-en-US]0.48	[$-en-US]0.57	[$-en-US]0.78	[$-en-US]1.07	[$-en-US]1.59	[$-en-US]2.08	[$-en-US]2.00	[$-en-US]2.09
Interest Coverage									[$-en-US]0.74	[$-en-US]28.85	[$-en-US]19.80	[$-en-US]5.81	[$-en-US]8.05	[$-en-US]3.48	[$-en-US]10.38	[$-en-US]7.65	[$-en-US]8.08	[$-en-US]9.69	[$-en-US]11.83	[$-en-US]8.14	[$-en-US]7.56	[$-en-US]6.05	[$-en-US]9.18	[$-en-US]17.29
EBITDA Interest Coverage									[$-en-US]3.59	[$-en-US]32.94	[$-en-US]23.82	[$-en-US]9.10	[$-en-US]11.71	[$-en-US]8.15	[$-en-US]15.32	[$-en-US]12.50	[$-en-US]12.39	[$-en-US]13.76	[$-en-US]16.36	[$-en-US]13.16	[$-en-US]12.93	[$-en-US]10.72	[$-en-US]13.03	[$-en-US]27.16
Capital Expenditure to EBITDA									[$-en-US]0.49	[$-en-US]0.08	[$-en-US]0.09	[$-en-US]0.17	[$-en-US]0.11	[$-en-US]0.20	[$-en-US]0.11	[$-en-US]0.13	[$-en-US]0.10	[$-en-US]0.08	[$-en-US]0.06	[$-en-US]0.07	[$-en-US]0.09	[$-en-US]0.08	[$-en-US]0.07	[$-en-US]0.12	[$-en-US]0.14	[$-en-US]0.12	[$-en-US]0.13	[$-en-US]0.14	[$-en-US]0.36	[$-en-US]0.14	[$-en-US]0.19	[$-en-US]0.32	[$-en-US]0.32	[$-en-US]0.38	[$-en-US]0.27	[$-en-US]0.40	[$-en-US]0.26	[$-en-US]0.31	[$-en-US]0.57	[$-en-US]0.38	[$-en-US]0.50	[$-en-US]0.41	[$-en-US]0.41	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00
Capital Expenditure to Sales									[$-en-US]0.07	[$-en-US]0.03	[$-en-US]0.03	[$-en-US]0.05	[$-en-US]0.05	[$-en-US]0.05	[$-en-US]0.04	[$-en-US]0.04	[$-en-US]0.03	[$-en-US]0.03	[$-en-US]0.03	[$-en-US]0.03	[$-en-US]0.03	[$-en-US]0.02	[$-en-US]0.02	[$-en-US]0.04	[$-en-US]0.04	[$-en-US]0.05	[$-en-US]0.04	[$-en-US]0.05	[$-en-US]0.06	[$-en-US]0.05	[$-en-US]0.07	[$-en-US]0.07	[$-en-US]0.09	[$-en-US]0.08	[$-en-US]0.08	[$-en-US]0.12	[$-en-US]0.07	[$-en-US]0.08	[$-en-US]0.08	[$-en-US]0.09	[$-en-US]0.09	[$-en-US]0.09	[$-en-US]0.08	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00
Altman Z-score (TTM)									[$-en-US]2.40	[$-en-US]3.87	[$-en-US]3.58	[$-en-US]2.43	[$-en-US]2.76	[$-en-US]3.04	[$-en-US]2.42	[$-en-US]2.09	[$-en-US]2.40	[$-en-US]2.70	[$-en-US]2.63	[$-en-US]2.24	[$-en-US]2.07	[$-en-US]1.82	[$-en-US]1.72	[$-en-US]2.83	[$-en-US]3.41	[$-en-US]4.55	[$-en-US]3.76	[$-en-US]3.52	[$-en-US]4.17	[$-en-US]7.02	[$-en-US]10.02	[$-en-US]12.61	[$-en-US]9.01	[$-en-US]12.60	[$-en-US]10.28	[$-en-US]6.52	[$-en-US]5.37	[$-en-US]4.67	[$-en-US]4.46	[$-en-US]5.22	[$-en-US]5.61	[$-en-US]4.11	[$-en-US]4.26	[$-en-US]4.29	[$-en-US]3.92	[$-en-US]6.11	[$-en-US]5.99	[$-en-US]5.40	[$-en-US]4.26	[$-en-US]4.19	[$-en-US]3.47	[$-en-US]3.61	[$-en-US]3.27
Dividend Metrics
Dividend Payout									[$-en-US]4.43	[$-en-US]0.29	[$-en-US]0.40	[$-en-US]1.29	[$-en-US]0.76	[$-en-US]2.13	[$-en-US]0.36	[$-en-US]1.03	[$-en-US]1.01	[$-en-US]0.74	[$-en-US]0.58	[$-en-US]0.73	[$-en-US]0.81	[$-en-US]0.70	[$-en-US]0.65	[$-en-US]1.08	[$-en-US]0.98	[$-en-US]0.63	[$-en-US]0.75	[$-en-US]0.44	[$-en-US]2.73	[$-en-US]0.37	[$-en-US]0.40	[$-en-US]0.64	[$-en-US]0.39	[$-en-US]1.49	[$-en-US]1.28	[$-en-US]2.67	[$-en-US]0.42	[$-en-US]0.46	[$-en-US]9.88	[$-en-US]5.48	[$-en-US]7.33	[$-en-US]12.00	[$-en-US]13.74	[$-en-US]10.51	[$-en-US]10.56	[$-en-US]10.26	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00
Normalized Dividend Payout									[$-en-US]0.89	[$-en-US]0.24	[$-en-US]0.38	[$-en-US]0.68	[$-en-US]0.49	[$-en-US]0.82	[$-en-US]0.48	[$-en-US]0.50	[$-en-US]0.51	[$-en-US]0.46	[$-en-US]0.43	[$-en-US]0.42	[$-en-US]0.37	[$-en-US]0.33	[$-en-US]0.46	[$-en-US]0.82	[$-en-US]0.80	[$-en-US]0.56	[$-en-US]0.55	[$-en-US]0.36	[$-en-US]0.70	[$-en-US]0.36	[$-en-US]0.36	[$-en-US]0.42	[$-en-US]0.38	[$-en-US]1.49	[$-en-US]1.28	[$-en-US]2.67	[$-en-US]0.42	[$-en-US]0.46	[$-en-US]9.88	[$-en-US]5.48	[$-en-US]7.33	[$-en-US]12.00	[$-en-US]13.74	[$-en-US]10.51	[$-en-US]10.56	[$-en-US]10.26	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00	[$-en-US]0.00
Reinvestment Rate									-7.38%	25.77%	18.61%	1.12%	12.96%	4.58%	22.22%	-0.20%	0.10%	3.35%	19.79%	9.89%	4.30%	2.83%	4.49%	-0.83%	0.20%	18.04%	3.78%	9.89%	-0.91%	31.13%	28.72%	8.74%	19.77%	0.10%	-1.77%	-7.07%	18.77%	18.40%	-11.50%	-8.24%	-7.41%	-7.53%	-7.64%	-7.29%	-7.34%	-7.69%	0.84%	0.89%	0.91%	0.37%	0.36%	0.34%	0.36%
Normalized Reinvestment Rate									1.29%	33.11%	20.35%	6.33%	14.08%	2.83%	13.72%	11.95%	10.17%	10.46%	11.19%	11.32%	12.49%	13.37%	9.71%	2.98%	3.11%	7.99%	6.92%	12.90%	4.08%	31.26%	28.70%	18.85%	20.15%	-3.56%	-2.30%	-7.58%	18.39%	18.40%	-11.50%	-7.79%	-7.48%	-7.57%	-7.64%	-7.29%	-7.34%	-7.69%	0.84%	0.89%	0.91%	0.37%	0.36%	0.34%	0.36%
Retention Rate									-343.24%	70.75%	60.31%	-28.81%	23.81%	-112.50%	63.64%	-2.56%	-0.90%	26.24%	41.82%	26.67%	19.19%	30.10%	34.96%	-7.56%	1.69%	36.84%	25.49%	56.01%	-172.73%	62.59%	60.36%	35.71%	61.19%	-48.94%	-28.38%	-166.67%	57.92%	53.54%	-888.21%	-447.56%	-633.33%	-1,100.05%	-1,273.93%	-950.90%	-956.05%	-925.95%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Normalized Retention Rate									10.87%	75.68%	61.58%	31.53%	51.19%	18.07%	51.70%	50.00%	49.09%	53.98%	56.76%	58.10%	63.30%	66.97%	53.67%	18.19%	20.36%	44.09%	44.52%	64.14%	30.38%	64.46%	63.86%	58.15%	61.64%	-48.94%	-28.38%	-166.67%	57.92%	53.54%	-888.21%	-447.56%	-633.33%	-1,100.05%	-1,273.93%	-950.90%	-956.05%	-925.95%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Sustainable Growth Rate									-7.74%	25.53%	19.09%	-2.99%	4.12%	-6.28%	22.04%	-0.30%	-0.10%	3.15%	6.02%	2.95%	1.72%	2.84%	4.47%	-0.94%	0.20%	5.90%	2.91%	9.09%	-5.67%	29.96%	25.61%	9.30%	30.89%	-18.88%	-8.07%	-47.57%	18.27%	17.44%	-138.60%	-96.67%	-90.76%	-183.14%	-196.38%	-183.89%	-180.84%	-192.71%	21.42%	21.77%	21.41%	18.21%	16.78%	17.05%	16.83%
Momentum
Normalized EBITDA Momentum									-17.05%	0.30%	14.78%	42.53%	-4.21%	-19.05%	-6.91%	15.13%	-0.32%	-6.61%	93.29%	-22.98%	-8.71%	23.07%	4.50%	-13.14%	4.45%	-3.26%	-0.93%	4.88%	-1.50%	11.29%	0.23%	-36.81%	-9.71%	-69.62%	10.34%	-6.17%	5.47%	5.15%	-0.61%	32.88%	-17.09%
Cash Flow Momentum									-45.48%	6.66%	12.72%	88.68%	9.79%	-40.86%	-12.40%	10.92%	3.51%	-10.39%	4.98%	8.74%	-15.49%	181.14%	-63.64%	-21.93%	-34.98%	47.13%	-3.40%	-1.77%	9.17%	8.11%	10.68%	-44.52%	-21.84%	-50.98%	72.08%	11.63%	0.61%	32.26%	-13.07%	-7.43%	15.42%
Dividend Momentum									0.61%	0.63%	0.65%	1.33%	1.41%	1.49%	1.59%	1.69%	1.82%	1.96%	2.13%	2.33%	2.56%	2.86%	-16.67%	2.40%	4.50%	5.49%	2.70%	3.28%	3.45%	4.00%	4.76%	2.86%	5.76%	2.68%	3.04%	3.45%	2.44%	2.76%	3.09%	2.75%	2.33%	2.15%	2.35%	2.59%	2.19%	33.33%
EBITDA Momentum									-53.34%	3.83%	11.58%	181.42%	8.23%	-48.66%	1.42%	9.77%	-11.96%	-6.48%	4.60%	3.08%	5.07%	5.72%	-1.26%	-17.75%	9.75%	-7.40%	2.86%	9.43%	-17.31%	12.18%	2.67%	-39.83%	-10.64%	-69.62%	10.34%	-6.17%	5.47%	5.15%	-0.61%	32.88%	-17.09%
Sales Momentum									-13.46%	0.55%	17.47%	29.70%	2.98%	-23.04%	0.35%	-0.22%	2.44%	-0.27%	2.42%	4.86%	-4.43%	-2.09%	4.67%	-0.90%	1.93%	0.78%	3.04%	-4.60%	6.12%	11.90%	-6.38%	-37.67%	-25.22%	-62.37%	14.41%	-9.73%	5.10%	4.24%	0.89%	1.44%	0.92%	4.80%	2.14%	1.84%	2.16%	1.89%	2.26%
Earnings per Share Momentum									-79.78%	4.79%	14.91%	35.63%	-33.68%	-83.76%	118.63%	15.84%	-17.16%	-12.96%	13.79%	1.69%	-20.16%	43.06%	3.36%	-23.23%	18.00%	-7.88%	3.03%	20.17%	-55.10%	13.01%	-0.89%	-5.08%	33.90%	-7.27%	20.46%	-82.21%	12.23%	1,124.74%	0.10%	35.00%	-10.00%	17.63%	-11.11%	0.00%	-5.56%	6.67%	0.00%
Other Ratios
Free Cash Flow to Sales									[$-en-US]0.12	[$-en-US]0.32	[$-en-US]0.21	[$-en-US]0.21	[$-en-US]0.22	[$-en-US]0.17	[$-en-US]0.25	[$-en-US]0.27	[$-en-US]0.25	[$-en-US]0.28	[$-en-US]0.38	[$-en-US]0.32	[$-en-US]0.26	[$-en-US]0.31	[$-en-US]0.07	[$-en-US]0.24	[$-en-US]0.25	[$-en-US]0.47	[$-en-US]0.28	[$-en-US]0.30	[$-en-US]0.23	[$-en-US]0.25	[$-en-US]0.22	[$-en-US]0.07	[$-en-US]0.14	[$-en-US]0.10	[$-en-US]0.15	[$-en-US]0.11	[$-en-US]0.12	[$-en-US]0.11	[$-en-US]0.09	[$-en-US]0.07	[$-en-US]0.09	[$-en-US]0.06	[$-en-US]0.07
Free Cash Flow to Net Income									[$-en-US]3.21	[$-en-US]1.01	[$-en-US]0.78	[$-en-US]1.30	[$-en-US]0.83	[$-en-US]1.83	[$-en-US]0.62	[$-en-US]1.95	[$-en-US]1.79	[$-en-US]1.52	[$-en-US]1.72	[$-en-US]1.96	[$-en-US]2.01	[$-en-US]2.44	[$-en-US]0.40	[$-en-US]1.45	[$-en-US]1.46	[$-en-US]2.05	[$-en-US]1.77	[$-en-US]1.33	[$-en-US]6.36	[$-en-US]0.88	[$-en-US]0.85	[$-en-US]0.59	[$-en-US]0.79	[$-en-US]0.70	[$-en-US]0.79	[$-en-US]0.60	[$-en-US]0.77	[$-en-US]0.73	[$-en-US]1.08	[$-en-US]0.46	[$-en-US]0.83	[$-en-US]0.46	[$-en-US]0.62
Free Cash Flow to Assets									[$-en-US]0.03	[$-en-US]0.17	[$-en-US]0.10	[$-en-US]0.05	[$-en-US]0.05	[$-en-US]0.04	[$-en-US]0.08	[$-en-US]0.08	[$-en-US]0.08	[$-en-US]0.08	[$-en-US]0.11	[$-en-US]0.10	[$-en-US]0.08	[$-en-US]0.10	[$-en-US]0.02	[$-en-US]0.10	[$-en-US]0.11	[$-en-US]0.20	[$-en-US]0.12	[$-en-US]0.12	[$-en-US]0.11	[$-en-US]0.19	[$-en-US]0.17	[$-en-US]0.07	[$-en-US]0.18	[$-en-US]0.14	[$-en-US]0.11	[$-en-US]0.08	[$-en-US]0.10	[$-en-US]0.09	[$-en-US]0.07	[$-en-US]0.05	[$-en-US]0.07	[$-en-US]0.04	[$-en-US]0.05
Free Cash Flow to Equity									[$-en-US]0.07	[$-en-US]0.36	[$-en-US]0.24	[$-en-US]0.13	[$-en-US]0.14	[$-en-US]0.10	[$-en-US]0.21	[$-en-US]0.22	[$-en-US]0.18	[$-en-US]0.18	[$-en-US]0.25	[$-en-US]0.22	[$-en-US]0.18	[$-en-US]0.23	[$-en-US]0.05	[$-en-US]0.18	[$-en-US]0.17	[$-en-US]0.33	[$-en-US]0.20	[$-en-US]0.22	[$-en-US]0.21	[$-en-US]0.42	[$-en-US]0.36	[$-en-US]0.15	[$-en-US]0.40	[$-en-US]0.27	[$-en-US]0.22	[$-en-US]0.17	[$-en-US]0.24	[$-en-US]0.23	[$-en-US]0.17	[$-en-US]0.10	[$-en-US]0.12	[$-en-US]0.08	[$-en-US]0.10
Book Value to EBITDA									[$-en-US]12.14	[$-en-US]2.13	[$-en-US]2.31	[$-en-US]4.87	[$-en-US]3.36	[$-en-US]6.45	[$-en-US]3.17	[$-en-US]4.23	[$-en-US]4.54	[$-en-US]4.06	[$-en-US]3.42	[$-en-US]4.07	[$-en-US]4.03	[$-en-US]4.58	[$-en-US]4.20	[$-en-US]4.62	[$-en-US]4.74	[$-en-US]3.76	[$-en-US]4.06	[$-en-US]3.64	[$-en-US]6.81	[$-en-US]1.49	[$-en-US]1.62	[$-en-US]2.11	[$-en-US]1.25	[$-en-US]1.61	[$-en-US]2.23	[$-en-US]2.14	[$-en-US]1.85	[$-en-US]1.85	[$-en-US]3.81	[$-en-US]2.82	[$-en-US]4.25	[$-en-US]3.64	[$-en-US]3.95	[$-en-US]3.16	[$-en-US]3.12	[$-en-US]2.86	[$-en-US]2.69	[$-en-US]2.51	[$-en-US]2.58	[$-en-US]2.82	[$-en-US]3.09	[$-en-US]3.04	[$-en-US]3.22
Book Value to EBIT									[$-en-US]58.62	[$-en-US]2.44	[$-en-US]2.78	[$-en-US]7.63	[$-en-US]4.89	[$-en-US]15.11	[$-en-US]4.68	[$-en-US]6.91	[$-en-US]6.95	[$-en-US]5.77	[$-en-US]4.74	[$-en-US]6.59	[$-en-US]6.90	[$-en-US]8.12	[$-en-US]5.97	[$-en-US]7.25	[$-en-US]7.39	[$-en-US]5.28	[$-en-US]6.16	[$-en-US]5.03	[$-en-US]15.22	[$-en-US]1.62	[$-en-US]1.78	[$-en-US]2.47	[$-en-US]1.42	[$-en-US]1.91	[$-en-US]2.56	[$-en-US]2.45	[$-en-US]2.15	[$-en-US]2.15	[$-en-US]4.96	[$-en-US]3.30	[$-en-US]5.36	[$-en-US]4.38	[$-en-US]4.84	[$-en-US]3.72	[$-en-US]3.62	[$-en-US]3.30	[$-en-US]3.09	[$-en-US]2.91	[$-en-US]3.01	[$-en-US]3.39	[$-en-US]3.78	[$-en-US]3.70	[$-en-US]3.94
Book Value to Revenue									[$-en-US]1.65	[$-en-US]0.87	[$-en-US]0.87	[$-en-US]1.54	[$-en-US]1.52	[$-en-US]1.69	[$-en-US]1.17	[$-en-US]1.19	[$-en-US]1.38	[$-en-US]1.53	[$-en-US]1.54	[$-en-US]1.49	[$-en-US]1.44	[$-en-US]1.35	[$-en-US]1.35	[$-en-US]1.34	[$-en-US]1.42	[$-en-US]1.42	[$-en-US]1.40	[$-en-US]1.37	[$-en-US]1.11	[$-en-US]0.59	[$-en-US]0.61	[$-en-US]0.49	[$-en-US]0.36	[$-en-US]0.36	[$-en-US]0.66	[$-en-US]0.63	[$-en-US]0.49	[$-en-US]0.48	[$-en-US]0.56	[$-en-US]0.70	[$-en-US]0.73	[$-en-US]0.75	[$-en-US]0.78	[$-en-US]0.76	[$-en-US]0.74	[$-en-US]0.71	[$-en-US]0.67	[$-en-US]0.61	[$-en-US]0.56	[$-en-US]0.53	[$-en-US]0.50	[$-en-US]0.49	[$-en-US]0.51
Book Value to Net Income									[$-en-US]44.35	[$-en-US]2.77	[$-en-US]3.16	[$-en-US]9.63	[$-en-US]5.77	[$-en-US]17.92	[$-en-US]2.89	[$-en-US]8.67	[$-en-US]9.66	[$-en-US]8.33	[$-en-US]6.94	[$-en-US]9.04	[$-en-US]11.15	[$-en-US]10.61	[$-en-US]7.82	[$-en-US]8.04	[$-en-US]8.35	[$-en-US]6.24	[$-en-US]8.75	[$-en-US]6.16	[$-en-US]30.48	[$-en-US]2.09	[$-en-US]2.36	[$-en-US]3.84	[$-en-US]1.98	[$-en-US]2.59	[$-en-US]3.52	[$-en-US]3.50	[$-en-US]3.17	[$-en-US]3.07	[$-en-US]6.41	[$-en-US]4.63	[$-en-US]6.98	[$-en-US]6.01	[$-en-US]6.49	[$-en-US]5.17	[$-en-US]5.29	[$-en-US]4.81	[$-en-US]4.67	[$-en-US]4.59	[$-en-US]4.67	[$-en-US]5.49	[$-en-US]5.96	[$-en-US]5.86	[$-en-US]5.94
© PitchBook Data, Inc. 2024
Public Fundamental Data provided by Morningstar, Inc.

Estimates

Estimates (Fiscal Year)
Downloaded On: 18-Apr-2024
Company: Pfizer (Pharmaceuticals) (NYS: PFE)	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Amounts in Thousands, USD (except Ratios, Multiples & per share items)
Total Revenue
Actual				58,496,000	100,330,000	81,288,000	41,651,000	40,905,000
Median	62,949,000	62,549,000	60,141,610	58,726,771	100,242,098	81,653,459	47,842,500	51,753,000
High	66,630,000	65,000,000	60,888,000	60,845,000	102,005,000	83,353,000	49,587,273	51,960,563
Low	58,677,000	58,267,000	58,500,000	57,980,000	99,500,000	81,093,000	46,780,000	51,034,000
Mean	63,180,224	62,545,810	60,040,935	58,777,744	100,342,364	81,764,526	47,937,770	51,679,936
Standard Deviation	1,949,621	1,506,767	717,633	611,629	627,521	574,212	1,109,774	289,955
Number of Estimates	19	20	20	20	16	19	6	10
Total Gross Profit
Actual				33,542,000	65,986,000	50,467,000	33,167,000	32,851,000
Median	46,414,085	45,636,000	42,726,595	34,203,500	66,653,000	50,670,000	33,315,000	41,720,000
High	49,241,000	47,137,000	43,603,000	35,042,000	67,493,000	50,671,000	33,316,000	41,720,000
Low	45,230,000	44,778,000	41,236,000	33,421,000	66,211,000	50,467,000	33,216,000	41,719,000
Mean	46,936,896	45,734,334	42,637,024	34,255,250	66,798,833	50,632,556	33,292,429	41,719,800
Standard Deviation	1,548,275	826,208	768,515	463,930	574,839	68,529	36,878	447
Number of Estimates	8	8	8	8	6	9	7	5
Normalized EBITDA
Actual				22,956,000	47,449,000	35,014,000	17,657,000	17,224,000
Median	20,887,000	20,530,000	18,896,000	10,127,000	41,532,811	30,657,500	16,794,000	21,287,500
High	20,887,000	20,530,000	18,896,000	10,127,000	42,361,000	31,749,000	18,971,000	21,480,000
Low	20,887,000	20,530,000	18,896,000	10,127,000	40,704,621	29,566,000	14,617,000	21,095,000
Mean	20,887,000	20,530,000	18,896,000	10,127,000	41,532,811	30,657,500	16,794,000	21,287,500
Standard Deviation					1,171,237	1,543,614	3,078,743	272,236
Number of Estimates	1	1	1	1	2	2	2	2
EBITDA
Actual				7,933,000	40,780,000	30,757,000	13,189,000	18,424,000
Median	22,600,711	22,427,363	19,388,439	10,076,726	42,515,581	29,526,500	16,114,000	23,609,485
High	29,260,592	27,057,555	23,438,000	14,188,070	49,295,995	32,788,550	19,535,000	23,609,485
Low	19,398,302	19,333,133	16,597,000	7,300,000	40,704,621	23,862,000	12,659,000	23,609,485
Mean	22,991,227	22,255,873	19,561,331	10,527,741	43,478,338	29,296,605	16,345,200	23,609,485
Standard Deviation	3,018,342	2,357,332	1,916,241	2,293,394	2,579,291	3,304,555	2,538,445
Number of Estimates	11	12	12	12	10	8	7	1
EBIT
Actual				1,643,000	35,716,000	25,566,000	8,412,000	12,669,000
Median	19,785,531	19,049,822	16,750,000	8,400,828	40,707,320	27,547,204	13,141,000	19,690,700
High	24,157,000	22,282,788	18,321,289	10,164,000	42,780,123	29,875,000	14,773,000	21,067,700
Low	17,242,255	17,257,978	14,586,000	7,512,000	39,813,000	27,356,000	13,024,000	19,419,000
Mean	20,093,406	19,258,789	16,613,063	8,459,737	40,864,200	27,817,750	13,336,875	19,761,138
Standard Deviation	1,705,139	1,293,658	1,021,447	731,638	659,907	684,240	593,667	544,762
Number of Estimates	17	19	19	18	16	13	8	8
Free Cash Flow
Actual				6,966,000	31,670,000	17,408,000	8,635,000	8,872,000
Median	13,807,000	12,374,000	8,475,000	9,313,636	36,389,000	27,778,000	10,236,000	17,976,500
High	18,156,420	15,721,200	11,288,000	11,997,000	38,697,251	31,719,000	12,151,000	23,656,000
Low	9,053,663	8,838,848	7,391,257	7,373,000	36,011,000	23,837,000	8,334,000	12,297,000
Mean	13,706,021	12,327,012	8,907,314	9,499,318	37,032,417	27,778,000	10,240,333	17,976,500
Standard Deviation	3,784,044	2,847,187	1,714,842	1,928,913	1,454,123	5,573,416	1,908,504	8,032,026
Number of Estimates	4	4	4	4	3	2	3	2
Capital Expenditure
Median	3,085,895	3,027,750	3,117,050	3,236,000	2,827,000	2,318,000	2,252,000	1,985,000
High	4,057,000	4,007,000	3,957,000	3,800,000	3,534,348	4,349,000	2,430,000	2,070,000
Low	1,838,255	1,859,209	1,872,884	1,813,049	2,710,000	1,439,000	1,922,000	1,960,000
Mean	2,927,132	2,912,205	2,912,673	2,905,882	3,012,519	2,816,148	2,206,400	2,000,000
Standard Deviation	845,392	826,787	822,273	794,197	336,503	1,032,263	184,366	49,666
Number of Estimates	10	10	10	9	8	7	5	4
Diluted EPS (Normalized)
Actual				1.84	6.58	4.06	2.22	2.95
Median	2.87	2.75	2.22	1.55	6.50	4.20	2.85	2.98
High	3.68	3.21	2.46	1.64	6.60	4.32	2.92	2.99
Low	2.43	2.22	2.05	1.45	6.40	3.96	2.69	2.94
Mean	2.89	2.74	2.22	1.55	6.50	4.21	2.82	2.97
Standard Deviation	0.31	0.26	0.10	0.06	0.06	0.08	0.09	0.02
Number of Estimates	19	21	21	20	18	20	9	12
Diluted EPS
Actual				0.37	5.47	3.85	1.63	2.82
Median	2.55	2.29	1.58	0.54	5.86	3.85	2.05	3.19
High	3.30	2.85	2.29	0.68	6.64	3.85	3.11	3.39
Low	1.79	1.71	1.29	0.49	5.48	3.85	1.62	2.98
Mean	2.47	2.30	1.70	0.56	6.05	3.85	2.18	3.19
Standard Deviation	0.52	0.41	0.36	0.09	0.49		0.51	0.29
Number of Estimates	9	10	11	4	7	1	6	2
Diluted EPS from Continuing Operations
Actual				0.37	5.47	3.93	1.18	1.89
Operating Cash Flow per Share
Actual				1.93	6.09	3.52	1.93	1.92
Median	2.83	2.81	2.15	1.89	7.37	5.31	2.68	3.68
High	3.75	3.66	3.44	3.56	7.86	5.94	3.22	3.94
Low	2.57	2.27	1.98	1.08	6.38	3.47	1.26	3.41
Mean	3.00	2.99	2.46	2.07	7.15	5.01	2.39	3.68
Standard Deviation	0.52	0.62	0.60	0.93	0.63	0.93	1.01	0.37
Number of Estimates	4	5	5	6	5	5	3	2
Dividend per Share
Actual				1.64	1.60	1.56	1.52	1.44
Median	1.76	1.72	1.68	1.64	1.61	1.58	1.52	1.44
High	1.97	1.93	1.85	1.77	1.69	1.75	1.53	1.45
Low	1.64	1.64	1.64	1.60	1.57	1.53	1.42	1.44
Mean	1.77	1.74	1.70	1.65	1.62	1.59	1.51	1.44
Standard Deviation	0.09	0.09	0.06	0.05	0.04	0.06	0.04	0.01
Number of Estimates	8	9	9	10	8	9	8	7
© PitchBook Data, Inc. 2024
Public Fundamental Data provided by Morningstar, Inc.

Sourcing

		Public Fundamental Data provided by Morningstar, Inc.
		©2024		www.pitchbook.com

http://www.pitchbook.com

Disclaimer

All data copyright PitchBook Data, Inc.
For customized data reports and analyses, contact us at:
[email protected]
This document and its contents may only be used or shared as permitted in	the PitchBook subscription agreement.		Subject to limited exceptions, this document may not be used or stored following the termination of your agreement with PitchBook.
If you have any further questions or concerns, please contact client services at +1 (206) 257-7775 or by email at		[email protected]
© PitchBook Data, Inc. 2024

[email protected] https://pitchbook.com/subscription-agreement [email protected]

Business & Finance finance assignment

Key Metrics

Income Statement

Balance Sheet

Cash Flow

Segments

Ratios

Estimates

Sourcing

Disclaimer

image1.png

image2.png